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Abstract
Kaposi’s sarcoma associated herpesvirus (KSHV), is a gammaherpesvirus from the 
Herpesviridae family and causes a number of proliferative diseases such as Kaposi 
sarcoma, primary effusion lymphoma and Castleman disease. The prime effectors of the 
cell proliferation occurring during KSHV infections are the latent gene products LANA, 
vCyclin and vFLIP. The analysis of the mRNA latent gene transcripts produced by 
KSHV showed no monocistronic transcript encoding vFLIP suggesting its expression 
was regulated by a non-canonical translation mechanism. Indeed, previous studies 
proposed that an 1RES element located within the vCyclin ORF is responsible for vFLIP 
expression. We have now shown that a minimum fragment of 252 nt of within the 
vCyclin ORF and directly upstream of vFLIP can function as 1RES. The KSHV 1RES 
252 fragment showed 1RES activity in Rabbit Reticulocyte Lysate (RRL) but not in KS- 
derived cell lines. Due to lack of information on the mechanism of internal initiation 
mediated by the KSHV 1RES, we have analyzed the role of eIF4A, eIF4E and eIF4G for 
the 1RES function in RRL. Surprisingly, the KSHV 1RES require the whole eIF4F 
complex for it to function. In addition, several 1RES framj-acting factors (ITAFs) have 
been shown to interact with KSHV 1RES by Mass spectrometry analysis. These are Y- 
box protein 1 (YB-1), eukaryotic translation elongation factor la  (EEF1A1 and 
EEF1A2), heterogenous nuclear ribonucleoprotein K (hnRPK), heterogenous nuclear 
ribonucleoprotein C1/C2 (hnRP C1/C2), and Poly(rc) binding protein 1 (PCBP1). 
Although the interaction between the KSHV 1RES and ITAFs has yet to be confirmed 
by direct interaction studies, analysis on the YB-1 showed an interaction with KSHV 
1RES based on Western blot result. With several ITAFs interacting with the KSHV
IRES and the requirement for eIF4F, we then characterized the RNA secondary structure 
of the KSHV 1RES in solution to understand how the 1RES structure could coordinate 
such interactions. Chemical and enzymatic probing, combined with structure folding 
prediction using Mfold revealed 3 domains with domain I is the most structured domain. 
In search of structure similarities among IRESes, X-linked inhibitor of apoptosis (XIAP) 
was found to be the closest, although the XIAP 1RES contains only two domains. The 
two IRESes also share similarities for a polypyrimidine sequence located in domain II. 
For the first time, we have showed the requirements of the KSHV 1RES for canonical, 
non-canonical initiation factors and preliminary prediction of secondary structure which 
shows that the KSHV 1RES does not belong to any existing functional groups of IRESes 
and a novel DNA virus 1RES.
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Chapter 1 
Introduction
1.1 Kaposi’s Sarcoma Associated Herpesvirus (KSHV)
1.1.1 Herpesviridae
The family Herpesviridae comprises over 100 viruses that infect a wide range of 
vertebrates, including fish, amphibians, reptiles, birds, marsupials and mammals, 
including humans (Minson, 2001; Roizman et ah, 1992). Herpesviruses are among the 
largest and most widely distributed group of large DNA viruses. The virus shares a 
common virion structure although they vary in host range, genome size and molecular 
composition. The virion structure consists of four basic elements which are double­
stranded DNA (dsDNA) core, an icosahedral capsid shell, a proteinaceous tegument 
compartment and a glycoprotein-decorated lipid envelope. The core of the mature virion 
consists of dsDNA arranged as closely packed cells (Zhou et ah, 1999). The dsDNA 
core is enclosed and protected by a 120-130 nm diameter rigid icosahedral capsid, 
surrounding this capsid is a layer of tegument proteins. Finally a lipid bilayer envelope 
wraps the tegument and consists of spikes of viral glycoproteins, giving an overall 
diameter of around 100 to 150 nm (Figure 1.1 and Figure 1.2).
These viruses are ubiquitous and highly successful parasites, but each is usually 
restricted in natural infection to a single species spreading from host to host by direct 
contact or by the respiratory route. Herpesviruses infecting reptiles, birds and mammals 
are grouped together within the family Herpesviridae (Table 1.1) in the subfamilies 
Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae (McGeoch et ah,
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2006). Phylogenetically more distant are the herpesviruses infecting amphibians and 
fish, which are included in the new family Alloherpesviridae. The single herpesvirus 
identified in oyster constitutes currently the only member of the Malacoherpesviridae 
(Davison et ah, 2005; McGeoch et ah, 2006).
1.1.2 Kaposi’s sarcoma-associated herpesvirus (KSHV)
Kaposi Sarcoma was discovered by a Hungarian dermatologist, Dr. Moritz Kaposi, who 
described the classical form of KS as “idiopathic multiple pigmented sarcoma of the 
skin” in 1872 (Kaposi, 1872). It was thought that an infectious agent was responsible for 
KS in 1950s. In 1972, a herpesvirus-like particle was identified in a tissue culture of 
Kaposi’s sarcoma (Giraldo et ah, 1972). A new human herpesvirus 8 (HHV-8) also 
known as Kaposi’s sarcoma-associated herpesvirus (KSHV) from an AIDS-KS lesion, 
was then identified using a representational difference analysis, a PCR-based subtractive 
hybridization method, which showed the presence of unique herpesviral sequences in the 
KS tissues in 1994 (Chang et ah, 1994). Initial analysis allowed KSHV to be classified 
as a gammaherpesvirus (genus Rhadinovirus) (Moore et ah, 1996) with sequence 
similarity to several other oncogenic gammaherpesviruses, including herpesvirus saimiri 
(HVS) and Epstein-Barr virus (EBV). These herpesviruses are transforming agents that 
cause tumours in their hosts or in experimental animals. The genome of KSHV was 
subsequently mapped and sequenced using cosmid and lambda phage genomic libraries 
from primary effusion lymphoma-derived (PEL) cell line, BC-1, stably coinfected with 
KSHV and Epstein-Barr virus (Russo et ah, 1996).
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Taxonomy of the Herpesviridae
Genus Viruses
Gammaherpesvirinae
Lymphocryptovirus -  Human herpesvirus 4 (Epstein-Barr 
virus)
Rhadinovirus -  Human herpesvirus 8 (Kaposi‘s Sarcoma 
associated herpesvirus)
Betaherpesvirinae
Varicellovirus -  Human herpesvirus 3 (Varicella-zoster 
virus)
Cytomegalovirus -  (Human herpesvirus 5 
(Cytomegalovirus)
Roseolovirus -  Human herpesvirus 6 (Human B 
lymphotropic virus)
Alphaherpesvirinae
Molluscipoxyvirus -  Molluscum contagiosum virus 
Yatapoxyvirus -  Yaba monkey tumour virus, tanapox 
virus
Simplexvirus -  Human herpesvirus 1 (Herpes simplex 
virus type 1)
Table 1.1. Members of the Herpesviridae family.
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Figure 1.1: Electron microscopy image of Herpesviruses.
Electron microscopy image of a member of Herpesviridae, (bar =100 nm). Taken from 
McGeoch et ah, 2006.
Figure 1.2: Herpesvirus virion structure.
Herpesvirus virion structure consists of dsDNA viral genome, capsid, tegument, lipid 
envelope and spikes of viral glycoprotein. Adapted from McGeoch et al., 2006.
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Subsequent to the discovery of KSHV, several new nonhuman primate rhadinoviruses 
were isolated that appear to have an even closer phylogenetic relationship to KSHV than 
either HVS or EBV. These new members define two distinct rhadinovirus lineages. One 
lineage is closely related to KSHV and includes retroperitoneal fibromatosis herpesvirus 
(Rose et al., 1997), Chlorocebus rhadinovirus 1 (ChRVl) (Greensill et al., 2000), and 
some chimpanzee and gorilla rhadinoherpesviruses (PanRHVl, PanRHV2, GorRHVl) 
(Lacoste et al., 2000). The second lineage includes a rhesus monkey rhadinovirus 
(Desrosiers et al., 1997) and ChRV2 (Greensill et al., 2000).
1.2 Clinical disease associated with KSHV infection
1.2.1 Kaposi Sarcoma
KS is a tumour of endothelial lymphatic origin and is highly vascular (Wang et al., 2004; 
Beckstead et al., 1985). KSHV-infected cells are histologically characterized by a 
spindle shaped, poorly differentiated and rapidly proliferating (Dupin et al., 1999). KS is 
characterized clinically by pigmented dermatological lesions which are red, brown, or 
purple. The lesions can be found cutaneously, mucosally, or viscerally. Six stages of 
clinicopathologic forms have been documented in KS. The forms are patch, plaque, 
nodular, lymphadenopathic, infiltrative, and florid (Kyalwazi, 1981; Taylor et al., 1971).
KS can be classified into four clinical subtypes which are classic, endemic, epidemic and 
iatrogenic. Classic KS which was described by Dr. Kaposi causes a localized lesion in 
the upper and lower extremities (Friedman-Bimbaum et al., 1990). Endemic KS is 
characterized by inactive or aggressive and with more lymph node involvement
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compared to classic KS. The aggressive form or lymphoadenophatic form is normally 
found in children at pre-puberty age (Dutz and Stout, 1960). The third subtypes of 
epidemic or AIDS-associated KS is the common and aggressive form, which affects 
most lymph nodes (Biggar and Rabkin, 1996; Beral and Newton 1998). The last form of 
KS is called iatrogenic or post-transplant KS. It was caused by suppression of immune 
system after prolonged immunosuppressive therapy which was used to prevent rejection 
of transplanted organs (Penn, 1988).
1.2.2 Primary effusion lymphoma
Another disease associated with KSHV is the primary effusion lymphoma (PEL), also 
known as body cavity based lymphoma (BCBL) [Cesarman et al., 1995a]. PEL is 
derived from clonally expanded malignant B cells and also a unique form of non- 
Hodgkin lymphoma (NHL). It presents as a lymphomatous effusion tumour and is 
detected in various body cavities such as pericardium, pleurum, and peritoneum and in 
solid mass state in lymph nodes and other organs (Arvanitakis et al., 1996). PEL cells 
are larger than normal lymphocytes and erythrocytes. It also contains a large cell 
immunoblastic lymphoma and anaplastic large cell lymphoma. The cells express CD45 
activation-associated antigen and clonal immunoglobulin with lack of B-cell associated 
antigens (Nador et al., 1996). High copy number of KSHV genome was shown in PEL 
cells with an amount of 50 -  150 viral genomes per-infected cell (Cesarman et al., 
1995a; Renne et al., 1996b).
7
1.2.3 Multicentric Castleman disease (MCD)
MCD is a non-neoplastic type of lymphadenopathy with B-cell populations normally 
found in the lesions (Radaszkiewicz et al., 1989; Hall et al., 1989). There are two types 
of MCD, which are the plasmablastic and hyaline types (Radaszkiewicz et al., 1989). 
The plasmablastic is highly associated with KSHV but not on the hyaline variant. 
Plasmablastic MCD can also become aggressive and with rapid progression, it can lead 
to high fatality. MCD causes germinal center expansion and vascular endothelial 
proliferation within MCD lymph nodes. Like the other two KSHV infections associated 
disease, KSHV genomes were also detected in almost all HIV-positive MCD cases 
(Soulier et al., 1995).
1.3 Epidemiology and transmission of KSHV
Several routes of transmission have been proposed for KHSV, but the real mode of 
transmission is still not clear (Dukers et al., 2000). Like other human herpesvirus, KSHV 
can be transmitted via saliva as reflected by the high copy number of KSHV DNA in 
saliva (Cattani et al., 1999; LaDuca et al. 1998). A study of KSHV-seropositive men 
who had sex with man and with no clinical evidence of KS showed that exposure to 
infectious saliva is a risk factor for KSHV procurement (Pauk et al., 2000). It is also 
possible that the transmission of KSHV can be through oral route but the transmission 
maybe difficult (Lucchini et al., 2001) and the levels of KSHV could be low in KSHV- 
infected person who are not HIV positive (Biggar et al., 2001). KSHV is normally 
detected in semen rather than spermatocytes suggesting secretion into seminal fluid is 
also one of the transmission routes (Howard et al., 1997; Monini et al., 1996). A report
by Diamond et al (1998) on prostate cells suggested that the cells shed virus into the 
semen and might be a crucial factor in determining whether KSHV is transmitted 
through sexual activities. KSHV can also be found in peripheral blood mononuclear 
cells (PBMC) of people carrying KSHV (Dupon et al., 1997) and depends on the 
seroprevalence of a particular region. KSHV has been suggested to replicate in the 
PBMCs of KS patients and not in patient with classical or AIDS-related KS (Decker et 
al., 1996). It has been demonstrated that viral load in the blood of KSHV infected 
patients varies and based on the stage of infection (Sitas et al., 1999). It also has been 
reported that a correlation between immunosuppression, HIV replication and KSHV 
expression (Dupon et al., 1997) when KSHV DNA count in PBMC and CD4+ correlated 
with increased plasma levels of HIV mRNA.
Other likely routes of transmission include the transplant of infected organs (Barozzi et 
al., 2003), transfusion of unprocessed blood (Hladik et al., 2006) and shared use of 
injection needles (Cannon et al., 2001). Transmission of KSHV via organ donation was 
also reported (Marcelin et al., 2007). Transmission to children normally happens if they 
have an infected mother (Minhas et al., 2008) or other family member (Plancoulaine et 
al., 2004). It was also recently reported that KS occurred threefold more frequently in 
KSHV seropositive recipients of organ transplant than in seronegative recipients 
(Frances et al., 2009). During the early days of the AIDS pandemic, KSHV was 
identified in patient with KS. KSHV has also been found in classic, endemic and 
transplant-related form of disease (Renwick et al., 2002). Patients with primary KSHV
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infection may present with cutaneous disease as shown by a cohort study of 86 
immunocompetent children (Cannon et ah, 2001).
1.4 KSHV genomic organization and structure
In common to herpesviruses, KSHV exhibits similar morphology of 100- to 150- nm 
particles with a lipid envelope and dense dsDNA core (Renne et ah, 1996b). The 
icosahedral capsid (110 nm) consists of 162 hexagonal capsomeres (Wu et ah, 2000) 
with glycoprotein coated virion (140 nm). The capsid and envelope are separated by 
protein-filled region of tegument. The core of the virus structure is where the complex of 
DNA and protein are located. Analysis of purified KSHV virions DNA by pulsed-field 
gel electrophoresis (Moore et ah, 1996) revealed the full-length genome is 165 to 170 kb 
(Figure 1.3). KSHV genome has a single conterminous region with the size of 140 -  
150 kb and is similar to HSV in term of coding region (Arvanitakis et ah, 1996). The 
genome has repeats of 803 bp in length with each molecule contains approximately 35 -  
45 of the repeats which has around 85% G+C content (Langunoff and Ganem, 1997). 
The genome of KSHV appears to be in circular conformation when in latent cycle but in 
an active linear DNA form when the virus switches to the lytic cycle and the similarity 
has been shown in EBV (Renne et ah, 1996a).
KSHV has been recorded to have at least five variants (A-E) based on the analysis of 
ORF-K1 and ORE-15 genes (Schulz, 2000). Similar variation has been found in the gene 
products of these two genes (Hayward, 1999), that functions as coding genes for 
membrane-signaling proteins. The genes contain conserved tyrosine kinase interaction
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motifs within their C-terminal cytoplasmic domains (Lee et ah, 1998; Nicholas et ah,
1998), and might play an important role in the biology and disease manifestation 
associated with KSHV (Hayward, 1999). Despite the variation between the KSHV based 
on both genes, it has no association with different pathologies, as it has been reported 
that high level of strain variability in KSHV might have important functional 
implications (reviewed by Ablashi et ah, 2002). The similarities among herpesviruses 
are not only in their structure but also in the homologies of the sequences (Searles et ah,
1999), apart from KSHV unique sequences itself (Bosch et ah, 1998). KSHV ORF-26 
gene which encodes the minor capsid protein has 51% homology to VP23 of HSV and 
39% homology to BD-LF1 gene of EBV ORF which codes for the tegument formation 
(Chang et ah, 1994). KSHV contains approximately 25 unique genes from its 95 genes, 
and are not found in other human herpesviruses. These unique genes represent captured 
and diverged homologues of cellular genes. ORF-K reference numbers are used if the 
genes do not have any homology between the HSV genome.
KSHV viral genes are involved in all sorts of function such as signal transduction (K1 
and K15), cell cycle regulation (vCyclin and LANA-1), inhibition of programmed cell 
death (Kl, vFLIP and Bcl-2), and immune modulation (viral chemokine receptors, 
vIRFs, K3 and K5). MicroRNAs have also been discovered in the KSHV genome 
(Cesarman et ah, 1995a; Cesarman et ah, 1995b; Cesarman et ah, 1996). Ten 
microRNAs were located in a non-coding region between K12 and K13, while the other 
two were located within the K12 ORF. Polyadenylated and exclusively nuclear (PAN), 
which is a non-coding RNA transcript is also produced by KSHV (Chaucan et ah, 1999).
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Figure 1.3: Structure of the KSHV genome. 140 -150 kb of coding region of KSHV 
virus is flanked by Terminal repeats (TR). White blocks represent conserve region of 
KSHV with other herpesviruses. Gray boxes represent unique gene of KSHV. ORFs that 
are not homologous to other herpesviruses are assigned with a prefix K. Taken from 
Neipel and Fleckenstein, 1999; Russo et ah, 1996.
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1.5 KSHV life cycle
Like other herpesviruses, KSHV exhibits a dual phase of life cycle; a predominant long 
latent and a short-lived lytic cycle. Latent infection is the dormant state of the viral life 
cycle, which is characterized by the expression of a limited number of viral genes with 
no production of virus particles. The majority of the herpesviruses other than the 
members of gammaherpesvirus (KSHV and EBV) family do not cause any obvious 
pathological effects during latent infection. Members of the gammaherpesvirus have the 
ability to drive cell proliferation and transformation and are broadly referred to as 
oncogenic viruses. Lytic cycle is characterized by the expression of most of the viral 
genes in an orderly fashion (immediate early, early, and late) and the production of 
infectious virion particles (Figure 1.4).
1.5.1 KSHV Latent cycle
In latent KSHV cycle, the genome is preserved in the majority of infected cells and in 
tumour cells as well (Decker et al., 1996). In this state of infection, the KSHV genome 
replicates and persists as an extra chromosomal episome associated with histones in the 
nucleus (Tempera and Lieberman, 2010). These episomes are assembled into 
nucleosomal structures that resemble bulk cellular chromatin. KSHV latency is 
established mainly in B cell lymphocytes as has been shown by Brown et al., 2003, with 
only a few viral genes expressed. Those genes are LANA (ORF73), vCyclin (ORF72), 
vFLIP (ORF71/K13) and a group of short membrane-associated proteins named Kaposin 
(K12) (Dittmer et al., 1998; Sarid et al., 1998). The function of the LANA gene is for the 
maintenance and replication of the episomal genome (Ballestas et al., 1999; Cotter and
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Robertson, 1999; Garber et al., 2002), by binding to p53 and Rb, thus inhibiting the 
activation of p53-dependent promoters (Friborg et ah, 1999) and inducing the activation 
of E2F-dependent genes (Radkov et ah, 2000). vFLIP protein functions by blocking 
FAS-induced apoptosis and has been suggested to act as a tumour progression factor by 
interfering with apoptotic signals induced by virus-specific killer T cells (Djerbi et ah, 
1999). The protein has also been postulated to play a role in the continuity of NF- 
kappaB activation in PEL cells (Liu et ah, 2002) and is also responsible in the 
maintenance of the latent phenotype in infected cells.
1.5.2 KSHV lytic cycle
Analysis of gene profiling from biopsies and also infection in cultured cells revealed that 
majority of KS tumour cells contain KSHV viral DNA and express abundant viral latent 
transcripts, and only a small amount of lytic genes (Staskus et ah, 1997; Sun et ah, 
1999). The transcripts expressed are viral macrophage inflammatory protein-I, viral 
interleukin 6, viral Bcl-2 homolog, and polyadenylated nuclear RNA (PAN RNA). 
Major capsid protein (MCP) and small viral capsid (sVCA), which are involved in the 
production of virion particles and responsible for the infection of the surrounding cells, 
are also expressed in the lytic cycle. Cells undergoing a lytic cycle also produce cellular 
cytokines, which function to enhance the growth of latently infected cells and contribute 
to tumour progression. PEL cells (BC-1, BC-3, and BCBL-1) can be used to study the 
KSHV lytic cycle in vitro by treatment with chemical agents such as phorbol esters or 
sodium butyrate (NaB) to induce the cascade of lytic cycle genes (Gradoville et ah, 
2000; Renne et ah, 1996b; Sarid et ah, 1998; Zhong et ah, 1996). From these findings
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the lytic gene expression pattern has been characterized as immediate early (IE), early 
(E), and late (L) gene patterns, as for other herpesvirus.
The IE genes are the first group of genes expressed during lytic replication whose 
transcription generally does not require de novo protein synthesis. The proteins encoded 
by the IE genes function in activating the cascade of downstream genes and also 
modulate the host cell environment for viral replication. Several genes have been 
identified in the IE groups which include ORF50, ORF45, ORF K4.2 (Gradoville et al., 
2000; Krishnan et al., 2004; Lukac et al., 1999; Sarid et al., 1998; Sharma-Walia et al., 
2005). One of the well characterized IE genes is OKF50, also known as RTA. RTA acts 
as a molecular switch from latent to lytic cycle. RTA also induces the cascades of other 
lytic gene expression such as vIL-6, PAN RNA, ORF59, ORF65, and K8.1 and also 
production of DNase-resistant encapsidated viral DNA (Gradoville et al., 2000; Lukac et 
al., 1998; Sun et al., 1998). RTA expression is controlled by various cellular and viral 
proteins and ORF50 itself in order to maintain sufficient amount of RTA for activation 
of the lytic cycle (Gradoville et al., 2000; Lan et al., 2004). One of the proteins is 
LANA, which controls RTA expression and suppresses lytic reactivation by repressing 
basal RTA promoter activity and RTA-mediated autoactivation (Lan et al., 2004).
The second group that are expressed during the lytic cycle is the early (E) genes. The E 
gene proteins encode involved in nucleic acid metabolism and modulation of cellular 
functions. The genes expression is controlled by the IE genes such as RTA. Direct and 
indirect mechanisms are activated by the IE genes on the E genes and examples of the E
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genes are PAN RNA, Kaposin, ORF57, K-bZIP (K8), vIL-6, K5, K9, K14, K15, ORF6, 
ORF59, ORF21, and ORF74 (Chang et ah, 2000; Chen et ah, 2000; Haque et ah, 2000; 
Jeong et ah, 2001; Lukac et ah, 2001; Wong and Damania, 2006; Zhang et ah, 1998). 
The most abundance E gene is PAN comprising approximately 80% of the total 
polyadenylated RNA in infected cells, but the real function of PAN RNA in the lytic 
cycle is yet to be determined (Song et ah, 2001). Another E gene, Kaposin, also 
expressed during latent infection and strongly induced by lytic reactivation, with the 
function in cell transformation (Kliche et ah, 2001; Muralidhar et ah, 1998). RTA 
expression also upregulates ORF57, a gene which encodes a post-transcriptional 
regulator, which is a conserved protein in herpesviruses, (Duan et ah, 2001; Kirshner et 
ah, 1999). ORF57 also promotes the accumulation and export of viral intronless RNA 
transcripts. vIL-6, another E gene which is encoded by ORFK2 is strongly induced by 
RTA and is one of the most abundant transcripts in PEL cells during the lytic cycle 
(Deng et ah, 2002; Sun et ah, 1999). A basic leucine zipper protein, K-bZIP (K8), whose 
expression is also controlled by RTA, is an early protein, and plays an important role in 
lytic viral DNA replication (Lin et ah, 2003). RTA also controls the expression of other 
early and late genes, which are structural genes and genes involved in virus maturation, 
by either directly binding to the RTA response elements or through binding with other 
cellular factors (West and Wood, 2003).
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Figure 1.4: KSHV episome mapping. KSHV encodes 87 ORFs and microRNAs. 
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1.5.3 KSHV latent genes
1.5.3.1 LANA
ORF73 of KSHV encodes a gene known as LANA or latent nuclear antigen (LNA). 
LANA was initially identified as a doublet of 220-230 kDa nuclear proteins by Western 
blotting, and as the most immunodominant latent antigen in KS patients (Gao et al.,
1996). The expression of LANA in KSHV-infected cells is continuous throughout the 
virus life cycle (Gao et al., 1996; Rainbow et al., 1997). LANA is involved in episomal 
DNA replication, maintenance, and segregation into daughter cells during mitosis 
(Ballestas et al., 1999; Cotter et al., 1999; Hu et al., 2002; Si et al., 2008). LANA acts as 
a transacting protein by binding to the terminal repeats (TRs) in KSHV genome which 
contains a DNA replication origin c/s-element, to form a DNA-protein complex 
(Ballestas and Kaye, 2001; Cotter et al., 2001; Garber et al., 2001). Both C- and N- 
terminals of LANA mediate its binding to TRs (Cotter et al., 2001; Barbera et al., 2004; 
Canham and Talbot, 2004; Komatsu et al., 2004) and the LANA-TR complex functions 
in episomal DNA replication (Fejer et al., 2003), indicating that cellular DNA 
replication mechanism was used by the complex to complete viral DNA replication. In 
lymphoblasts, LANA is necessary and sufficient for the persistence of an artificial 
episome containing two TR units (Fejer et al., 2003; Grundhoff and Ganem, 2003). 
LANA tethers KSHV DNA to chromosomes during mitosis for efficient segregation of 
KSHV episomes to progeny cells and this hypothesis was supported by immunostaining 
results of colocalization of LANA with the artificial episomes in nuclei and along 
mitotic chromosomes (Ballestas and Kaye, 2001). Apart from that, interactions of 
LANA with bromodomain protein Brd4 also mediate LANA tethering on mitotic
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chromosomes. The interaction is proposed to be through the extra-terminal domain of 
Brd4 and a carboxyl-terminal region of LANA (You et ah, 2006).
Association of LANA with the nuclear mitotic apparatus protein (NuMA) has also been 
recorded (Si et ah, 2008). The two proteins are colocalized in interphase cells and are 
separated during mitosis at the start of prophase and reassociated at the end of telophase 
and cytokinesis. Interaction between LANA and two proteins, kinetochore proteins 
CENP-F and Bubl helps in KSHV genome tethering and segregation of new daughter 
cells, with Bubl having a major role in long-term persistence of the viral genome in the 
infected cells. All the interactions between LANA and cellular proteins above shows that 
LANA play a very critical role in number of events including episomal DNA replication, 
maintenance, and segregation of the viral genomes into daughter cells during mitosis. 
These finding were further supported by rapid loss of KSHV genomes in human cells 
upon LANA gene disruption thus preventing KSHV from establishing persistent 
infection (Ye et ah, 2004).
LANA also plays a role in promoting KSHV latency through inhibition of viral lytic 
gene expression. Interaction of LANA with mSinB core-repressor complex (Krithivas et 
ah, 2000) and a nuclear transcriptional repressive protein named “KLIP-1” (KSHV 
LANA-interacting protein 1) produce a negative regulatory effect on gene transcription 
(Pan et ah, 2003). Gene expression is also repressed by an interaction between LANA 
and DNA methyltransferases (Dnmts) through DNA méthylation at the promoter region 
(Shamay et ah, 2006).
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LANA contributes to KSHV latency by inhibiting the expression of RTA (Lan et al., 
2004) as well as inhibiting its transactivation of downstream genes. Inhibition of RTA 
activity by LANA has been shown by deletion analysis of LANA gene. Following the 
deletion of LANA, expression level of all classes of lytic genes including RTA, MTA, 
vIL-6 (ORF-K2), ORF59, and ORF-K8.1 were increased with and without induction of 
12-O-tetradecanoylphorbol-13-acetate (TPA) and sodium butyrate (Li et al., 2008). 
Interaction of LANA with p53 and pRb promotes cell growth and survival of KSHV- 
infected cells (Friborg et al., 1999). Furthermore, LANA stimulates cell cycle 
progression by stabilizing and activating oncogene c-Myc (Liu et al., 2007).
1.5.3.2 vCyclin
Cyclins are regulatory subunits of a specific class of cellular kinase. vCyclin, a gene 
encoded by ORF72, is a homologue of cellular D-type cyclins (Cesarman et al. 1996; Li 
et al. 1997). vCyclin shares common substrates with cellular cyclins in the Gl/S phase 
transition. Substrates include GO D-type cyclin/cdk substrate, Rb (Godden-Kent et al. 
1997), cyclinE/cdk2 substrate, p27Cip (Ellis et al. 1999; Mann et al. 1999) and 
cyclinA/cdk2 substrates, origin recognition complex-1 and Cdc6 (Laman et al. 2001). 
The ability of vCyclin to function like the Gl/S phase cyclins with an unregulated kinase 
activity results in the loss of normal cell cycle checkpoints, allowing cells to exit from 
quiescence and re-enter cell cycle (Swanton et al. 1997; Child and Mann 2001). 
Although vCyclin and cellular cyclin share 32% homology, the kinase activity between 
the two is different, as vCyclin/cdk complex is resistant to pl6INK4A, p21Cip and 
p27Kip inhibitors (Swanton et al. 1997). Cellular cyclin is regulated by cyclin-activating
2 0
kinases (CAK) but not vCyclin (Kaldis et al. 2001). This property of vCyclin along with 
its resistance to CDKIs showed that vCyclin is an active kinase and regulated in a 
different mechanism as compared to the cellular Cyclin.
Unlike cellular cyclins, vCyclin possess additional functions. vCyclin interacts with 
signal transducer and activator of T cells 3 (STATS) for the inhibition of the growth 
suppressive effects of oncostatin M signaling by blocking its DNA binding and 
transcriptional activation (Lundquist et al. 2003). Another property of vCyclin is the 
phosphorylation of cellular bcl-2, for the inactivation of its anti-apoptotic properties 
(Ojala et al. 2000). vCyclin also has oncogenic properties; expression of vCyclin was 
shown to induce lymphoma when tested on the transgenic mouse model suggesting the 
importance of vCyclin to mediate lymphomagenesis (Verschuren et al. 2004). In KSHV 
infection, vCyclin induces oncogenesis synergistically by interaction with other latently 
expressed genes such as LANA, by inactivating the p53 pathway.
1.5.3.3 vFLIP
Like vCyclin, the viral FLICE [Fas-associated death domain (FADD)-like IL-lb- 
converting enzyme] inhibitory protein (vFLIP) is a homologue to the cellular gene FLIP 
(cFLIP) hijacked from the host. vFLIP is encoded by ORF71 of the viral episome which 
is transcribed from the same promoter as LANA and vCyclin where LANA transcript is 
spliced (Talbot et al. 1999). An internal ribosome entry site (1RES) within the vCyclin 
coding region has been shown to direct the translation of vFLIP; s monocistronic vFLIP 
transcript failed to be identified (Bieleski and Talbot, 2001; Grundhoff and Ganem,
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2001; Low et al., 2001). FLIPs function by binding to adaptor proteins (TRADD and 
F ADD) of the Fas/TNFR signaling pathway via their death effector domains (DEDs) 
(Thome et al., 1997). The binding leads to blockade of a caspase activation cascade due 
to impairment of caspase 8 recruitment and activation and results in programmed cell 
death. Like cFLIP, vFLIP also contains DEDs which inhibit Fas-mediated cell death and 
block cleavage of procaspase 8 to its active form (Djerbi et al. 1999; Belanger et al. 
2001).
Like cFLIP, vFLIP has anti-apoptotic functions by activating the NF-kB signaling 
through the death receptors. One of the receptor is TNFR1 which is able to activate NF- 
kB via interaction with NIK and RIP proteins in the NF-kB-activation cascade and 
association with the receptor adaptor proteins TRAF2 and F ADD (Chaudhary et al. 
1999; Liu et al. 2002; Field et al. 2003). The alternative pathway of NF-kB is also 
activated by vFLIP via upregulation of NF-kB precursor protein p i00 (Matta and 
Chaudhary, 2004). NF-kB activity is always associated with lymphoproliferative 
diseases and it has been shown that the survival of PEL cell lines is highly dependent on 
NF-kB (Keller et al. 2000; Liu et al. 2002; Field et al. 2003). A study on vFLIP 
knockdown by RNA interference (RNAi) showed that vFLIP is an essential component 
for good PEL cell survival, as activation of NF-kB by vFLIP proved to be important for 
PEL cell viability (Guasparri et al. 2004). The nature of the interaction between vFLIP 
and NF-kB has been a subject of study on the therapeutic approach for the treatment of 
KSHV lymphomas by targeting the vFLIP and NF-kB pathway either by RNAi and/or 
pharmacological inhibitors (Matta et al. 2003).
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1.6 Translation process
The translation process is one of the most complicated cellular process, involving 
numerous translation components that interact in multiple sequential steps involving a 
simultaneous action of over a hundred different RNA, protein molecules and several 
other factors (Waters et ah, 2003). In eukaryotes, the process can be divided into 3 steps 
which are initiation, elongation and termination (Figure 1.5). Translation occurs in the 
cytoplasm of eukaryotic cells soon after the transcription of the DNA to mRNA and 
post-transcriptional modification of messenger RNA molecules, which takes place in the 
nucleus. The translational process is the final step in a complex network of regulatory 
processes involved in the control of gene expression. In this process, the initiation step is 
the most rate limiting step (reviewed in Matthews et ah, 1996).
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Figure 1.5: Model of eukaryotic translation initiation process. Several steps involve 
in the protein synthesis process. Step 1 is the dissociation of the 80S ribosomal 
complexes into the 40S and 60S subunit. Step 2 is where the 40S subunit interacts with 
cellular proteins for the formation of 43 pre-initiation complex (PIC). Activation of 
mRNA by interaction with eIF4F complex (Step 3). Step 4 is where the 43S complex is 
attached to the mRNA. 43 S complex scanning of the 5' UTR in the 5' to 3' direction 
(Step 5). Recognition of start codon and 48S initiation complex formation (Step 6). In 
step 7 60S subunits joined the 48S complexes. GTP hydrolysed by eIF5B and elFlA and 
GDP-bound eIF5B are released from 80 ribosomes (Step 8). Termination (Step 9). 
(Taken from Jackson et al., 2010).
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1.6.1 The mechanism of translation initiation
1.6.1.1 Dissociation of 80S ribosomes
The initiation process begins with a separation of ribosomal subunit. Ribosomes are 
released from mRNA after translation termination and are recycled from the post­
termination ribosomal complex still attached to mRNA, P-site deacylated tRNA and 
eukaryotic release factor 1 (eRFl). 60S and 40S subunits are separated by eIF3, eIF3j, 
elFl and elFlA from 80S subunit by inducing structural changes in 60S subunit and also 
blocking its surface for attachment to 40S subunit (Figure 1.6). elFl is then dissociate 
tRNA from 40S and trigger conformational changes in 40S to release deactylated tRNA. 
The eIF3j subunit binds to 40S subunits and releases the mRNA from the 40S 
(Unbehaun et ah, 2004; Fraser et ah, 2007). The 40S subunit remains associated with 
eIF3, elFl and elFlA preventing re-association with 60S subunits (reviewed in Hershey 
and Merrick, 2000; reviewed by Jackson et ah, 2010). It was recently shown that eIF6 
has also plays a significant anti-association activity by binding to the 60S subunit, 
preventing its association with 40S (Si and Maitra, 1999; Jackson et ah, 2010).
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Figure 1.6: 80S dissociation into 40S and 60S subunits. elFl, elFlA, eIF3 and eIF3j 
separate 40S and 60S from the 80S subunit. elFl, elFlA and eIF3 then bind to the 40S 
subunit while eIF6 binds to 60S subunit to prevent re-association.
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1.6.1.2 Ternary complex formation
The formation of 43 S preinitiation complex comprises of initiator methionyl-tRNAi 
(Met- tRNAj) molecule (required for identification of the initiator AUG), initiation 
factor eIF2 and a molecule of GTP before it binds the 40S subunit (reviewed in Pestova 
et ah, 2007). eIF2 and GTP are linked together to form the eIF2-GTP binary complex. 
The affinity of eIF2 for the initiator tRNA is strictly dependent on the presence of GTP. 
In fact, GTP-bound eIF2 has high affinity for the initiator tRNA, therefore it facilitates 
the formation of a translationally competent eIF2-Met-tRNAj complex (Figure 1.7). On 
the other hand, conversion of GTP into GDP results in low affinity of eIF2 for Met- 
tRNAj, and occurs when the initiator tRNA has to be released into the ribosome 
positioned at the initiation codon, in a reaction induced by eIF5 (Chakrabarti and Maitra, 
1991). The base-pairing of AUG with Met-tRNAi stimulates the hydrolysis of the GTP 
bound to eIF2; this is dependent on the GTPase-activating protein (GAP) eIF5 (Pestova 
et al., 2000; Pestova et al., 2007). After every round of initiation, eIF2 is left in a 
conformation with low affinity for Met-tRNAi, therefore it has to cycle between an 
inactive GDP-bound conformation to an active GTP-bound translationally competent 
form. The recycling of eIF2-GDP to eIF2-GTP is catalysed by the guanine nucleotide 
exchange factor, eIF2B (Alone and Dever, 2006; reviewed in Pestova et al., 2007).
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Figure 1.7: 43S preinitiation complex formation. The formation of 43S 
preinitiation complex consists of assembly of elFl, elFlA, eIF3, eIF2-GTP-Met- 
tRNAi complex and the 40S subunit.
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1.6.1.3 Recruitment of 43S complexes to capped mRNA
Synergistic effect of 5' terminal cap and 3' poly(A) tail has been proposed for the 
binding of eukaryotic mRNAs to the ribosomal 43 S preinitiation complexes (Gallie, 
1991; Tarun and Sachs, 1995; lizuka et ah, 1994; Preiss and Hentze, 1998) along with 
canonical eukaryotic initiation factors (eIF4E, eIF4A and eIF4G subunits of eIF4F, 
eIF4B and PABP). The theory was proved by eIF4A cycling through eIF4F (Yoder-Hill 
et al., 1993) and inhibition of eIF4E-eIF4G interaction by 4E-binding proteins (Pause et 
al., 1994b; Altmann et al., 1997; Haghighat et al., 1995).
The process of translation initiation in eukaryotes is mostly dependent on a cap structure 
(m7GpppN, where m is a methyl group and N is a nucleotide). The 5' end of the vast 
majority of mRNAs contains a structure called a “cap” that results from removal of one 
phosphate from the 5' end of the mRNA, addition of a guanosine monophosphate in a 
reverse linkage (5' to 5') and addition of a methyl group to the guanosine (reviewed in 
Shatkin and Manley, 2000). The m7G aromatic ring of the cap structure is 
accommodated in a binding pocket within the eIF4E structure. Therefore, within the 
eIF4F complex eIF4E is called the “cap-binding factor”, while eIF4G acts as a large 
scaffolding protein interacting with eIF3, the 40s subunit and poly(A) binding protein 
(PABP). eIF4G-PABP interaction helps to circularize mRNA by connecting the cap 
structure at the 5' end to poly(A) tail at the 3' end of mRNA (Haghighat and Sonenberg,
1997). eIF4A has an RNA helicase activity required during scanning by relaxing the 
secondary structure of mRNA (Linder et al., 1989; Marintchev et al., 2009). The 
helicase activity of eIF4A is enhanced by eIF4B and eIF4H (Pestova et al., 2007).
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1.6.1.4 Scanning
After the attachment of the 43 S complex to the mRNA, scanning to locate an initiation 
codon takes place. The scanning processes comprise two steps, first, the unwinding of 
secondary structure in the 5' UTR and second the movement of the 43S complex along 
the mRNA. Once the 43S preinitiaton complex has been loaded onto the mRNA, it has 
to reach the initiation codon. Most mRNAs contain a 50-70 nt untranslated region 
(UTR) between the 5' cap structure and the AUG initiation codon (reviewed in Hershey 
and Merrick, 2000). It is accepted that the 40S subunit, carrying the Met-tRNAi and a set 
of elFs, scans along the UTR until it reaches the start site (Kozak, 1978). Although this 
process is referred to as “ribosomal scanning”, it involves not only ribosomal 
translocation, but also conformational changes in the initiation factors, unwinding of 
secondary structures in the mRNA and selection of the initiation codon. It was shown 
that elFl and elFlA binds to the 40S and facilitates tRNA binding, allows scanning of 
mRNA, and maintains fidelity of start codon recognition (reviewed by Passmore et al., 
2007). The interaction was also shown to stabilize a conformational change that opens 
the mRNA binding channel elFl with elFl and elFlA accelerate the rate of ternary 
complex (eIF2v GTPV Met-tRNAi Met) binding to 40S (Passmore et al., 2007).
For 5' UTR mRNAs that have weak secondary structure, the 43S scanning requires ATP, 
eIF4A, eIF4G and eIF4B. ATP and eIF4A are not required to unwind the mRNA 
secondary structure complexity (Jackson, 1991; Svitkin et al., 2001; Pestova and 
Kolupaeva, 2002). It shows that eIF4A, eIF4G and eIF4B have multifunctional roles by 
not just in the attachment of the 43 S complex to mRNA but also in scanning for the
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initiation codon. The recognition process of start codon by 43 S complex has been 
proposed and based on a codon-anticodon interaction as been shown by mutating the 
Met-tRNAi anticodon (Cigan et ah, 1988). eIF2 and eIF5 also contribute to the 
recognition of AUG codon as eIF2-bound GTP hydrolysis, mediated by its GTPase- 
activating protein (GAP) eIF5, and is stimulated by the base-pairing between AUG and 
Met-tRNAi (Pestova et ah, 2007).
1.6.1.5 Formation of the 80S complex to commence translation
The final stage in the initiation process is joining of a 60S ribosomal subunit to the 48S 
complex assembled at the initiation codon of an mRNA for the 80S formation for 
translation initiation. When the Met-tRNAi anticodon recognizes the first start codon 
within the Kozak sequence, codon-anticodon base-pairing occurs (Kozak, 1987). This 
leads to hydrolysis of the GTP associated with eIF2 to form eIF2-GDP which is 
mediated by eIF5. The eIF2-GDP releases the Met-tRNAi into the P site of the 40 S 
subunit, and dissociates from the complex (reviewed by Kapp and Lorsch, 2004). 
Binding of eIF5B-GTP to the 40S subunit mediates the joining of the 60S subunit to the 
40S-Met- tRNAi-mRNA complex resulting in GTP hydrolysis by elFSB and release of 
the eIF5B-GDP (Pestova et al., 2000; Lee et al., 2002). The formation of 80S complexes 
was shown to be facilitated by the interaction of elFlA and eIF5B. elFlA plays an 
important role in subunit joining and GTP hydrolysis mediated by eIF5B. The GTP 
hydrolysis by elFSB is not required for 80S complex formation but causes rapid 
dissociation of Met-tRNAi when added to 43 S complexes and eIF5B also has ribosome-
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dependent GTPase activity. It can dissociate eIF2-GDP completely from 40S subunit 
during the actual formation of 80S complexes (Pisarev et al., 2006).
1.6.1.6 Elongation and termination of translation
The empty A site of the ribosome can be occupied by an aminoacyl tRNA (aa-tRNA), in 
the form of a ternary complex with elongation factor 1A (eEFlA) and GTP. The 
selection of the correct tRNA is initially mediated by codon-anticodon base-pairing 
between the mRNA and aa-tRNA. Correct base-pairing results in conformational 
changes in the small ribosomal subunit that triggers GTP hydrolysis by eEFlA. GTP 
hydrolysis in turn causes dissociation of the aa-tRNA from the ternary complex. The 
ribosomal peptidyl transferase centre then catalyses the formation of a peptide bond 
between the amino acid in the A site with that in the P site. The deacylated tRNA is then 
released in the exit site as a consequence of conformational changes (reviewed in Kapp 
and Lorsch, 2004). When a stop codon (UAA, UAG, UGA) occupies the ribosomal A 
site, the eukaryotic release factor (eRFl), complexed with GTP, enters the ribosome and 
promotes hydrolysis of the peptidyl ester bond of the last tRNA, release of the newly 
synthesized polypeptide and of the deacylated tRNA, and ribosome dissociation from 
the mRNA (reviewed in Kapp and Lorsch, 2004).
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1.7 Role of eIF4F complex in translation
As described above, translation initiation in eukaryotes depends on the presence of 
various canonical initiation factors which facilitate the process. These include eIF4A, 
eIF4E and eIG4G, collectively known as the “eIF4F complex” or “cap binding complex- 
CBC” (Figure 1.8). The eIF4F complex plays an important role in translation initiation 
by allowing the correct alignment of the ribosome on the mRNA, recognition of the 
correct initiation codon and relaxing of the secondary structure of the mRNA for 
translation. The brief role of each component of eIF4F complex is given below.
1.7.1 Initiation factor eIF4A
eIF4A is one of the components in eIF4F complex. The protein was categorized into 
DEAD (D: Aspartic acid; E:Glutamine; A:Alanine; D:Aspartic acid) box family of 
proteins. eIF4A properties include a highly nine conserved motifs shared with other 
DEAD box proteins and ATP-dependent RNA helicase activity (Linder et al., 1989). 
eIF4A catalyze the unwinding of mRNA in the 5' untranslated region of mRNA, 
allowing the 40S ribosomal subunit to bind the mRNA and scan for the initiation codon 
in a 5' to 3' direction (Hershey and Merrick, 2000). eIF4A has been reported to have a 
helicase activity and the action is bidirectional with 5' to 3' and 3' to 5'. The degree of 
unwinding is RNA duplexes dependent rather than the length of RNA (Rogers et ah, 
2001). eIF4A RNA helicase and RNA binding ability can be affected by mutation and 
can inhibit cap-dependent translation (Pause and Sonenberg, 1992). Furthermore, 
mutation of eIF4A is thought to inhibit translation because it is defective in recycling 
through eIF4F and inhibits RNA helicase activity of eIF4F complex (Pause et ah,
3 3
1994b). eIF4A possesses two structural conformations which are eIF4A-open 
confirmation in an inactive form and eIF4A-closed conformation in an active form 
(Cordin et ah, 2006; Pyle, 2008). The structural conformations enable the unwinding of 
RNA duplex which requires the binding and hydrolysis of ATP. The open confirmation 
occurred in the absence of ATP and RNA, whilst, with the presence of both ATP and 
RNA would trigger a closed conformation resulting in formation of active helicase core 
and provide a surface for RNA binding (Andersen et ah, 2006; Karow and Klostermeier, 
2010).
The binding of helicase core with RNA resulted in RNA bending which then 
destabilized its secondary structure for the RNA unwinding step (Aregger and 
Klostermeier, 2009). eIF4A undergoes conformational changes by binding to ATP, RNA 
and other proteins of eIF4F complex as shown by thermodynamic and kinetics studies 
(Lorsch and Herschfag, 1998).
eIF4A also interacts with other canonical eukaryotic initiation factors such as eIF4G, 
eIF4B, and eIF4H. eIF4A interacts with eIF4G via three HEAT repeat domains (HEAT 
1 - 3 )  (Marcotrigiano et ah, 2001) The binding sites are located on the N- and C- 
terminals of eIF4G. Apart from eIF4G, eIF4A helicase activity can also be stimulated by 
eIF4B (Rogers et ah, 2001). A study by Feng et al, (2005) has reported that binding of 
eIF4B and eIF4H enhances the helicase activity of eIF4A. Furthermore, a number of 
techniques including NMR, site-directed mutagenesis and biophysical assay (Marintchev 
et ah, 2009) have suggested a model of eIF4A-elF4G-eIF4H which showed that eIF4A
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Figure 1.8: Translation initiation complex (eIF4F). This complex is made up of the 
associated cap-binding protein (eIF4E), scaffold protein (eIF4G) and RNA helicase 
protein (eIF4A).
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uses different surfaces to interact with two HEAT repeat domains of eIF4G and 
eIF4B/4H. It was predicted that these dynamic interactions was changed during ATP 
binding and hydrolysis. From the proposed model, it shows that association between 
eIF4A and mRNA at the point of entry and exit of the 40 S subunit facilitate the 
unwinding of RNA (Marintchev et ah, 2009).
The activity of eIF4A can be inhibited by two compounds. The compounds are 
Pateamine A (Low et ah, 2005) and hippuristanol (Bordeleau et ah, 2005). Pateamine A 
posses an antiproliferative and proapoptotic properties which was identified in natural 
marine compound (Hood et ah, 2001). The compound was proposed to inhibit eIF4A- 
eIF4G complex formation (Low et ah, 2005). The binding site between Pateamine A and 
eIF4A has yet to be determined but a linker region connecting the N- and C- terminal 
domains of DEAD-box family members has been suggested to be responsible for the 
activity (Low et ah, 2007). Another compound, hippuristanol, inhibits the eIF4A activity 
by lowering the binding ability of eIF4A to mRNA (Bordeleau et ah, 2005). As reported 
by Lindqvist et ah, (2008), the binding site of hippuristanol on eIF4A is differ from the 
ATP binding site, as the binding of hippuristanol on eIF4A does not inhibit the binding 
of ATP to eIF4A.
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1.7.2 Initiation factor eIF4G
eIF4G plays an important role by recognizing the proteins which are bound to the 5' and 
3' ends of mRNA. eIF4G serves as a linker for the mRNA and cap-binding complex by 
facilitating eIF4E binding to the 5' cap. eIF4G is also responsible in mRNA 
circularization by binding to poly-A binding protein (PABP) which interacts with the 
poly(A) tail on the 3' end of mRNA (Gross et al., 2003; Mathews et al., 2007). 
Functional mapping revealed that eIF4G interacts with eIF4A, eIF4E, PABP and eIF3 
simultaneously (Lamphear et al., 1995; Imataka and Sonenberg, 1997). eIF4G possesses 
a binding sites for eIF4E, PABP, eIF3, MAP kinase-interacting kinase 1 (Mnk-1) and 
two eIF4A binding sites.
A new homologue of eIF4G, known as eIF4GII (176 kDa) was discovered by Gradi et 
al., (1998). Therefore, the original eIF4G was renamed as eIF4GI with the size of 171 
kDa. eIF4GII has 46% homology to eIF4GI and both eIF4GI/eIF4GII play an essential 
roles in mRNA recruitment by acting as a linking bridge on which the translation 
initiation complex is assembled. Apart from the similarities between both of them, it has 
been reported that in the formation of eIF4F complexes during differentiation of 
megakaryocytes, eIF4GII was the preferred eukaryotic initiation factor (Caron et al., 
2004).
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1.7.3 Initiation factor eIF4E
Another important subunit of eIF4F complex is eIF4E and also known as the cap- 
binding protein. eIF4E was identified initially during the studies of proteins that has 
direct interaction with the m7G cap (Sonenberg and Shatkin, 1977; Sonenberg et al., 
1979). The protein is a well conserved protein of 25 kDa. eIF4E has been reported to 
have a high binding specificity and affinity to the 5' cap structure of the mRNA 
molecule (Haghighat and Sonenberg, 1997). The binding affinity is further enhanced by 
eIF4G through the N-terminus of eIF4E and a conserved domain of eIF4G (Mader et al., 
1995; Hershey et al., 1999).
The activity of eIF4E is regulated by phosphorylation via mitogen-activated protein 
kinase (Mnk-1) on Serine 209 (Waskiewicz et al., 1997; Waskiewicz et al., 1999). 
Although phosphorylation is responsible for the eIF4E activity, several studies have 
shown a mixed opinion on the role of eIF4E phosphorylation in translational regulation 
(Scheper and Proud, 2002; Wendel et al., 2007). Besides phosphorylation, eIF4E is also 
being regulated by eIF4E-Binding Proteins (4E-BPs). These proteins act as a 
competitive inhibitor during eIF4F complex formation (Mader et al., 1995; Richter and 
Sonenberg, 2005) by binding of its several isoforms (4E-BP1, 4E-BP2 and 4E-BP3) to 
eIF4E. The binding of 4E-BPs to eIF4E will inhibit the cap-dependent translation by 
competing with eIF4G for the binding sites on eIF4E.
38
1.8 Alternative methods of translation initiation
Most eukaryotic translation mechanisms involve in cap-dependent mechanism as 
described above. However, there is some exception which does not require the 
traditional mechanism (Figure 1.9). Such examples of the alternative mechanisms are 
reinitiation and internal initiation. The two mechanisms differ in the origin of the 
ribosomes used in translation. In reinitiation, the same ribosomes that have translated an 
upstream ORF (uORF) via the canonical initiation process continue to scan and reinitiate 
translation at a downstream AUG codon. In Internal Ribosome Entry Site (IRES)- 
mediated initiation, the translation of a cistron is 5' end-independent and the ribosomes 
are recruited internally to the mRNA, at or close to the initiation site. Another alternative 
mechanism of translation initiation involves the process of initiation codon selection 
called leaky scanning. In this mechanism, one molecule of mRNA directs the synthesis 
of two different proteins since multiple AUGs can be chosen as the start codon. In this 
scenario, a scanning 43 S complex misses the first AUG(s) on the mRNA and initiates 
downstream translation. The other mechanism is the ribosome shunting which is where 
the scanning ribosome is believed to jump a large region of the UTR and relocate itself 
closer to the initiation codon. In ribosome frameshifting, a translating ribosome slips 
forward or backward 1 nt, resulting in synthesis of a single fusion protein from two or 
more overlapping ORFs.
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1.8.1 Reinitiation
Reinitiation is a mechanism by which ribosomes are able to translate a downstream 
ORF, when translation of a short upstream open reading frame (sORF) has already 
terminated. During normal translation termination, 40S and 60S subunits will dissociate. 
When a very short ORF being transcribed, there is possibility of the 40S subunit may 
remain associated with the mRNA, thus resume scanning and reinitiate translation at the 
downstream AUG codon (reviewed by Jackson et al., 2012). It is thought that certain 
initiation factors that are still attach to the ribosome during translation of the short ORF 
are responsible for the 40S subunit re-association with the mRNA. After the translation 
of short ORF, the 40S subunit of the ribosome is not immediately competent to 
reinitiate, but becomes competent after scanning for some distance. The 40S subunit 
time of action is almost exactly to the time required for other initiation factors such as 
eIF2-Met-tRNAi-GTP ternary complex.
Short ORF reinitiation mechanism was normally found in cellular genes for expression 
regulation of downstream protein-encoding ORFs (Morris and Geballe, 2000; Ingolia et 
al., 2011). One of the examples is GCN4 Short ORF reinitiation that occurs in 
eukaryotic mRNAs (reviewed in Jackson, 2007). The yeast GCN4 mRNA of 
Saccharomyces cerevisiae, contains a highly A/U rich region on the downstream of 
ORF4 (Grant and Hinnebush, 1994). Translational control of GCN4 depends on four 
short open reading frames of two or three codons in length present in the GCN4 mRNA 
leader, of which the first (uORFl) and fourth (uORF4) are sufficient for translation. A 
diverse collection of A+U rich sequences present in the termination region of uORFl
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could restore efficient reinitiation at GCN4 in the present of the third codon derived 
from uORF4. Many different A+U-rich triplets at the third codon of uORFl can 
overcome the inhibitory effect of the termination region derived from uORF4 on the 
efficiency of reinitiation at GCN4. Efficient reinitiation is not associated with codons 
specifying a particular amino acid or isoacceptor tRNA.
1.8.2 Leaky scanning
Leaky scanning is a mechanism commonly used by RNA viruses to translate 
functionally multicistronic messages. It was first discovered in the SI segment of 
mammalian orthoreovirus (Ernst and Shatkin, 1985). Within the SI segment, the AUG 
signaling the start of o l protein (49 kDa) is suboptimal while another AUG lies further 
downstream to encode the 14 kDa non-structural o ls protein. Leaky scanning can occur 
when the first AUG is in a suboptimal Kozak context, scanning ribosomes fail to 
recognize it and continue to scan until they recognize new initiation codon further 
downstream (reviewed by Kozak, 2002). Results of this process produces an expression 
of multiple C-terminally coincident isoforms of a single protein, different proteins 
encoded by different overlapping ORFs, or different proteins encoded by non­
overlapping sequential ORFS (reviewed by Firth and Brierley, 2012). One of the 
example is HIV-1 envelope protein (Env) which is translated from mRNAs of Vpu 
protein in a different reading frame (Schwartz et al., 1992). Apart from that, translation 
of three or even more distinct proteins have been reported from a single transcript which 
involve a non-AUG codon or poor AUG codon context (Turina et ah, 2000; Castano et 
ah, 2009).
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The efficiency of leaky scanning depends on several factors. One of the factors is the 
location of nucleotides adjacent to the AUG codon. The location of nucleotides 
immediately in front of AUG and the identity of nucleotides right after the start codon 
itself (Kozak, 1986; Nakagawa et ah, 2008). The distance of 5' end transcripts is another 
factor that might promote leaky scanning mechanism. If the AUG codon is located at 
very close to the 5' end of transcripts, it is often not recognized efficiently. The 
effectiveness will decrease proportionally if the distance is below 30 nt and particularly 
below 12 nt (Sedman et ah, 1990; Kozak, 1991).
1.8.3 Ribosome shunting
Ribosome shunting is a process where a ribosome is scanning downstream ORFs in a 5'- 
end-dependent manner but at least partly scanning-independent (Firth and Brieley, 
2012). In this mechanism, the 40S ribosomal subunit is believed to skip a region of the 
mRNA at a distance up to hundreds of nt long and relocate itself at a downstream 5' end 
of mRNA. Most ribosome shunting process occurs when there is a hairpin structure in 
the ribosome scanning area. The best characterized ribosome shunting mechanism has 
been shown in the virus family of Caulimoviridae (Futterer et ah, 1993; reviewed by 
Thiebeauld et ah, 2007). In the case of the cauliflower mosaic virus, the translating 
ribosomes skip a large region of the mRNA folding into a large stem-loop structure. 
Translation occurs through 5' cap-dependent and the 40S subunits scan and translate the 
short ORF which are upstream of stem-loop. Upon termination process, the ribosome 
was able to ‘jump through’ the stem-loop and proceed with scanning at a landing site at 
3' end of stem-loop (Schmidt-Puchta et ah, 1997; Pooggin et ah, 2006).
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Figure 1.9: Noncanonical or alternative translation mechanisms among viruses.
Reinitiation, leaky scanning, ribosome shunting and 1RES are the most common 
alternative translation mechanism. Red arrows represent start of translation process with 
green arrows show a movement of 40S subunit in a noncnonical manner. Start of 
translation process and movement indicated with red arrows. Adapted from Firth and 
Brierley, (2012).
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1.8.4 Internal ribosome entry site (IRES)-mediated initiation of translation
Internal ribosome entry site (1RES) elements are RNA elements that direct ribosome 
entry at an internal site on the mRNA. Most 1RES consist of a complex RNA structure 
that functions by recruiting the ribosomes to internal positions on mRNAs (reviewed by 
Kieft et ah, 2008; Balvay, 2009). The mRNAs translated via this mechanism are usually 
uncapped with long 5' UTRs and multiple AUG codons (reviewed by Belsham and 
Jackson, 2000). 1RES elements were first identified in picomavirus RNAs (Jang et ah, 
1988; Pelletier and Sonenberg, 1988). The 1RES function allows viral mRNA 
translation to continue while the host translation mechanism is suppressed or inhibited.
1RES elements have also been reported in mRNAs expressed in animal cells, vertebrate 
and invertebrate (Fernandez et ah, 2006; Yang et ah, 2006; Pickering et ah, 2004), plants 
(Dinkova et ah, 2005) and yeasts (Gilbert et ah, 2007). All these eukaryotic 1RES 
elements have similar functions or use the same regulatory pathway in their protein 
translation process. A few examples of the pathways are nutrient deprivation, apoptosis 
or heat shock (Fernandez et ah, 2006; Riley et ah, 2010; Macejak and Samow, 1991). A 
website riittD://iresite.ors) has been developed to store all the published 1RES elements 
found (Mokrejs et ah, 2006).
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1.8.4.1 Types of 1RES
Viral IRESes differ in nucleotide sequence, RNA secondary structure and trans-acting 
factor requirement. Picomaviruses 1RES which were first reported to have 1RES 
elements (Jang et ah, 1988; Pelletier and Sonenberg, 1988) are classified into four types 
(I, II, III and IV) based on the RNA structure organization. Other than the picomavirus 
1RES, there are also HCV 1RES, IGR 1RES and cellular 1RES.
1.8.4.1.1 Type I picomavirus 1RES
Type I picomavirus 1RES are found in the mRNAs of enteroviruses such as poliovims 
(PV) or coxsackie B vims (CBV) and rhino vimses such as human rhino vims (HRV). 
They require eIF4G, eIF4A, eIF2 and eIF3 for 48S complex formation (Figure 1.10; 
Kolupaeva et al., 1998). eIF4E is not required in the complex formation and the PV 
1RES activity is stimulated in eIF4E silenced-cells (Svitkin et al., 2005). The 1RES 
require HeLa cell extracts for it to function in the in vitro cell-free mammalian Rabbit 
Reticulocyte Lysate (RRL) system suggesting that cellular trans-acting factors are 
required for optimal 1RES activity (Brown and Ehrenfeld, 1979; Borner et al., 1984). 
This type of 1RES element is also stimulated by the proteases L and 2A, which cleave 
eIF4G, both in in vitro cell systems and in mammalian cells (Borman et al., 1995; 
Roberts et al., 1998).
Secondary structure analysis of type I picomavirus 1RES revealed that the structure 
consists of six domain, named I to VI (Figure 1.11; Pelletier et al., 1988). Domains II 
through domain VI have been reported as a requirement for 1RES activity (reviewed by
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Jang, 2006). The 3' terminus of 1RES is located 150 nt downstream of the start codon 
and the presence of AUG codon upstream of the 1RES does not affect translation. 
However, insertion of AUG codon on the 3' end of the 1RES suppresses viral protein 
synthesis due to disruption of scanning mechanism and codon selection initiation (Kuge 
et ah, 1989).
As being mentioned above, PV 1RES is not inactive in the RRL translation system. 
However, upon supplement with HeLa cell extracts, the 1RES activity was enhanced 
(Domer et al., 1984). This finding leads to the discovery of noncanonical translation 
factors for type I picomavirus 1RES such as Unr (upstream of N-ras1) factor for 
rhinovims 1RES (Hunt et al., 1999) and the RNA binding protein PCBP-2 for poliovims 
1RES (Blyn et al., 1997).
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Figure 1.10: Initiation factors requirement for Type I picomavirus 1RES.
Type I picomavirus 1RES requires eIF4A, eIF4G, eIF3, eIF2 and ITAFs for function. 
The AUG codon is located downstream of the 1RES.
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1.8.4.1.2 Type II picomavirus 1RES elements
Type II picomavirus 1RES has been identified in cardiovimses (e.g. EMCV and TMEV) 
and apthovimses (e.g. FMDV) and these elements reside in the 5' UTRs of the vimses 
(Jackson and Kaminski, 1995). These elements function efficiently in the RRL and are 
only moderately stimulated by viral proteases (Borman et al., 1997; Roberts et al.,
1998). Similar to type I picomavirus 1RES, type II picomavirus 1RES require only 
eIF4G, eIF4A, eIF2 and eIF3 to assemble 48S complex formation (Figure 1.12; Pestova 
et al., 1996; Kolupaeva et al., 1998; Filipenko et al., 2000, 2001). The formation of the 
complex is absent of eIF4E, as been shown that infection of EMCV induces 
sequestration of eIF4E by déphosphorylation (Gingras et al., 1996).
Analysis of the secondary structures revealed that the 5' UTR of type II picomavirus is 
longer with more structural elements. The 1RES contains twelve domains, named A to L, 
of which H-L are essential for 1RES activity (Figure 1.11; Duke et al., 1992). Type II 
1RES elements are located 450 nt upstream of the initiation codon. The ribosome is 
recmited by the 1RES at, or very close to the initiation codon and little scanning is 
involved (reviewed in Jackson and Kaminski, 1995).
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Figure 1.11: Secondary structure of type I and II picomavirus 1RES elements.
Secondary structure of PV 5' UTR (Type I) and EMCV 5' UTR (Type II). Numbers 
indicate nucleotide starting at the 5' end of the genomic RNA. Shown are the poly(C), 
the pyrimidine-rich tracts and stem-loop* conserved in types I and II 1RES elements. 
Taken from Jang, (2006).
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Figure 1.12: Initiation factor requirement for Type II picomavirus 1RES.
Type II picomavirus 1RES requires eIF4A, eIF4G, eIF3, eIF2 and ITAFs for function 
similarly to type I picomavirus 1RES. The AUG codon is located near the 1RES.
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Like type I picomavirus 1RES, noncanonical translation factor or 1RES frares-acting 
factors (ITAFs) also required by certain 1RES element on type II picomavirus 1RES. For 
example, in FMDV 1RES, formation of 48S complex is enhanced with the presence of 
PTB and ITAF45 (Filipenko et ah, 2000, 2001). PTB also has been reported to function 
as ITAF for TMEV 1RES (Filipenko et ah, 2001) and EMCV 1RES (Kafasla et al. 2009).
1.8.4.1.3 Type III picomavirus 1RES elements
The 1RES in the Hepatitis A virus (HAV) genome is the only example of the third type 
of 1RES element. Unlike other picomaviruses, HAV infection does not result in host cell 
translational shutoff and develops into a slow non-cythopathic replication cycle, both in 
cell culture and in vivo. Translation of HAV has been shown to be poor due to low 
efficiency in translation of its RNA (Whetter et al., 1994). Furthermore, translation of 
HAV 1RES has been reported to be much less efficient compared to type I and II 
picomavirus 1RES either in vitro or in cell (Whetter et al., 1994; Bonnan et al., 1995). In 
contrast to PV 1RES which requires HeLa cell extracts addition in RRL system, HAV 
1RES was inhibited, suggesting different requirement in cellular proteins needed for 
1RES to function (Brown and Ehrenfeld, 1979; Domer et al., 1984). However, with 
addition of liver cell extracts, HAV 1RES was able to function properly although the 
activity is limited (Glass and Summers, 1993).
The HAV 5' UTR is 730 nt long, contains ten AUG codons and is predicted to fold into 
six domains, I to VI (Figure 1.13; Brown et al., 1991). Two pyrimidine-rich tracts are 
found at the 5' end and the 3' end of the 1RES. The borders of the HAV 1RES have been
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identified between domains III and V (Brown et al., 1994). The pyrimidine tract at the 3' 
end falls within the 1RES and is located in a similar position to the oligopyrimidine tract 
in the EMCV 5' UTR (Brown et al., 1991).
Unlike other picomavirus types of 1RES elements, the HAV 1RES is functional only in 
the presence of an intact eIF4G (Borman and Kean, 1997; Ali et al., 2001). This 1RES 
element is inhibited by 4E-BP1 and eIF4G cleavage and requires all the components of 
the eIF4E complex (Ali et al., 2001; Borman et al., 2001). It has been suggested that the 
cap-binding factor eIF4E is required not for its cap- or RNA-binding ability, but for the 
conformational change that induces in eIF4G (Ali et al., 2001). Another proposed 
explanation for the HAV 1RES requirement for eIF4E involves a direct eIF4E-IRES 
interaction. This would potentially occur at an internal G nt, proposed to be methylated. 
The resulting weak interaction would be stabilised by the presence of eIF4G. This is 
supported by the inhibitory effect of a cap analogue on HAV 1RES activity (Ali et al., 
2001; Jackson, 2005). Although secondary structure analysis revealed an organisation 
reminiscent of that of EMCV (Brown et al., 1991), the HAV 1RES requirement for 
initiation factors is unique amongst the other picomavirus 1RES elements and requires 
the 1RES to be placed in a separate group (Figure 1.14).
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Figure 1.13: Secondary structure of type III picomavirus 1RES element. Secondary 
structure of the HAV 5’ UTR. The small open box represent the AUG used as an 
initiation codon. pYI represents the pyrimidine rich tract. Taken from Schultz et al., 
(1996).
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Figure 1.14: Initiation factor requirement for Type III picomavirus 1RES.
Type III picomavirus 1RES requires eIF4F complex along with eIF3, eIF2 and ITAFs 
for function.
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1.8.4.1.4 Type IV picomavirus 1RES elements
Type IV picomavirus 1RES elements has been discovered during a study on the outbreak 
of polioencephalomyelitis in swine and named porcine teschovims 1 Talfan strain (PTV- 
1; Kaku et ah, 2001). The 5' UTR of PTV-1 is much shorter than the 5' UTRs of the 
majority of picomaviruses, being only 411 nt long (Belsham and Jackson, 2000; Kaku et 
ah, 2002). In addition, 125 nt at the 5' end of the PTV-1 5' UTR can be deleted, resulting 
in a 280 nt long functional 1RES element (nt 126-411; Kaku et ah, 2002). The PTV-1 
1RES is active in vitro and in cell culture systems and is not affected by eIF4G cleavage 
(Kaku et ah, 2002; reviewed in Bedard and Semler, 2004). Despite sharing these 
properties with the aptho- and cardiovimses, sequence alignment analysis suggested that 
the PTV-1 1RES was distinct from the picornaviridae family and very similar to the 
1RES element of the Hepatitis C vims, a Flavivirus (HCV; Pisarev et ah, 2004). Indeed, 
secondary structure prediction of the PTV-1 1RES revealed an organizational pattern 
unique within the picomaviral 1RES elements, but one highly reminiscent of the 
domains and pseudo-knot of the HCV 1RES (Figure 1.15; Pisarev et ah, 2004). In 
addition, as for the HCV 1RES, the PTV-1 1RES has a minimal elF requirement, limited 
to eIF2 and Met-tRNA and the 40S ribosomal subunit (Pisarev et ah, 2004). eIF3, 
although not strictly required for 48S formation, binds directly to the PTV-1 1RES 
(Figure 1.16; Pisarev et ah, 2004).
Other recently discovered picomavirus 1RES elements also showed similarities to the 
group which include porcine enterovirus-8 (PEV8), simian vims 2 (SV2), avian 
encephalomyelitis vims (AEV) and simian picomavims 9 (SPV9) [Chard et ah, 2006;
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Bakhshesh et al., 2008; de Breyne et al., 2008]. Furthermore, on the basis of sequences 
information and RNA structure prediction, it has been suggested that the duck hepatitis 
virus 1 (Ding et ah, 2007), a seal picomavirus (Kapoor et ah, 2008), Seneca valley vims 
(Hellen and Breyne, 2007) and porcine kobuvims (Reuter et ah, 2009) also contain this 
type of 1RES.
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Figure 1.15: Secondary structure of type IV picomavirus 1RES elements. The PTV- 
1 1RES structure has been derived by comparison with the related 1RES from HCV. 
Domains are labeled according to the corresponding domains in the HCV 1RES. From 
Chard et al., (2006).
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Met-tRNA
Figure 1.16: Initiation factor requirement for Type IV picomavirus 1RES.
Type IV picomavirus 1RES only requires eIF3, eIF2 and Met-tRNA for function.
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1.9 7>ti/is-acting factors
Variation in 1RES efficiency within different cell types has led to a search for factors 
required for efficient IRES-mediated translation, in addition to the canonical initiation 
factors (Borman et ah, 1997; Roberts et ah, 1998; reviewed in Belsham and Jackson, 
2000). A growing number of proteins have been shown to act as 1RES-/Turns' acting 
factors (ITAFs). All ITAFs found to promote 1RES activity so far contain multiple 
RNA-binding domains and are likely to interact with more than one part of the 1RES at 
once, acting as RNA chaperones. These factors would hold the 1RES in specific 
conformations, contributing towards the optimal structure-function relationship of the 
1RES (Belsham and Sonenberg, 2000).
Noncanonical factors or ITAFs was postulated to influence translation initiation came 
from the observation of poliovirus and rhinovirus 1RES element which were very weak 
in rabbit reticulocyte lysate (RRL). However, the 1RES activity can be rescued by the 
addition of HeLa cell cytoplasmic extracts, while HAV 1RES activity in RRL is 
stimulated by the addition of mouse liver cytoplasmic extracts (Homer et ah, 1984; 
Glass and Summers, 1993; Jackson and Kaminski, 1995). This suggests that HeLa 
extracts and liver extracts contain translation factors, or higher concentrations of factors, 
that are missing/not abundant in the RRL.
So far, the cellular proteins identified to be involved in interaction with picomavirus 
1RES elements are polypyrimidine-tract binding protein (PTB), La, poly(rC)-binding 
protein 2 (PCBP2), upstream of N-ras (Unr), Unr interacting protein (Unrip), 1RES
5 9
toms-acting factor 45 (ITAF45) and nucleolin (Jang and Wimmer, 1990; Meerovitch et 
al., 1989; Blyn et al., 1995; Hunt et al., 1999; Filipenko et al., 2000; Waggoner and 
Samow, 1998).
1.10 The Hepatitis C Virus (HCV) 1RES element
HCV is a positive stranded RNA virus with a genome of approximately 9600 
nucleotides. The virus is classified in the Hepacivirus genus within the Flavivirus family 
(Choo et al., 1989) and was proposed to contain 1RES element on the 5' UTR of the 
virus (Tsukiyama-Kohara et al., 1992). The HCV 5' UTR is highly structured and is 340 
nt long. Interestingly, the boundaries of the 1RES have been mapped to nt 40 -  370. 
Therefore, the HCV 1RES includes the AUG initiation codon (nt 341-3) and extends into 
the viral coding region (Brown et al., 1992; Wang et al., 1993; Reynolds et al., 1995). 
Structural analysis revealed that the HCV 5' UTR folds into 4 domains (I-IV; Figure 
1.17). The 1RES is found in domain II-IV and the AUG initiation codon is found in 
domain IV (Honda et al., 1996; Reynolds et al., 1996; Zhao and Wimmer, 2001). The 
HCV 1RES binds directly to the 40S ribosomal subunit and requires only eIF3 and eIF2 
to assemble a functional preinitiation complex (Figure 1.18; Pestova et al., 1998; Kieft 
et al., 2001a). Most of the HCV 1RES is involved in interactions with the 40S subunit, 
while only the apical part of domain III (i.e. subdomains Illa-IIIc) interacts with eIF3 
(Pestova et al., 1998; Kieft et al., 2001b). The structure of the HCV IRES-40S complex 
has been solved by cryo electron microscopy. It was shown that the HCV 1RES induces 
a conformational change in the 40S subunit in the region of the mRNA-binding cleft. 
Domain II of the HCV 1RES is involved in this change through interactions with the E
6 0
site region of the 40S subunit (Spahn et al., 2001). The HCV IRES-40S subunit complex 
is believed to be assembled first and followed by the joining of eIF3 and formation of a 
preinitiation complex (Otto and Puglisi, 2004). The current model of the HCV IRES-40S 
subunit-eIF3 complex involves extensive interactions between eIF3 and 40S subunit. 
The HCV 1RES is responsible for holding together eIF3 and the 40S subunit 
(Siridechadilok et al., 2005). Interestingly, the structure of the HCV IRES-40S subunit- 
eIF3 complex is similar to that of the 40S subunit-eIF3-eIF4G complex. This suggests 
that the HCV 1RES and eIF4G might have a similar function in anchoring the mRNA to 
the 40S subunit (Siridechadilok et al., 2005).
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Figure 1.17: Secondary structure of HCV 5' UTR 1RES. The HCV 1RES comprises 
nucleotide 40-340, that correspond to domain II-IV. A predicted pseudoknot within 
domain III (subdomain lllf) is indicated by solid lines. The initiation codon is found 
within domain IV of the 1RES and is highlighted. Taken from Honda et al., (1999).
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Figure 1.18: Initiation factor requirement for HCV 1RES. The HCV 1RES only 
requires eIF3, eIF2 for function.
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1.11 Dicistroviridae 1RES elements
The dicistroviridae are a group of insect viruses with non-segmented single-stranded 
linear positive-sense RNA genome. It was previously referred as “Cricket paralysis-like” 
viruses or insect picoma-like viruses, because of the similarities with the mammalian 
picomaviruses (D’Arcy et ah, 1981; Mayo, 2002). Members of the typifying genus 
Cripavirus are Cricket paralysis virus (CrPV), Drosophila C virus (DCV), Plautia stali 
intestine virus (PSIY), Triatoma virus (TrV), Taura syndrome virus (TSV) and 
Rhopalosiphum padi virus (RhPV). Dicistroviruses infect a wide range of insects, 
including aphids, honeybees and Drosophila (reviewed in Jan, 2006). The 
Dicistroviridae have a genome that consists of a single plus-strand RNA with a genome- 
linked protein VPg at the 5’ end and poly(A) residues at the 3' end (King and Moore, 
1988). The dicistrovirus RNA contains two ORFs, each one encoding a polyprotein: the 
S' ORF encodes the precursor of the non-structural proteins, while the 3' ORF encodes 
the structural proteins (Figure 1.19; Johnson and Christian, 1998; Moon et ah, 1998; 
Domier et ah, 2000). These two ORFs are separated by an intergenic region (IGR) of 
approximately 200 nt length and are expressed by two distinct IRESes (Wilson et a., 
2000). Translation initiation of the downstream cistron is independent from any of the 
canonical initiation factors and Met-tRNA (Figure 1.20) but dependent on structural 
features of the intergenic 1RES, especially a pseudoknot preceeding the initiation codon 
(Jan and Samow, 2002; Kanamori and Nakashima, 2001). Translational of the 
downstream ORF is initiated at a non-AUG codon so that either a glutamine (CAA) or 
alanine (GCU and GCA) will be replaced at the N-terminal residue of the capsid protein 
precursor (Wilson et ah, 2000; Sasaki and Nakashima, 2000). The CrPV 5' UTR, which
6 4
precedes 0RF1, has some features similar to the mammalian picomaviruses; it is very 
long (709 nt) and contains many AUGs and stop codons, and it was shown to be able to 
direct initiation of translation via an 1RES element (Wilson et ah, 2000). The IGR also 
contains an 1RES element. However, the CrPV IGR 1RES is much shorter than the 
picomavirus 1RES elements, being only 192 nt long. In addition to CrPV, other 
members of the Dicistroviridae family have been found to contain an 1RES element 
upstream of both ORFs, including the 5' UTRs and the IGRs of PSIV and RhPV, the 5' 
UTR of TrV and the IGR of TSV (Domier et ah, 2000; Sasaki and Nakashima, 2000; 
Woolaway et ah, 2001; Cevallos and Samow, 2005; Czibener et ah, 2005, 2006).
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Figure 1.19: Secondary structure of CrPV IGR 1RES element.
The IGR 1RES element of CrPV is predicted to adopt a structure in which three 
pseudoknots (PKI, II and III) are the main secondary structures. PKI occupies the 
P site of the ribosome and contributes to positioning the initiation codon (GCU) in 
the A site. Ala is alanine and Thr is threonine. The stemloops 1 and 2 (SL1 and 
SL2) are involved in the contacts with the 40S ribosomal subunit. Taken from Jan, 
2006.
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Figure 1.20: Initiation factor requirement for Dicistroviridae 1RES. The 
Dicistroviridae 1RES requires no initiation factor for function.
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1.12 Internal initiation on cellular mRNAs
The presence of 1RES elements in cellular mRNAs was first noticed when some cellular 
proteins are translated during poliovirus infection although the cap-dependent translation 
is inhibited (Samow, 1989). The first cellular 1RES was identified in the mRNA of the 
immunoglobulin heavy-chain binding protein, BiP (Macejak and Samow, 1991). Since 
then, many cellular 1RES elements have been discovered in mRNAs encoding proteins 
associated with different cell events. These include growth/cancer, mitosis and apoptosis 
(reviewed in Elroy-Stein and Merrick, 2007). Examples are the fibroblast growth factor 
2 (FGF2, Vagner et al., 1995), the mitotic protein PITSLRE kinase (Comelis et al., 
2000; Tinton et al., 2005), the X-linked inhibitor of apoptosis, XIAP (Holcik eta 1.,
1999), the apoptotic protease-activating factor 1 (Apaf-1; Coldwell et al., 2000), the 
oncogene c-myc (Nanbu et al., 1997; Stoneley et al., 1998) and the tumour suppressor 
p27 (Kullmann et al., 2002). Like the viral 1RES elements, cellular 1RES elements are 
generally found in long 5' UTRs. However, in contrast to the viral mRNAs, the cellular 
mRNAs that contain 1RES elements also possesses a cap structure at their 5' end and 
seem to be lack of a compact and complex RNA structure
Chemical and enzymatic RNA structure probing has been performed on some cellular 
1RES elements, including c-myc and Apaf-1 (Le Quesne et al., 2001; Mitchell et al., 
2003). These studies revealed that there are no conservation structural domains among 
the cellular 1RES elements, in a similar way to different types of picomavirus 1RES 
elements (reviewed in Belsham and Jackson, 2000). However, in contrast to the viral 
1RES elements, the cellular 1RES elements appear to tolerate small deletions and point
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mutations (reviewed in Stoneley and Willis, 2004). This suggests that the structure of the 
cellular 1RES elements is more flexible than the picomavirus 1RES elements. It has also 
been reported that the mechanism of the cellular 1RES of Gtx, from the Gtx mRNA that 
encodes a homeodomain protein, and of Rbm3, from the Rbm3 mRNA that encodes a 
putative RNA-binding protein, involve conserved short nt repeats that give a modular 
character to the 1RES. Interestingly, one of these sequences is complementary to the 18S 
rRNA, suggesting a direct interaction between the 1RES and the 40S subunit. However, 
multiple copies of the conserved nt repeats (5-10) are required for efficient 1RES activity 
(Chappell et al., 2000; Chappell and Mauro, 2003; Dobson et al., 2005).
As with the case of the picomavirus 1RES elements, some cellular 1RES elements are 
also stimulated by ITAFs. PTB and Unr have been shown to bind to the Apaf-1 1RES 
and increase its activity (Mitchell et al., 2001). Binding of these ITAFs promotes a 
change in the 1RES conformation. In particular, Unr promotes unwinding of two regions 
of the 1RES. One is the Unr-binding site itself. The other one is further downstream, 
where the PTB binding site is located. The overall dismption of secondary structures 
induced by the ITAFs favors the recmitment of the translational machinery (Mitchell et 
ah, 2003). However, it is has to be noted that PTB appears to have an inhibitory effect 
on the BiP 1RES, suggesting that ITAFs might negatively affect internal initiation (Kim 
et ah, 2000).
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Cellular 1RES elements have been shown to be related to a specific disease (reviewed in 
Elroy-Stein and Merrick, 2007). Yoon et al. (2006) showed that the aetiology of X- 
linked Dyskeratosis Congenita (X-DC), which is characterised by the increased 
susceptibility to cancer, resides in the inability of the ribosome to assume a 
conformation that is competent to the 1RES binding. Specifically, the lack of a 
functional copy of a pseudoridine synthase {DKCI) prevents a modification of ribosomal 
RNA that results in low affinity for 1RES elements. Therefore, in patients affected by X- 
DC, the ribosomes are not able to efficiently take part in IRES-mediated translation. As 
a result, the IRES-containing mRNAs of the tumour suppressor p27, and the pro- 
apoptotic XIAP and bcl-xL are not efficiently translated. The lack of the corresponding 
proteins results in the increased susceptibility to cancer associated with X-DC (Yoon et 
al., 2006).
1.13 KSHV 1RES
It has previously demonstrated that an 1RES element was detected from the transcription 
and splicing of latent ORFs 71 (K13), 72, and 73 of KSHV in the primary effusion 
lymphoma cell line, BCP-1 (latently infected with KSHV) (Bieleski and Talbot, 2001; 
Grundhoff and Ganem, 2001; Low et al., 2001). The three genes encoded by these ORFs 
are transcribed from a common transcription start site in BCP-1 cells during both latency 
and the lytic cycles. From the experiment, the transcript is spliced to yield a 5.32 kb 
message encoding LANA, vCyclin and vFLIP and 1.7 kb bicistronic message encoding 
vCyclin and vFLIP. Since a monocistronic transcript coding for vFLIP alone has never 
been detected, the expression of the vFLIP may be derived from some other
7 0
unconventional mechanism such as 1RES (Figure 1.21). It was later confirmed that 
1RES is responsible for the vFLIP expression which located in vCyclin coding region 
(Bieleski and Talbot, 2001).
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Figure 1.21: Location of the KSHV 1RES. The KSHV 1RES is located within the 
vCyclin ORF and is thought to be responsible for the vFLIP expression.
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1.14 Project aims
The objective of this project was to conduct studies on the mechanism of translation 
initiation of KSHV 1RES. To do so, the specific aims of the project were the following:
1. The identification of the minimal sequences of the KSHV 1RES in vitro and in 
vivo systems.
2. The identification of eukaryotic initiation factors (elFs) associated with KSHV 
1RES and KSHV 1RES-interacting proteins.
3. Secondary structure analysis and prediction of KSHV 1RES
7 3
Chapter 2 
General Materials and Methods
2.1 Polymerase chain reaction (PCR)
The reactions consisted of 30 ng template DNA, 5 pi 1 Ox PCR buffer (Promega), 1 pi 
dNTPs (5 mM; Promega), 1 pi each primer (1 pg/pl; Sigma Genosys) and 5 units of Taq 
enzyme (5 u/ pi; promega). The reactions were made up to 50 pi with autoclaved water. 
The list of primers and specific conditions for each PCR reaction are given in the 
relevant chapter.
2.2 Purification of PCR products
PCR products were purified using the QIAquick PCR product purification kit (Qiagen) 
as described in the manufacturer’s instructions.
2.3 Agarose gel electrophoresis
Agarose gels (1% w/v; Melford) containing ethidium bromide (10 mg/ml) were made 
with 1 x TAB (Appendix). Samples were loaded in 6 x loading dye (Promega). The gels 
were run at 125 V in 1 x TAB. For RNA analysis, agarose gels made with 1 x TBE 
(Appendix) were used and the samples were loaded in 2 x TBE sample buffer 
(Appendix).
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2.4 Restriction enzyme digestion
Analytical digests were carried out in a final volume of 20 \i\. Reactions consisted of 
plasmid DNA (1 pg), 2 pi restriction enzyme buffer (lOx; Promega) and 10 units 
restriction enzyme (Promega). The volume was made up to 20 pi with autoclaved water. 
Restriction digests were incubated at 37°C for 2 h and analysed by agarose gel 
electrophoresis (Section 2.3).
When the fragments were required for subsequent cloning steps, digests of 10 pg of 
plasmid DNA in a final volume of 50 pi were performed.
2.5 Dephosphorylation of digested plasmid DNA
Calf intestinal alkaline phosphatase (1 pi; 2 units/ pi; Boehringer Mannheim) was added 
directly to restriction digests and incubated at 37°C for 30 min. The reactions were 
stopped by incubation on ice for 5 min.
2.6 Production of blunt ended DNA inserts
To produce blunt ended inserts, 1 pi T4 DNA polymerase (7.9 units/ pi; Promega) was 
added directly to the restriction digests along with 1 pi dNTPs (10 mM; Promega) and 
incubated at 37°C for 30 min.
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2.7 Gel extraction
After electrophoresis of DNA through an agarose gel (Section 2.3), the correct bands 
were excised after visualisation under a UV lamp. The QIAquick gel extraction kit 
(QIAGEN) was used to extract DNA from agarose gels according to the manufacturer’s 
protocol.
2.8 Ligation reactions
Ligations were performed in a final volume of 10 pi or 20 pi. The 10 pi reactions 
consisted of 20 ng vector, 5-20 ng purified inserts, 2 pi T4 DNA ligase buffer (10 x; 
Promega) and 1 pi T4 DNA ligase (3 u/ pi; Promega). The volume was made up to 10 pi 
with autoclaved water. Ligation reactions were incubated at 16°C overnight. Ligation 
reactions in a final volume of 20 pi consisted of 100 ng linearised vector, 5-30 ng 
purified insert, 10 pi T4 ligase buffer (2 x; Promega) and 1 pi T4 DNA ligase (3 u/ pi; 
Promega). The volume was made up to 20 pi with autoclaved water. The reactions were 
incubated at 16°C overnight.
2.9 Transformation of competent E. coli
Plasmid DNA (1 pi) or ligation reaction (3-5 pi) was added into 50 pi precompetent E. 
coli DH5a cells and incubated on ice for 30 min. The mixture was heat-shocked at 42°C 
for 45 sec and allowed to recover on ice for 5 min. LB broth (200 pi; Appendix) was 
added and the mixture incubated at 37°C for 1 hour. Cells were then spread onto LB 
agar plates containing ampicillin (25mg/ml) and incubated at 37°C o/n. Colonies were
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picked on the next day, grown overnight in LB/ampicillin (25 mg/ml) and plasmid 
miniprep was performed.
2.10 Plasmid DNA Minipreparation (QIAGEN Kit)
The QIAGEN plasmid miniprep kit was used to extract plasmid DNA from bacteria as 
described in the manufacturer’s protocol.
2.11 Sequencing plasmid DNA
After minipreparation using the QIAGEN kit (Section 2.10), the concentration of 
plasmid DNA was quantified by Nanodrop 1000 (Thermo scientific) and agarose gel 
electrophoresis. DNA sequencing was performed by Cogenics Inc. using primers as 
detailed in the specific chapters.
2.12 Plasmid Midipreparation
Midipreparation of plasmid DNA was performed using QIAGEN Midiprep Kit, 
according to the manufacturer’s protocol. The DNA was then precipitated using 2.5 
volumes 100% ethanol and 1/10th volume 2M NaAC o/n at -20°C. The solution was 
centrifuged at 14,000 rpm for 15 mins at 4°C and the pellet was washed in 70% ethanol. 
The supernatant was removed with a 1 ml syringe, allowed to dry and resuspended in 
nuclease free autoclaved water. The DNA concentration was quantified by Nanodrop 
(Thermo Scientific).
7 7
2.13 Production of RNA transcripts in vitro
Linearised plasmids were phenol/chloroform extracted and ethanol precipitated. 
Linearised and purified plasmids (0.5 -  1 pg) were transcribed using the T7 Megascript 
and T7 mMessage mMachine kits (Ambion) according to the manufacturer’s protocol. 
To stop the reactions, 115 pi sterile nuclease-free water and 15 pi Ammonium Acetate 
(5M, Ambion) were added and placed on ice. An equal volume of phenol/chloroform 
was added and vortexed briefly. The reactions were centrifuged for 1 min at 14,000 rpm. 
The top layer was transferred to a new tube and then precipitated by adding 1 volume of 
isopropanol and incubated o/n at -20°C. The samples were centrifuged at 14,000 rpm for 
15 mins at 4°C to pellet the RNA. The supernatant was carefully removed and the pellet 
was resuspended in 30 pi sterilized water. The integrity of the RNA was determined by 
agarose gel (Section 2.3) and the concentration was quantified using Nanodrop.
2.14 Coupled transcription and translation (TNT) in the Rabbit Reticulocyte 
Lysate (RRL) system
Plasmid DNA (2 pg) containing a T7 RNA polymerase promoter was combined with 6.5
pi of TNT T7 Quick Master Mix (Promega) and 0.5 pi [35S]-methionine (500 pCi;
PerkinElmer). The reaction was made up to a final volume of 10 pi with nuclease-free
water and incubated at 30 °C for 90 mins. After incubation, the sample was analysed by
SDS-PAGE and autoradiography (Section 2.17).
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2.15 Translation of mRNA transcripts in the rabbit reticulocyte lysate system 
(RRL)
Rabbit reticulocyte lysate (17.5 pi), 0.5 pi amino acid mixture minus methionine, 1 pi of 
[35S]-methionine (500 pCi; PerkinElmer), 0.5 pi RNAsin® ribonuclease inhibitor and 
1 pg RNA was combined and the total volume of the reactions were made up to 25 pi 
with nuclease free water. The reactions were incubated at 30 °C for 90 mins according to 
the manufacturer’s protocol (Promega).
To analyse the samples, 4 pi of each sample was mixed with 10 pi 3x SDS sample 
buffer (New England BioLabs), 1 pi DTT 3Ox reducing agent (New England BioLabs) 
and 15 pi nuclease free water. The samples were boiled for 5 mins at 100 °C and were 
subjected to SDS-PAGE analysis and autoradiography (Section 2.17).
2.16 Translation of mRNA transcripts in the Flexi® rabbit reticulocyte lysate 
system (RRL)
Reactions containing Flexi® rabbit reticulocyte lysate (7.5 pi), 0.25 pi amino acid 
mixture minus methionine, 0.5 pi of [35S]-methionine (500 pCi; PerkinElmer), 0.25 pi 
RNAsin® ribonuclease inhibitor and 500 ng RNA were supplemented with 0.5 pi of 2.5 
M KC1 and, 0.25 pi of 25mM MgOAc. The total volumes of the reactions were made up 
to 25 pi with nuclease free water. The reactions were incubated at 30 °C for 90 mins 
according to the manufacturer’s instructions (Promega).
To analyse the samples, 4 pi of each sample was mixed with 10 pi 3x SDS sample 
buffer (New England Biolabs), 1 pi DTT 3Ox reducing agent (New England BioLabs)
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and 15 pi nuclease free water. The samples were boiled for 5 mins at 100 °C and were 
subjected to SDS-PAGE analysis (Section 2.17).
2.17 SDS-PAGE
Acrylamide gels (Laemmli, 1970 and Appendix) were used. Mini gels (Biorad) were 
run at 100 V; large gels were run at 200 V. Mini gels were used in Western blot analysis 
as outlined in Section 2.18. When the gels were used for autoradiography with 35S- 
Methionine, they were stained with Coomasie blue stain (Appendix), destained in 20 % 
methanol, 7.5 % glacial acetic acid (Appendix) and dried on a gel dryer (BioRad) for 2 
h and exposed to Fuji medical X-ray film (New England BioLabs).
2.18 Western blot analysis
After SDS-PAGE, proteins were transferred to Immobilon-P membranes (Milipore 
Corp) at 100 V/400 mA for 90 mins in Tris/glycine/methanol buffer (Appendix). 
Membranes were blocked o/n in 5 % Marvel (w/v) in 1 % TBS + 0.1 % Tween 
(Appendix). Proteins were detected using anti-CAT primary rabbit antibodies (Sigma. 
1:1000) and anti-LUC primary goat antibodies (Promega, 1:1000). Membranes were 
incubated with primary antibody in 5% Marvel for 1 h with continuous shaking. 
Membranes were washed in 1 % TBS + 0.1 Tween (2 x 30 sec and 2 x 10 min). This 
was followed by 1 h incubation with peroxidase-linked anti-rabbit IgG (1:3000, 
Amersham) or anti-goat Immunoglobulins (1:1000, DakoCytomation) in 5% Marvel.
Washes were repeated and the signal developed using chemiluminescence reagents as
/
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outlined in the manufacturer’s protocol (Super Signal West Pico chemiluminescent 
substrate, Pierce).
2.19 Growth and maintenance of cell lines
2.19.1 Growth of Human Embryonic Kidney cells (HEK293)
HEK293 cells obtained from the lab were grown in D-modified Eagles medium (D- 
MEM) (Gibco) containing 10% heat-inactivated foetal bovine serum (FBS) (Gibco), 100 
U/ml penicillin (Gibco), 100 pg/ml streptomycin (Gibco) and 1% (v/v) non essential 
amino acids (Gibco). The cell lines were grown in a humidified incubator at 37 °C with 
5% CO2 . When the cells were 90% confluent, the FBS-DMEM medium was removed 
and the cells were washed twice with 5 ml of 1:10 trypsin/versene (Gibco). The cells 
were collected in a 20 ml universal tube containing 5 ml of fresh FBS-DMEM to 
neutralize the trypsin; the cells were then centrifuged at 2,500 rpm for 2.5 mins. The 
supernatant was discarded and the pellet was resuspended in 6 ml of growth media. Of 
this 6 ml, 2 ml were used to seed a new 75 cm2 flask containing 15 ml fresh medium. 
The cells were then maintained as described above until the next passage was necessary.
2.19.2 Growth of Sofia Levinton-Kriss (SLK) cells
SLK cells, an immortalized but KSHV-negative spindle cell line derived from a classical 
Kaposi’s sarcoma tumor (from Dr. David Blackboum, University of Birmingham, UK) 
were grown in Roswell Park Memorial Institute 1640 media (RPMI1640; Gibco) 
containing 10% heat-activated foetal bovine serum (FBS) (Gibco), 100 U/ml penicillin 
(Gibco), 100 pg/ml streptomycin (Gibco) and 1% (v/v) Glutamine (Gibco). The cell
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lines were grown in a humidified incubator at 37 °C with 5% CO2 . The cells were 
maintained as described in Section 2.19.1.
2.20 Production of recombinant vTF7-3 virus
A recombinant vaccinia virus, vTF7-3 (Fuerst et ah, 1986) was used to express T7 RNA 
polymerase in mammalian cells. In order to prepare a vaccinia virus vTF7-3 stock, 500 
pi of virus stock in 25 ml DMEM+HEPES was added to a 175 cm2 tissue culture flask 
of human TK-143 cells and incubated for 1 h. Growth media (50 ml) was added and the 
cells were incubated at 37 °C for 24 h. The cells were freeze-thawed three times and 
aliquots stored at -20 °C. To determine the optimum volume giving the maximum 
reading in the LUC assay, different volumes of the virus were assayed in the transient 
expression system (Section 2.21).
2.21 Transfection of plasmid DNA into mammalian cells (Transient expression 
system)
HEK293 cells in 35 mm tissue culture dishes were used in these experiments (Section
2.19.1). To an 80% confluent monolayer, 25 pi vTF7-3 (Fuerst et ah, 1986) was added 
and incubated for 1 h at 37 °C and 5% CO2 . Per 35 mm dish, 7 pi Lipofectin reagent 
(Invitrogen) was mixed with 193 pi Optimem (GibcoBRL) and incubated at room 
temperature for 15 mins. Plasmid DNA (T7-CAT/IRES/LUC; 2 pg) in 200 pi 
autoclaved water was added to the Lipofectin/Optimem mixture and incubated at RT for 
20 mins. The inoculum was removed from the cells and the cells were washed with 1 ml 
2% FBS medium. The DNA/Lipofectin/Optimem mix was added to the cells, which 
were incubated for 5 h at 37 °C. Growth medium was added to each dish and the cells
8 2
incubated o/n at 37 °C. The cells were harvested in 200 jxl cell lysis buffer (Promega) 
and spun at 14,000 rpm for 5 mins at 4 °C. CAT and LUC assays were performed 
(Section 2.22 and 2.23).
As for SLK cells (Section 2.19.2), 25 pi of vTF7-3 (Fuerst et ah, 1986) was added to 
80% confluent cells in 35 mm dishes and incubated for 1 h as above. Per 35 mm dish, 3 
pi of Fugene 6 (Roche) was added to 97 pi of Optimem (Gibco) and incubated at RT for 
5 mins. Plasmid DNA (T7-CAT/IRES/LUC; 2 pg) in 20 pi autoclaved water was added 
to the Fugene 6/Optimem mixture and incubated at RT for 40 mins. The inoculum was 
removed from the cells and the cells were washed with 1 ml 2% FBS medium. The 
DNA/Lipofectin/Optimem mix was added to the cells, which were incubated for 5 h at 
37 °C. Growth medium was added to each dish and the cells incubated o/n at 37 °C. The 
cells were harvested in 200 pi cell lysis buffer (Promega) and spun at 14,000 rpm for 5 
mins at 4 °C. LUC and CAT assays were performed (Section 2.23 and 2.24).
2.22 Transfection of capped KSHV 1RES transcripts into mammalian cells
For transfection of capped KSHV 1RES transcripts, approximately 1 x 106 cells of HEK 
293 and SLK cells were seeded into 35 mm dishes one day prior to transfection. For the 
transfection into HEK 293 cells, 7 pi of Lipofectin (Invitrogen) was added to 193 pi of 
Optimem (Gibco) and left at RT for room temperature for 15 mins. In addition, 10 pg of 
each KSHV 1RES transcript was added to 200 pi of sterile water and mixed with the 200 
pi Lipofectin mix. The mixture was incubated at room temperature for 20 mins. The 
mixture was then added into each dish and the cells incubated at 37° C for 5h. The
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medium was removed and 400 jrl of chilled Promega lysis buffer was added to each 
dish. The cells were scrapped off and transferred into an eppendorf tube, vortexed and 
incubated on ice for 5 mins. The cells were centrifuged at 14, 000 rpm, 4° C, for 5 mins 
in a pre-chilled microcentrifuge and the supernatant was transferred to a new eppendorf 
tube and stored at -20° C.
For SLK cells, the transfection mixture was prepared by adding 3 pi of Fugene 6 
(Roche) to 97 pi of Optimem (Gibco) and incubated at room temperature for 5 mins. 
Ten microgram of each KSHV 1RES transcript was added into 20 pi of sterile water and 
mixed with 100 pi of the diluted Fugene 6. The mixture was incubated at room 
temperature for 40 mins. The Lipofectin-transcripts mix was added into each dish and 
the cells incubated at 37° C, for 5 h. The medium was removed and 400 pi of chilled 
Promega lysis buffer was added to each dish. The cells were scrapped off and transferred 
into an eppendorf tube, vortexed and incubated on ice for 5 mins. The cells were 
centrifuged at 14, 000 rpm, 4° C, for 5 mins in a pre-chilled microcentrifuge and the 
supernatant was transferred to new eppendorf tube and stored at -20° C.
2.23 Luciferase assay
The luciferase assay was carried out on cell lysates (Section 2.21). Cell extracts (10 pi) 
were added to 100 pi of the LUC assay substrate luciferin (Promega) and the 
luminescence was measured with a Bio-orbit luminometer (Labtech). The values are 
shown as arbitrary units.
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2.24 Chloramphenicol Acetyl Transferase (CAT) assay
Cell extracts were combined with sample buffer from the CAT ELISA kit (Roche) and 
CAT expression was determined as stated in the manufacturer’s instructions. In brief, 
cell lysates (10 pi; Section 2.21 and 2.22) were combined with 190 pi sample buffer 
and added to wells pre-coated with antibodies to CAT (anti-CAT). The wells were 
covered and incubated at 37 °C for 1 h, after which time the wells were rinsed using the 
supplied washing buffer. To each well, 200 pi of a digoxigenin-labelled antibody to 
CAT (anti-CAT-DIG; 2 pg/ml) were added and the samples incubated at 37 °C for 1 h. 
After this incubation, the wells were washed as before. An antibody to digoxigenin 
conjugated to peroxidase (200 pi anti-DIG-POD; 20 u/ml) was added and the wells were 
incubated at 37 °C for 1 h and then rinsed as before. Following the final wash, 200 pi 
peroxidase substrate ABTS (POD substrate ready-to-go solution) was added and 
incubated at RT for 5 to 10 mins for the colour to develop. The samples were assayed 
along with CAT enzyme standards at concentrations of 0, 0.125, 0.25, 0.5 and 1 ng/ml. 
The colour development was measured on an ELISA plate reader (Labsystems 
Multiscan BICHROMATIC) at 405 nm.
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Chapter 3
Identification of the minimal sequences of the KSHV 1RES
3.1 Introduction
The determination of the minimum size of an 1RES element is important in 
understanding its function and can be performed by mutational analysis. Grundhoff and 
Ganem (2001), Bieleski and Talbot (2001) and Low et al (2001) demonstrated that there 
is an 1RES within the KSHV vCyclin gene responsible for translation of the KSHV 
vFLIP protein. The 1RES was shown to function in mammalian cells as well as in vitro 
(Grundhoff and Ganem, 2001, Bieleski and Talbot, 2001 and Low et al., 2001). Since 
the KSHV 1RES is the first 1RES element that was found in a coding region of a DNA 
virus (Bieleski and Talbot, 2001), it is important to know the minimum size of the 1RES 
in order for it to function efficiently. Furthermore, as the 1RES element in vCyclin is 
thought to be responsible for vFLIP expression (Grundhoff and Ganem, 2001), 
pinpointing the region upstream of vFLIP which is responsible for its expression is 
important.
We determined the minimum size of the KSHV vCyclin 1RES element by cloning 
various fragments of the vCyclin coding region into the intercistronic space of the 
dicistronic vector pGEM-CAT/LUC. The ability of these fragments to direct translation 
initiation was analysed in mammalian cell lines and in the Rabbit Reticulocyte Lysate 
(RRL) system. In the systems, plasmid containing the picomavirus EMCV 1RES 
(pGEM-CAT/EMCV/LUC) was used as a positive control, and the empty plasmid 
lacking any 1RES element (pGEM-CAT/LUC) was used as a negative control.
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METHODS
3.2 Construction of dicistronic plasmids containing KSHV 1RES fragments
Plasmids containing the putative KSHV 1RES fragments of 233, 252, 363, 658, and 856 
nt upstream of the vFLIP coding sequence (Figure 3.1) were provided by Dr. David 
Blackboum (University of Birmingham). The fragments were in the TOPO TA vector 
(Invitrogen). All the fragments were constructed based on Bieleski and Talbot as they 
have shown that the fragments can function as 1RES (Bieleski and Talbot, 2001).
vCyclin vFLIP
856 nt
658 nt
363 nt
252 nt
233 nt
Figure 3.1: The full length and truncated fragments of the KSHV vCyclin gene and 
sequences upstream of the vFLIP gene. All the fragments were cloned into TOPO TA 
vector (Invitrogen).
The KSHV 1RES fragments were inserted in the intercistronic space of the dicistronic 
vector, pGEM-CAT/LUC (van der Velden et al., 1995) between the chloramphenicol 
acetyltransferase (CAT) and firefly luciferase (LUC) open reading frames (ORFs), using 
the unique itamHI cloning site (Figure 3.2). Transcription from this vector results in a 
single mRNA molecule of the form CAT-IRES-LUC. The expression of the first cistron 
(CAT) occurs via the canonical cap-dependent mechanism, whilst the expression of the
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second cistron (LUC) occurs only if the sequence immediately upstream contains a 
functional 1RES element.
KSHV 1RES Fragments
T 7
Figure 3.2: The structure of the plasmid used in the cloning of KSHV 1RES 
fragments. The fragments were digested by BamHI and inserted between CAT and 
LUC ORFs in the plasmid pGEM-CAT/LUC.
3.2.1 Generating the dicistronic constructs containing KSHV 1RES fragments
In order to generate KSHV IRES-containing pGEM-CAT-IRES-LUC plasmids, all the 
KSHV 1RES fragments in the TOPO TA vector were subjected to restriction enzyme 
digestion (Section 2.4) using BamHI. The digestion products were analysed by agarose 
gel electrophoresis (Section 2.3) and the KSHV 1RES fragments (233, 252, 363, 658, 
and 856) were purified by gel extraction (Section 2.7). The dicistronic vector, pGEM- 
CAT/LUC was also digested with BamHI restriction enzyme, dephosphorylated 
(Section 2.5), and was gel purified for subsequent ligation.
3.2.2 Ligation into the vector pGEM-CAT/LUC
The purified KSHV 1RES fragments (Section 2.7) were ligated into the pGEM- 
CATZLUC vector (20 pi reaction; Section 2.8) and the ligation reactions were used to 
transform competent E.coli DH5a cells (Section 2.9). Plasmid DNA was extracted from 
overnight cultures by plasmid minipreps (Section 2.10) and the constructs were checked 
for the presence of the inserts by restriction enzyme analysis and for correct orientation 
of the inserts by PCR and sequencing (Section 2.1 and 2.11). In PCRs, the CAT 
Forward primer (CAT For, 5’ - TACCTGCATTCTAGTTGTGG) was used as the 
forward primer, while the reverse primers were KSHV Reverse 1 (KSHV Revl, 5’ -  
GGTGCCGGCTTGTATATGTG) for 252, 363, 658, and 856 fragments; KSHV 
Reverse 2 (KSHV Rev2, 5’ -  CCTGCAGGCTGTGCGCTGTT) for the 233 
fragment. The constructs that contained the expected inserts in the correct orientation 
were verified by sequencing using the primer CAT For (Section 2.11), and were then 
produced on a large scale by midiprep (Section 2.12)
3.3 KSHV 1RES activity in mammalian cells
In order to assess the activity of the KSHV 1RES fragments in cells, all the KSHV 1RES 
constructs in pGEM-CAT/LUC were transfected into HEK 293 cells and SLK cells 
(Section 2.21). The transfected cells were incubated 24 h, 36 h, and 48 h before being 
harvested for LUC and CAT assays (Section 2.23 and 2.24). In these experiments, 
different concentrations of KSHV 1RES plasmids were used (2 pg, 5 pg and 10 pg) in 
HEK 293 cells and SLK cells.
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For transfection of capped KSHV 1RES transcripts, the transcripts were transfected into 
HEK 293 cells and SLK cells (Section 2.22). The transfected cells were incubated for 5 
h, 10 h and 24 h before being harvested for LUC and CAT assays (Section 2.23 and 
2.24). Different concentrations of KHSV 1RES transcripts were used (5 pg, 10 pg and 
20 pg) in HEK 293 cells and SLK cells.
3.4 KSHV 1RES activity in Rabbit Reticulocyte Lysate (RRL) system
The dicistronic constructs containing the KSHV 1RES fragments were analysed in the 
coupled transcription and translation system as described in Section 2.14. They were 
analysed by SDS-PAGE and autoradiography (Section 2.17) and LUC assay (Section 
2.23).
3.5 Translation in the Rabbit Reticulocyte Lysate (RRL) and Flexi® RRL 
systems
The dicistronic KSHV IRES-containing constructs were linearised with Xhol (Section 
2.4) and phenol/chloroform extracted and ethanol precipitated. Capped and uncapped 
RNAs were transcribed as described in Section 2.13 and used to programme the RRL 
translation system (Section 2.15) and Flexi® RRL system (Section 2.16). In RRL, the 
final concentration of Mg2+ is 0.5 mM, and K+ is 79 mM. For Flexi® RRL, the final 
concentration of Mg2+ and K+ is 2.05 mM and 50 mM (plus endogenous K+), 
respectively. The translation products were analysed by SDS-PAGE and 
autoradiography (Section 2.17) and LUC assay (Section 2.23).
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3.6 Generating KSHV 1RES plasmids containing a stable stem loop
To determine whether the KSHV 1RES indeed functions as an 1RES, and to refute any 
possibility of other noncanonical translation such as leaky scanning, a stable stem loop 
(CAGATCTACGCGGTTCGCCGCGTAGATCTG) was introduced by molecular 
cloning upstream of the 252 KSHV 1RES fragment as this fragment is sufficient to direct 
translation in vitro.
In order to produce the plasmid pGEM-CAT/SL-252/LUC (Figure 3.3), PCR (Section
2.1) was performed. The primers used to generate the stem loop-252 fragment were 
5’GATCTGAGGATCCCAGATCTACGCGGTTCGCCGCGTAGATCTGGGTG 
CGCTGTTGGTTCCTGC3’ for the forward primer and 
5’CGCCCAATTCGCCCTTTTGGATCCGGTGCCGGCTTGTATATGTGAAGG 
CACCGATGTGGAAAAAC3’ for the reverse primer. Both primers contain BamHI 
restriction sites to enable cloning into the pGEM-CAT/LUC vector between the two 
ORFs. In the PCR, the template used was the pGEM-CAT/252/LUC plasmid. The PCR 
product was purified (Section 2.2) and digested before being purified again. The 
purified product was then ligated with pGEM-CAT/LUC vector (Section 2.8) and 
transformed into E.coli DH5a (Section 2.9). Plasmid minipreps (Section 2.10) were 
then performed and the positive clones were screened by PCR (Section 2.1) and 
sequencing (Section 2.11). The construct with the insert in the correct orientation was 
subjected to plasmid midipreparation (Section 2.12). Linearised plasmids containing SL- 
252 were transcribed using the T7 Megascript and T7 mMessage mMachine kits 
(Ambion) to produce uncapped and capped mRNA transcripts (Section 2.13). The
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transcription products were analysed by agarose gel electrophoresis (Section 2.3) and 
the concentration was quantified by Nanodrop.
Figure 3.3: Schematic diagram of the plasmid pGEM-CAT/SL-252/LUC. The
plasmid has the reporter cistrons CAT and LUC with stable stem loop cloned 
immediately upstream of 252 nt fragment of KSHV 1RES.
3.7 Radiolabelled immunoprécipitation
Besides Western blot analysis of KSHV 1RES expression in mammalian cells and in 
vitro analysis, radiolabelled immunoprecipitaion was conducted to ensure that the 
inability to detect any 1RES activity was due to the 1RES itself and not the transfection 
technique. Besides, the approach was also to ensure that the failure to detect any LUC 
activity downstream was not due to initiation from AUG upstream of the authentic 
vCyclin AUG which would result in an inactive LUC expression. Following transfection 
of the dicistronic plasmid into SLK cells, anti-CAT and anti-LUC antibodies were used 
to precipitate the expressed proteins because any CAT and LUC protein expressed will 
be detected by the antibodies. SLK cells were transfected as in Section 2.21 and 
incubated overnight. On the next day, the cells were labelled with [35S]-Methionine and 
Cysteine. Firstly, the media was replaced by 400 pi of media with no Methionine and
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Cysteine and incubated for 30 mins before 400 gl of media containing 296 kBq/gl, [35- 
S]-Methionine and Cysteine (37 TBq/mmol, MP Biomedicals) being added and later 
incubated for 90 mins. The media was removed and 400 \i\ of RIPA Buffer (Appendix) 
was added). The cells were then washed with RIPA Buffer before being transferred into 
cooled eppendorf tube and incubated for 5 mins. The samples were spun at 14,000 rpm 
for 5 mins and the supernatant were collected and transferred into new eppendorf tube.
For immunoprécipitation, 75 pi of radiolabelled cell lysates were added into eppendorf 
tube along with 75 pi of RIPA buffer (Appendix). Anti-CAT and anti-LUC antibodies 
were added into respective tubes and incubated for 1 h at RT on a whirlimix. During the 
incubation, Pansorbin cells (Calbiochem) were prepared by spinning the solution at 8000 
rpm for 1 min and the supernatant was removed. The pellet was then resuspended in 
RIPA buffer, spun, and resuspended again. After 1 h of incubation, 20 pi of Pansorbin 
was added into the mixture and incubated again for 20 mins. The samples were spun at 
8000 rpm for 1 min and the supernatant was removed before 500 pi of RIPA buffer was 
added and incubated for 2 mins. The samples were spun again and this was repeated 
twice. The process was repeated again but this time with TBS buffer. After the 
supernatant was removed, the pellet was resuspended in SDS sample buffer (20 pi of 
mill Q water, 10 pi 3 X SDS sample buffer and 1 pi DTT). The immunoprecipitaion 
products were analysed by SDS-PAGE and autoradiography (Section 2.17).
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RESULTS
3.8 KSHV 1RES fragment activity in mammalian cells
The KSHV 1RES fragments (in pGEM-CAT/LUC) were assayed in mammalian cells 
(HEK 293 and SLK cells) along with a positive control, represented by pGEM- 
CAT/EMCV/LUC (containing the EMCV 1RES; Roberts et ah, 1998), and a negative 
control, the construct in the form of pGEM-CAT/LUC (No 1RES), which lacks any 
1RES element. In HEK 293 cells, all constructs expressed CAT as expected, which is a 
measure of cap-dependent translation (Figure 3.4A and 3.4B) as evidenced in CAT 
assays and Western blot. However, all the constructs failed to express LUC except the 
EMCV 1RES.
Similar results were obtained when the construct were expressed in SLK cells (results 
not shown). All the constructs expressed CAT when compared with the control. 
However, only the positive control EMCV 1RES expressed LUC and none of the KSHV 
1RES constructs expressed LUC efficiently (Figure 3.4C).
Different parameters have been tested for the successful expression of LUC in both cell 
lines (HEK 293 and SLK cells) such as by using different concentrations of KSHV 1RES 
plasmids (2 pg, 5 pg and 10 pg) and different incubation periods (24 h, 36 h and 48 h). 
In these approaches, only the positive control of EMCV 1RES successfully expressed 
LUC while the LUC expression from the KSHV 1RES fragments in the pGEM- 
CAT/LUC plasmid was not detectable (results not shown). As LUC expression is IRES- 
dependent this suggests that the KSHV 1RES fragments were not functional in these
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cells.As for the transfection with capped KSHV 1RES transcripts on HEK 293 and SLK 
cells, similar approaches to plasmid transfection have been performed. Different 
incubation periods with the cell lines (5 h, 10 h and 24 h) after transfection, combined 
with different concentrations of KSHV transcripts (5 pg, 10 pg and 20 pg) showed no 
1RES activity when CAT assay and LUC assay were performed (results not shown).
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Figure 3.4: Analysis of the dicistronic containing KSHV 1RES fragments in HEK 293 and 
SLK mammalian cells. A) The plasmids of the form pGEM-CAT/KSHV IRES/LUC were 
expressed in HEK 293 cells and analysed by SDS-PAGE and immunoblotting. B) LUC 
expression from HEK 293 cell lysates and C) from SLK cell lysates was quantitatively measured 
(Section 2.19) and was normalised against CAT expression from three separate transfections. 
LUC expression from EMCV was set at 100%. Mean LUC values (plus standard deviation of the 
means) are shown. The data shown are representative of results from three independent 
experiments (panel A), and the error bars represent the mean plus/minus standard deviation of 
LUC values from three experiments (panel B).
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3.9 KSHV 1RES activity in coupled transcription and translation (TNT) in the 
Rabbit Reticulocyte Lysate (RRL) system
In the experiments, all the constructs expressed CAT as expected (Figure 3.5A). For the
expression of the IRES-dependent cistron, LUC, only the positive control of the EMCV
1RES was efficiently expressed. Some of the KSHV 1RES activity was detected from the
LUC assay, but the level of 1RES mediated LUC expression from the KSHV fragments
was not significantly above the level of the no 1RES negative control (Figure 3.5B).
3.10 KSHV 1RES activity in the Rabbit Reticulocyte Lysate (RRL) system
Capped RNA transcripts, in the form of CAT/IRES/LUC containing the KSHV 1RES 
fragments were in vitro translated in the RRL system. As expected, CAT was efficiently 
expressed from all RNAs. The positive control containing the EMCV 1RES also directed 
efficient LUC expression, as expected. In addition, the capped mRNA transcripts 
containing the KSHV 1RES fragments expressed LUC protein. In this case, all KSHV 
fragments, except the smallest (233 nt), directed efficient LUC expression which was 
significantly above the background from the no 1RES control. The 363 nt fragment was 
the most efficient at directing LUC expression (Figure 3.6A). LUC assay analysis 
supported these results (Figure 3.6B).
1RES activities from the uncapped RNA transcripts were also analysed. Expression of 
LUC protein from all KSHV 1RES mRNA transcripts was low compared to that from 
capped KSHV 1RES mRNA transcripts (Figure 3.7A). This was supported by the LUC 
assay which showed the level of LUC expression from the uncapped KSHV 1RES 
fragments was low compared to activity from the capped transcripts (Figure 3.7B).
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Figure 3.5: KSHV 1RES activity in RRL TNT system. The pGEM-CAT/LUC 
plasmids containing KSHV 1RES fragments were transcribed and translated in the RRL 
TNT system. (A) Reactions were subjected to SDS-PAGE and autoradiography. (B) 
LUC expression was analysed by LUC activity assay. LUC activity of the positive 
control (EMCV 1RES) was set at 100%. The data shown are representative of results 
from three independent experiments (panel A), and the error bars represent the mean 
plus/minus standard deviation of LUC values from three experiments (panel B).
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Figure 3.6: Translation in Rabbit Reticulocyte Lysate System. (A) Capped KSHV 
1RES containing transcripts were translated in RRL and reactions analysed by SDS- 
PAGE and autoradiography for the detection of LUC and CAT expression. (B) LUC 
assay from in vitro translation of capped transcripts. The positive control EMCV 1RES 
expression was set at 100%. The data shown are representative of results from three 
independent experiments (panel A), and the error bars represent the mean plus/minus 
standard deviation of LUC values from three experiments (panel B).
99
Figure 3.7: Translation in Rabbit Reticulocyte Lysate System. (A) Uncapped KSHV 
1RES containing transcripts were translated in RRL and reactions analysed by SDS- 
PAGE and autoradiography for the detection of LUC and CAT expression. (B) LUC 
assay from in vitro translation of uncapped transcripts. The positive control EMCV 
1RES expression was set at 100%. The data shown are representative of results from 
three independent experiments (panel A), and the error bars represent the mean 
plus/minus standard deviation of LUC values from three experiments (panel B).
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3.11 KSHV 1RES activity in Flexi® Rabbit Reticulocyte Lysate (RRL) system
In order to improve the efficiency of KSHV 1RES activity, Flexi® RRL was used to 
compare whether there were any differences between the two systems as the Flexi® RRL 
provides greater flexibility of reaction conditions than RRL due to the capacity to 
manipulate and optimize the concentration of Mg2+ and K+, in comparison to the 
standard RRL that contains Mg2+ and K+ endogenously (Section 3.5). Both capped and 
uncapped mRNA transcripts were analysed in this system. In the assay with capped 
mRNA transcripts, expression of LUC from the KSHV 1RES fragments was efficient 
and significantly higher than the control (Figure 3.8A). The 1RES activities were higher 
compared to translation in the standard RRL although the activity of the 233 nt fragment 
was similar. Analysis by LUC assay (Section 2.23) also supported these results (Figure 
3.8B).
Translation of uncapped transcripts of KSHV IRES-containing mRNAs resulted in LUC 
expression that was similar to that from the no 1RES control (Figure 3.9A). The LUC 
activity detected by the LUC assay (Section 2.23) also showed that expression from the 
KSHV 1RES was similar to the background control (Figure 3.9B).
These results suggested that the KSHV 1RES functions more efficiently with a capped 
mRNA than with an uncapped mRNA.
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Figure 3.8: Translation in Flexi® Rabbit Reticulocyte Lysate System. The capped 
transcripts of the form CAT/KSHV/LUC were translated in Flexi® RRL and analysed by 
SDS-PAGE and autoradiography. A) Expression of LUC and CAT from capped KSHV 
1RES transcripts. B) LUC assay of the capped KSHV 1RES transcripts. The positive 
control EMCV 1RES expression was set at 100%. The data shown are representative of 
results from three independent experiments (panel A), and the error bars represent the 
mean plus/minus standard deviation of LUC values from three experiments (panel B).
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Figure 3.9: Translation in Flexi® Rabbit Reticulocyte Lysate System. The uncapped 
transcripts of the form CAT/KSHV/LUC were translated in Flexi® RRL and analysed by 
SDS-PAGE and autoradiography. (A) Detection of LUC activity from the in vitro 
translation of uncapped KSHV 1RES RNA by LUC assay (B). The positive control 
EMCV 1RES expression was set at 100%. The data shown are representative of results 
from three independent experiments (panel A), and the error bars represent the mean 
plus/minus standard deviation of LUC values from three experiments (panel B).
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3.12 KSHV 1RES mRNAs containing an upstream stemloop function in Flexi® 
Rabbit Reticulocyte Lysate (RRL) system
With the stem loop sequence inserted upstream of the 252 nt KSHV 1RES sequence, it 
was postulated that any ribosome scanning from the upstream cistron (CAT) could be 
stopped/halted, to ensure decoupling of any 1RES activity from the presence of the cap 
structure. Uncapped and capped 252 nt KSHV 1RES transcripts were in vitro translated 
in Flexi® RRL. From the analysis with uncapped transcripts, LUC expression from the 
stem loop containing transcripts was slightly higher compared to those without a stem 
loop but were still very low (Figure 3.10A), and was supported by LUC assay analysis 
(Figure 3.10B). However, LUC expression levels were higher from the capped mRNA 
transcripts when compared with the uncapped transcripts as seen previously. LUC 
expression from the transcripts containing a stem loop upstream of the KSHV 1RES was 
almost the same as from transcript without a stem loop. LUC assay analysis supported 
the autoradiography analysis. This suggested that KSHV 1RES does not capture 
ribosomes that have scanned from the 5’end of the mRNA, even though the 1RES 
functions more efficiently for a capped mRNA. For the upstream cistron, the CAT 
expression was detected in all samples as well as the positive control of downstream 
cistron EMCV 1RES.
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Figure 3.10: Translation in Flexi® Rabbit Reticulocyte Lysate System. The
transcripts of the KSHV 1RES were translated in Flexi® RRL and analysed by SDS- 
PAGE and autoradiography. A) Expression of LUC and CAT from uncapped and 
capped of 252 and SL-252 KSHV 1RES transcripts. B) LUC assay analysis of the 
uncapped and capped of 252 and SL-252 KSHV 1RES transcripts from LUC expression. 
The positive control EMCV 1RES expression was set at 100%. The data shown are 
representative of results from three independent experiments (panel A), and the error 
bars represent the mean plus/minus standard deviation of LUC values from three 
experiments (panel B).
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3.13 CAT and LUC protein detection by radiolabelled immunoprécipitation
In order to determine the failure in LUC detection was not due to any AUG upstream of 
vCyclin, CAT and LUC proteins were immunoprecipitated (Section 3.7). For this 
analysis, only the KSHV 1RES 252 nt plasmid was used along with all the controls. As 
expected, CAT protein expression was detected in all samples tested (Figure 3.11 A). 
For LUC expression, only the positive control of the pGEM-CAT/LUC plasmid 
containing the EMCV 1RES was able to direct LUC expression (Figure 3.1 IB). No 
LUC expression was detected from the KSHV 1RES containing plasmid which is in 
agreement with the ealier result and suggests that the KSHV 1RES does not function in 
SLK cells from a CAT/LUC plasmid.
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Figure 3.11: Analysis of KSHV 1RES expression in mammalian cells by 
immunoprécipitation. The CAT/KSHV252/LUC was transfected into SLK cells and 
the cell lysates were immunoprecipated with anti-CAT and anti-LUC antibodies and 
analysed by SDS-PAGE and autoradiography (A) Immunoprécipitation with anti-CAT 
antibody. (B) Immunoprécipitation with anti-LUC antibody. The data shown are 
representative of results from three independent experiments.
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3.14 DISCUSSION
Previous studies have suggested that an 1RES element within the vCyclin coding region 
directed expression of vFLIP (Bieleski and Talbot, 2001; Low et ah, 2001; Grundhoff 
and Ganem, 2001). It was due to an analysis of latent KSHV mRNAs (LANA, vCyclin 
and vFLIP) which revealed no monocistronic vFLIPmRNA (Dittmer et ah, 1998; Sarid 
et ah, 1998, Sarid et ah, 1999, Talbot et ah, 1999), as vCyclin and vFLIP are believed to 
be coexpressed from the spliced bicistronic transcript. Since a monocistronic transcript 
coding for vFLIP alone has never been detected, it was therefore postulated that some 
other unconventional translation mechanism is involved in the expression of vFLIP, for 
example the presence of an 1RES.
The KSHV 1RES was shown to function in mammalian cells such as BCP-1 cells, a cell 
line latently infected with KSHV (Bieleski and Talbot, 2001), HEK 293 and SLK cells 
(Grundhoff and Ganem, 2001; Low et ah, 2001). The 1RES also functioned well in vitro 
in the Rabbit Reticulocyte Lysate system (Low et ah, 2001). We decided to determine 
the smallest fragment of KSHV 1RES within the vCyclin gene that mediates the 
translation of vFLIP in mammalian cell lines (HEK 293 and SLK). These two cell lines 
were selected in our experiment due to the documented ability of the KSHV 1RES to 
function (Grundhoff and Ganem, 2001; Low et ah, 2001). Furthermore, HEK 293 cells 
are available in our lab while SLK cells were provided by Dr. David Blackboum 
(University of Birmingham).
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From the experiment by using HEK 293 cells, no 1RES activity was observed from any 
of the KSHV 1RES fragments (DNA and RNA) tested. Similar results were shown by 
Bieleski and Talbot (2001) in HEK 293 cells although our findings and those of Bieleski 
contrast with those of Low et al (2001), who showed that the 1RES functions in HEK 
293 cells. Besides the HEK 293 cells, no 1RES activity was observed in KSIMM cells 
(KSHV-negative endothelial cell line derived from a KS biopsy) either (Bieleski et al.,
2001). However, 1RES activity was observed when BCP-1 cells, a KSHV-positive PEL 
B-cell line was used (Bieleski et al., 2001).
Similar results to transfection in HEK 293 cells were also observed; no 1RES activity 
was detected when KSHV 1RES fragments (DNA and RNA) were transfected into SLK 
cells (Section 3.3). However, the 1RES fragments were efficiently expressed in the SLK 
cells by Grundhoff and Ganem (2001). The underlying reason for this discrepancy is yet 
to be ascertained. One reasonable explanation could be that we and Bieleski used the 
same type of promoter for expression which is the T7 RNA polymerase promoter which 
relies on cells first being infected with a recombinant vaccinia virus (vTF7-3) (Fuerst et 
al., 1986) and the promoter that was used to drive the expression of the 1RES in the 
Grundhoff and Low study is the cytomegalovirus (CMV) promoter. The purpose of 
using the T7 RNA polymerase promoter is that this system can bypass the nuclear 
transcription pathway and allow cytoplasmic transcription of the bicistronic mRNAs. 
With this, it will eliminate any possibility of splicing being responsible for expression of 
the downstream cistron. With the CMV promoter based vector, the transcripts are made 
in the nucleus (Stoneley et al., 2000). Studies on cellular IRESes showed that when a
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plasmid containing the c-myc 1RES was introduced directly into the cytoplasmic 
compartment, the 1RES was almost completely inactive, suggesting that a ‘nuclear 
experience’ is needed for internal initiation from the 1RES (Stoneley et ah, 2000). It has 
since been found that members of the poly (rC) binding family, poly (rC) binding 
protein 1 (PCBP1), poly (rC) binding protein 2 (PCBP2) (Makeyev and Liebhaber,
2002) and hnRNPK (Michael et ah, 1997) are able to shuttle between the nucleus and 
the cytoplasm. It is possible that the poly (rC) binding family proteins interact with the 
c-myc 1RES in the nucleus and that the formation of a nuclear RNA/protein complex 
renders the 1RES competent for internal initiation (Evans et ah, 2003). This actually 
prompted us to investigate the association of 1RES transacting factor (ITAE) with the 
KSHV 1RES (see Chapter 4).
Regarding the unsuccessful attempts on KSHV 1RES activity in HEK 293 and SLK cell 
lines, I tried to optimize different parameters and approaches for nearly six months, to 
obtain KSHV 1RES activity in cell lines. I used different concentrations of plasmids 
containing KSHV 1RES fragments with different incubation periods post-transfection 
(Section 3.3). However, none of the parameters or approaches produced successful 
KSHV 1RES activity apart from the positive control of EMCV 1RES. Transfection using 
KSHV 1RES mRNA transcripts also produced no KSHV 1RES activity although the 
experiments were performed with different concentrations of KSHV 1RES mRNA 
transcripts in each different incubation period post-transfection, for both HEK 293 cells 
and SLK cells.
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In order to determine that the plasmid containing the KSHV 1RES was successfully 
transfected into cells, we have performed a radiolabelled immunoprecipition assay on 
the cell lysates of the transfected cells. The assay is very sensitive and specific as 
specific antibodies are used (anti-CAT and anti-LUC antibodies). The results confirmed 
the Western blot analysis and showed that the plasmids were transfected successfully 
into the cells and the lack of KSHV 1RES activity was not due to initiation at a different 
AUG to the LUC AUG. The results suggest that specific factors, either KSHV or 
cellular factors, may be required for efficient functioning of the KSHV 1RES.
Since no 1RES activity was detected when the assays were performed in cells, we tested 
the vCyclin 1RES activity in vitro in the RRL TNT system. However, we could not 
detect any 1RES activity in the system as the level of expression was not significantly 
above the background level from the control pGEM-CAT/LUC plasmid. The positive 
control (EMCV 1RES) efficiently expressed LUC and this was further confirmed by the 
LUC assay. We subsequently tried an in vitro translation of the mRNA transcripts 
containing the KSHV 1RES sequences (capped and uncapped) in the RRL System and 
Flexi® RRL System. The results showed that the latter system gave better KSHV 1RES 
activity compared to the RRL System when capped mRNA transcripts were used. The 
IRES-directed LUC expression from uncapped mRNA transcripts was significantly 
lower compared to that from capped mRNA transcripts in either the Rabbit Reticulocyte 
or Flexi® Rabbit Reticulocyte System. It therefore seems that the KSHV 1RES works 
efficiently in the context of capped mRNA, but inefficiently when in the context of an 
uncapped mRNA. The KSHV 1RES also functions better in the Flexi® RRL System as
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the system provides greater flexibility of reaction conditions than the standard RRL 
System as it allows translation reactions to be optimized for a wide range of parameters 
including Mg24" and K+ concentrations. It has been reported that different IREses have 
different optimal activities in different Mg2+ and K+ concentrations in RRL (Jackson, 
1991).
The standard RRL System is different from Flexi® RRL System: in standard RRL, the 
concentration of Mg2+ and K+ have been determined from the endogenous magnesium 
acetate (0.5 mM) and potassium acetate (79 mM) from the lysate respectively. However, 
in Flexi® RRL, the concentration of magnesium acetate is 1.8 mM while the 
concentration of potassium acetate is not determined by the manufacturer, as according 
to them, the concentration of K+ is less critical than the Mg24" concentration. 
Furthermore, the concentration of K+ is in a much broader range (70 -  100 mM), while 
the Mg24" concentration has a very narrow range (within 0.1 mM) of optimal 
concentration. Any changes in Mg2+ concentration can affect the efficiency of translation 
dramatically (Jackson, 1991; Promega). Unlike the standard RRL, the Flexi® RRL kit is 
supplemented with separate magnesium acetate (25 mM) and potassium chloride (2.5 
M). With the manipulation of Mg24" and K+ concentrations in Flexi® RRL system 
compared to the standard RRL, the latter system provides greater flexibility in term of 
optimizing translation activity as the final concentration of K+ and more importantly 
Mg24" can be manipulated for higher translation efficiency. Higher translation product 
has been reported from the manufacturer’s (Promega) protocol, in Flexi® RRL compared 
to standard RRL, when EMCV RNA transcript was used.
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In the experiments performed on standard RRL and Flexi® RRL systems, the final 
concentration of Mg2+ and K+ in RRL are 0.5 mM and 79 mM, while, the final 
concentration of Mg2+ and K+ in Flexi® RRL are 2.05 mM and 50 mM plus endogenous 
K+ respectively. The difference in Mg2+ concentration between the standard RRL and 
Flexi® RRL systems may therefore account for the increased efficiency of the Flexi® 
RRL system.
The smallest functional fragment of the KSHV vCyclin 1RES we have identified is the 
252 fragment, which was then introduced with a stable stem loop at the 5’ end of the 
fragment. From the results, it showed that although the stable stem loop has been 
introduced in order to prevent any leaky scanning to happen, the LUC expression still 
occur. Similar result was shown by Bieleski and Talbot (2001) although they introduced 
the stable stem loop on the 5’ of the first upstream cistron. The purpose is still the same 
which is to prevent any leaky scanning by the ribosome.
In analysing the truncated 1RES fragments, it seems that all the KSHV 1RES fragments 
function in RRL except the smallest fragment which is the 233 nt fragment. This result 
is contradictory with the result from Bieleski and Talbot (2001) which showed that the 
233 fragment also functioned as an 1RES in vivo. One possible explanation is that the 
secondary structures adopted in vitro may differ from those generated in vivo and may 
influence the accessibility of the ribosome to the 1RES. However, the 233 and 252 
fragments do not contain any overlapped sequence. Furthermore, it has also been shown
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that the individual fragments of the KSHV 1RES did not all behave identically (relative 
to one another) in the two assays (Low et al., 2001).
We can conclude that a minimum fragment of 252 nt from the upstream region of the 
KSHV vFLIP gene is sufficient to function as an 1RES and the 1RES works efficiently in 
Flexi® Rabbit Reticulocyte Lysate System within capped mRNA transcripts. Because of 
these intriguing results, we were prompted to investigate the initiation factor 
requirements for KSHV 1RES function (Chapter 4).
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Chapter 4
Eukaryotic Initiation Factors (elFs) requirements of the KSHV 1RES
4.1 Introduction
Eukaryotic translation is a tightly regulated process. The mechanism begins with the 
recognition of the 5' cap on the mRNA, which requires several initiation factor proteins 
(Pestova et ah, 2007) before ribosome scanning in order to find the start codon. 
Although the cap dependent and scanning processes are the major processes of 
translation initiation, some viral RNAs do not require a cap for the initiation process. 
The translation occurs by a cap-independent mechanism where the translation initiation 
is directed by 1RES. One of the best characterized examples is the viral mRNAs from 
picomaviruses, which contain extensive secondary structure elements that have been 
shown to interact with the translation machinery and a variety of cellular proteins 
(Belsham and Jackson, 2000). Although these picomavirus mRNAs are all able to 
mediate internal entry of the ribosomes, the requirement for initiation factors and 
cellular proteins for the 1RES to function can differ from one to another. For example, 
type I picomavirus 1RES elements (e.g. poliovims [PV]) requires that RRL are 
supplemented with an extract from HeLa cells, whereas the EMCV 1RES, which is a 
type II picomavirus 1RES, works well in RRL without additional proteins (Brown and 
Ehrenfeld, 1979; Borner et al., 1984). As for the canonical initiation factor requirements, 
both type I and II picomavirus IRESes do not require an intact eIF4G, as shown when 
the scaffold protein is cleaved by the expression of an entero-Zrhinovims 2A or 
apthovims L protease (Borman et al., 1997; Roberts et al., 1998). eIF4E is also not 
required by these IRESes as the binding site of eIF4E is on the N terminus of eIF4G
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which is not essential for these IRESes (Lloyd, 2006). The other canonical factor, 
eIF4A, is also required by these two 1RES groups since their activities were blocked by 
either an inhibitor of eIF4A or dominant negative mutants of the protein (Pause et al., 
1994b; Svitkin et al., 2001; Chard et al., 2006).
Besides the canonical factors involved in the translation initiation process on a viral 
1RES, 1RES trans-acting factors (ITAFs) also play an important role, although the 
requirements are different between viral IRESes. One of the ITAFs or cellular proteins 
that is important for the picomavirus IRESes is the polypyrimidine tract binding protein 
(PTB). This protein stimulates PV 1RES in vitro (Hunt and Jackson, 1999) and hepatitis 
C and A vims IRESes in vivo (Gosert et al., 2000).
Based on the previous results (Chapter 3), we suggested that the KSHV 1RES had 
unique functional properties. Therefore, we set out to investigate the requirement for 
individual elFs for KSHV 1RES activity by performing studies in Flexi® RRL System 
using specific inhibitors. In addition, we also searched for potential KSHV 1RES ITAFs 
by using an RNA-protein binding assay and Mass Spectrometry.
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METHODS
4.2 Requirement of the KSHV 1RES for initiation factor eIF4A
Hippuristanol is a specific inhibitor of eIF4A (Bordeleau et al., 2005). Capped KSHV 
1RES transcripts (Section 2.13) were translated in the Flexi® RRL System (Section
2.16), with or without hippuristanol (10 pM). The translation products were analysed by 
SDS-PAGE and autoradiography (Section 2.17).
4.3 Requirement of the KSHV 1RES for initiation factor eIF4E
The requirement for eIF4E was tested by using a commercially available m7GpppG cap 
analogue (Promega). This cap analog will competitively bind to eIF4E and reduce its 
availability to bind to the 1RES (Bergamini et al., 2000). A concentration of 50 pM and 
500 pM along with a control which contained no cap analog but only DMSO solvent 
were used. The translation was performed using Flexi® RRL System (Section 2.16). The 
lysate mixture containing the cap analog and a control were incubated at 30° C for 15 
mins and put on ice prior to addition of KHSV 1RES-containing mRNA transcripts. The 
mixture was then incubated as in Section 2.16. The translation products were later 
analysed by SDS-PAGE and autoradiography (Section 2.17).
4.4 Requirement of the KSHV 1RES for initiation factor eIF4G
To determine whether the KSHV 1RES requires eIF4G for translation initiation, the foot 
and mouth disease virus (FMDV) L-protease was used. The protein was kindly given by 
Prof. Simon Morley (University of Sussex). The ideal concentration of L-protease on 
eIF4G cleavage was first determined before the analysis on the KSHV 1RES was
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performed. From the initial concentration of 2.55 mg/ml, the protease was diluted 1:25, 
1:50, 1:100 and 1:200 in Buffer A (Appendix). The diluted protease was then added into 
Flexi® RRL and incubated at 30° C for 10 mins before the reaction was stopped on ice. 
The reactions were then analysed by SDS-PAGE (Section 2.17) and Western blot 
(Section 2.18) using a-WF polyclonal antibody of eIF4G (a kind gift from Prof. Simon 
Morley, University of Sussex) as a primary antibody (1:1000) and anti-rabbit IgG (1: 
2000) as a secondary (Amersham).
After several tests, it was decided that a dilution of 1:25 should be used for further 
analysis. The experiment was performed by incubation of diluted L-protease with Flexi® 
RRL as above. The lysates were then incubated on ice and 10 mM of Elastatatinal 
(Calbiochem) was added to completely stop the reaction. The translation process was 
continued as in Section 2.16. The reaction was then incubated for 90 mins at 30° C and 
the translation products were analysed by SDS-PAGE and autoradiography (Section
2.17).
Besides L-protease, we also used an inhibitor that blocks the interaction between eIF4E 
and eIF4G. The inhibitor, known as 4E2RCat has been reported to bind eIF4G (Cencic 
et al., 2011). For this experiment, the initial inhibitor stock of 10 mM was diluted to the 
final concentration of 50 pM, 70 pM and 100 pM. The Flexi® RRL along with all the 
mixture minus the mRNA (Section 2.16) was preincubated at 30 °C for 15 mins. After 
the incubation, the mixture was immediately put on ice and the capped KSHV 1RES 
mRNA transcripts were added and the reaction was further incubated for 90 mins at 30
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°C. The translation products were later analysed by SDS-PAGE and autoradiography 
(Section 2.17).
4.5 Determination of eIF4F binding site on KSHV 1RES
Due to these intriguing results concerning the requirement of the KSHV 1RES for the 
components of the eIF4F complex, we next set out to refine our understanding of these 
requirements on the KSHV 1RES. In order to determine whether the elFs bind internally 
to the 1RES, we engineered a KSHV 1RES fragment containing a poly(A) region at the 
5’ end of the hybrid RNA and performed the RNA-protein binding assay. Since there is 
a possibility that the elFs especially eIF4E could be recruited by the 5' end of the KSHV 
mRNA transcripts, we introduced a poly(A) fragment upstream of the KSHV mRNA 
transcripts to block the 5’end and tether it to the beads prior to the incubation with the 
lysate. Any detection of elFs from the assay by Western blot will further confirm that 
the elFs bind internally to the KSHV 1RES mRNA transcripts.
For the experiment, a sequence of T7 promoter, poly-A and KSHV 1RES 252 was 
designed by PCR (Figure 4.1). The primer used to generate the fragment of T7-Poly(A)- 
252 was 5' GGTAATACGACTCACTATAGGGAAAAAAAAAAAAAAAAAAAA 
AAAAAAAAAAGTGCGCTGTTGGTTCCTGCCA 3' for the forward primer and 5' 
CAGGTGCCGGCTTGTATATGTGAAGGCACCGATGTG 3' for the reverse 
primer. In the PCR, the KSHV 1RES 252 fragment was used as the template. The PCR 
product was then gel purified (Section 2.7) and the sequence of the fragment was 
confirmed by sequencing (Section 2.11). The RNA was transcribed using T7 Megascript
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and mMessage mMachine kit (Ambion) to produce uncapped and capped mRNA 
transcripts. For the A-capped mRNA transcript, the capped mRNA transcript kit was 
used with the 2XNTP/CAP solution being replaced with A-capped analog mixture 
(Ambion). All the transcription products were analyzed by agarose gel electrophoresis 
(Section 2.3) and the concentration was quantified by nanodrop.
T7 Poly(A) 252
Figure 4.1: A schematic structure of T7-Poly(A)-252 sequence for internal binding 
analysis. The sequence was prepared by PCR and the product was transcribed as 
uncapped, capped and A-capped mRNAs for RNA-protein binding assay.
4.6 RNA-protein binding assay
Once all the required transcripts were prepared, an RNA-protein binding assay was 
performed using Oligo(dT)^ Dynabeads (500 pi; Dynal-Invitrogen). The beads contain 
oligo-dT and will bind to the poly(A) chain in the poly(A)-252 fragment. The beads 
were firstly placed on a magnetic stand and left for 30 s to equilibrate. The supernatant 
was removed and the beads were resuspended and washed with 500 pi 0.5x SSC 
(Appendix). The beads were then washed with 500 pi of Ix Bead Binding Buffer (BBB; 
Appendix), and placed on the magnetic stand. The supernatant was removed and the 
pellets were resuspended in 500 pi Ix BBB. Once finished, 5 pg of mRNA transcripts 
were added and left to mix on a rotor at 4 °C for 30 min. The beads were washed twice 
in 500 pi Ix BBB as before. An amount of 50 pi of RRL was added along with 5 pg
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tRNA as competitor (Sigma) and incubated with the immobilised RNA transcripts for 60 
min at 4 °C as before. After the incubation, the supemantant was removed and the beads 
were washed twice with 500 pi Ix BBB as before. The RNA bound proteins were eluted 
in 20 pi sterile water, 1 pi DTT (New England Biolabs), and 10 pi SDS sample buffer 
(New England Biolabs) and incubated as above for 10 min. The eluted products were 
then centrifuged for 1 min and collected for analysis by Western blot against eIF4A, 
eIF4E and eIF4G antibodies (Section 2.18). The antibodies were kindly given by Prof. 
Dr. Simon Morley (University of Sussex).
4.7 Identification of KSHV 1RES trans acting factors (ITAFs)
To complement and expand our studies on the elF requirements for KSHV 1RES 
activity, we next investigated whether additional cellular factors or ITAFs could be 
interacting with the KSHV 1RES and mediate its activity. The minimal KSHV 1RES 252 
fragment and the pSP64 Poly(A) vector (Promega) were used for this purpose. The 252 
insert from TOPO TA vector was digested with BomHI restriction enzyme (Section 2.4) 
and blunt-ended (Section 2.6). For the pSP64 poly(A) vector, Smal restriction enzyme 
was used and dephosphorylised (Section 2.5). Both the insert and the vector were ligated 
(Section 2.8) before the ligation products were transformed (Section 2.9). The colonies 
from the transformation were then selected and grown overnight and the plasmid DNA 
was extracted (Section 2.10). The positive clones were screened by sequencing (Section
2.11) and subjected to midiprep for large scale production of the plasmid DNA (Section
2.12).
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In order to produce RNA transcripts, the constructs were linearised, phenol/chloroform 
extracted and ethanol precipitated. The products were then transcribed in vitro using the 
SP6  MegaScript kit (Ambion) according to the manufacturer’s protocol. RNA transcripts 
were phenol/chloroform extracted, precipitated with isopropanol, and resuspended in 2 0  
pi Nuclease-free water. The integrity of the RNA was checked on an agarose gel 
(Section 2.3) and the concentration measured with Nanodrop. The transcripts were then 
subjected to RNA-protein binding assay as in Section 4.6, analysed by SDS-PAGE and 
the desired bands were excised for Mass Spectrometry analysis.
4.7.1 In-gel trypsin digest of excised bands
In-gel trypsin digests of the excised bands was performed by Dr Jane Newcombe, 
University of Surrey. Briefly, the gel slices were washed three times in 25 mM 
NH4HCO3 in 50% ACN and then dried with a Speed Vac centrifuge. Enough 10 mM 
DTT in 25 mM NH4HCO3 was added to cover the dried slices and incubated at 56 °C for 
1 h. The supernatant was replaced with 25 pi 55 mM iodoacetamide and the reactions 
were incubated for 45 min at RT. The gel slices were then washed in 25 mM NH4HCO3 
in 50% ACN and dried with a Speed Vac. Trypsin was added to the gel slices and 
reactions were incubated at 37 °C for 4 h. The digest solution was trabsferred into a 
siliconised tube. The gel pieces were sonicated in 50% ACN/5% formic acid. The 
extrated digests were then analysed by Mass Spectrometry.
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4.7.2 Mass Spectrometric analysis
Mass Spectrometric analysis was performed by Dr Jane Newcombe, University of 
Surrey, using a QSTAR® XL Hybrid LC/MS/MS System (Applied Biosystem). Briefly, 
5 pi trypsin digested proteins were separated by liquid chromatography (LC) on a 2-50% 
acetonitrile gradient on a CIS 75 pm column (PepMap, Dionex). As the peptides were 
eluted from the LC, they were sprayed into the first Mass Spectrometer (MS) via Nano- 
Electrospray ionization. The two most abundant peptides within a survey scan were 
redirected to a Collision Energy cell to be broken down into aminoacids, which in turn 
were analysed by a second MS.
4.7.3 Mass spectrometric data analysis
The mass spectrometric data were analysed using the Mascot search engine for protein 
identification (Perkins et al., 1999).
4.7.4 Mascot search fields
i. Database. NCBInr was selected as the sequence database to be searched.
ii. Taxonomy. The taxonomy parameters were set to limit the search to particular 
groups of species, according to the origin of the lysate. The search for proteins 
from the RRL system was limited to mammalian species.
iii. Enzyme. Trypsin was selected as the reagent used for protein digestion
iv. Modifications. Carbamidomethyl was selected as fixed modification. Oxidation 
and Phospho (Serine or Threonine) were selected as variable modifications.
v. Protein mass. No restriction on protein mass was set.
1 23
vi. Peptide tolerance. The error window for fragment mass values was set at 50 part 
per million (ppm).
vii. Peptide charge. 2+ and 3+ were chosen as peptide charge states as recommended 
for the identification of unknown proteins (Perkins et al., 1999).
viii. Missed cleavage. To allow for partial trypsin digest, one missed cleavage was 
considered in the search.
ix. Instrument.MS data were generated by an ESI QuadTOF instrument.
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RESULTS
4.8 The effect of eIF4A inhibition on KSHV 1RES activity
The requirement of the KSHV 1RES for eIF4A was analysed by using hippuristanol, an 
eIF4A inhibitor. Hippuristanol was added to the Flexi® RRL System, along with the 
capped dicistronic CAT/IRES/LUC mRNA transcripts containing KSHV 1RES 
fragments. We excluded the 233 1RES fragment transcript since no 1RES activity was 
detected in the previous assays (Figure 3.8). As expected, the positive control 
containing the EMCV 1RES showed inhibition of both CAT and LUC expression when 
hippuristanol was added (Bordeleau et al., 2006). Hippuristanol completely inhibit the 
EMCV 1RES activity. Furthermore, inhibition of eIF4A resulted in inhibition of KSHV 
1RES where no 1RES activity was detected at all (Figure 4.2). Both the control for 
capped mediated translation, CAT, and the expression of the IRES-mediated LUC 
expression were inhibited. This suggests that the KSHV 1RES requires eIF4A for its 
function.
4.9 The effect of eIF4E inhibition on KSHV 1RES activity
As the results from the previous chapter suggested that the capped KSHV 1RES 
transcripts resulted in more efficient KSHV 1RES activity, we analysed the requirement 
of the KSHV 1RES for the cap binding protein eIF4E. The requirement of the KSHV 
1RES for eIF4E was analysed by using a cap analog (Section 4.3). For this experiment, 
only the capped 252 KSHV 1RES fragment was used along with the control, the EMCV 
1RES. The presence of m7GpppG cap analogue resulted in inhibition of KSHV 1RES 
activity (Figure 4.3). LUC expression mediated by the KSHV 1RES was inhibited at low
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concentrations (50 (xM) up to 50% of the untreated 252 KSHV 1RES. For the inhibition 
with high concentration of cap analogue (500 pM), the KSHV 1RES activity was almost 
completely abolished, with less than 10% of activity compared to the control 252 KSHV 
1RES. In contrast, LUC expression directed by the EMCV 1RES control was unaffected 
at any concentration. For CAT expression, all samples that were preincubated with cap 
analog were inhibited as expected. This experiment suggests that the KSHV 1RES 
requires eIF4E to function efficiently in RRL.
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Figure 4.2: The KSHV 1RES is inhibited in the presence of hippuristanol. In vitro 
translation in Flexi* RRL System with (+) or without (-) hippuristanol (10 pM). A) The 
translation products were analysed by SDS-PAGE and autoradiography. B) The LUC 
expression levels were quantitatively measured by densitometry analysis. The positive 
control was set at 100 and the activities of the KSHV 1RES elements were expressed as 
a percentage of this. The results are representative of three independent experiments 
(panel A), and the error bars represent the mean plus/minus standard deviation of 
densitometry readings from three experiments (panel B).
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Figure 4.3: The KSHV 1RES is inhibited in the presence of cap analogue. In vitro 
translation of capped inRNA transcripts in Flexi® RRL System with different 
concentrations of cap analog. A) The translation products were analysed by SDS-PAGE 
and autoradiography. B) The LUC expression levels were quantitatively measured by 
densitometry analysis. The positive control was set at 100 and the activities of the 
KSHV 1RES elements were expressed as a percentage of this. The results are 
representative of three independent experiments (panel A), and the error bars represent 
the mean plus/minus standard deviation of densitometry readings from three 
experiments (panel B).
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4.10 The effect of eIF4G inhibitor on KSHV 1RES
In order to study the effect of impairing eIF4G activity on the KSHV 1RES in RRL, 
FMDV L-protease and 4E2RCat were used. For the analysis using L-protease, the 
optimum concentration of L-protease to efficiently cleave eIF4G was first determined, 
as Flexi® RRL was incubated with increasing concentration of L-protease (Figure 4.4). 
The samples incubated with L-protease showed inhibition of CAT expression from all 
mRNAs. LUC expression which represents KSHV 1RES activity was inhibited when the 
lysate was treated with L-protease, where the activity of the KSHV 1RES is less than 
10% compared to the untreated KSHV 1RES (Figure 4.5). EMCV 1RES activity was 
not affected by eIF4G cleavage. The EMCV 1RES showed no inhibition of its activity 
when preincubated with L-protease as the EMCV 1RES only needs the carboxyl- 
terminal domain of eIF4G to support 1RES driven translation (Ohlmann et al., 1996).
To confirm the requirement for both eIF4E and eIF4G for KSHV 1RES activity, we also 
used an inhibitor that inhibits the 4E/4G interaction (4E2RCat). LUC expression from 
the KSHV 1RES was affected and the inhibition levels increased with higher 
concentrations of the inhibitor suggesting that the interaction between eIF4E and eIF4G 
is required for KSHV 1RES function (Figure 4.6). The KSHV 1RES activity was 
reduced proportionally compared to the untreated KSHV 1RES where it was reduced to 
70% in treatment with 50 pM of inhibitor, to less than 60% (70 pM 4E2RCat) and less 
than 30% with the highest concentration of 4E2RCat inhibitor (100 pM). The positive 
control EMCV 1RES activity, however, was not affected, even higher concentrations of 
inhibitor was used. As for the cap dependent CAT expression, the expression levels on
129
all samples decreased proportionally with the increase of inhibitor concentration, as 
expected.
From the results above, the KSHV 1RES requires eIF4G for it to function in translation.
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Figure 4.4: L-protease induced cleavage of eIF4G in Flexi® RRL. Cleavage of eIF4G 
in Flexi® RRL with different dilutions of L-protease from 2.55 mg/ml stock. The lysate 
was incubated with different dilutions of FMDV L-protease and analysed by SDS-PAGE 
and Western blot. The results are representative of three independent experiments.
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Figure 4.5: The KSHV 1RES is inhibited in the presence of L-protease. In vitro 
translation of capped transcripts in the form CAT/IRE S/LUC in Flexi® RRL System with 
(+) or without (-) L-protease (1:25). A) The translation products were analysed by SDS- 
PAGE and autoradiography. B) The LUC expression levels were quantitatively 
measured by densitometry analysis. The positive control was set at 100 and the activities 
of the KSHV 1RES elements were expressed as a percentage of this. The results are 
representative of three independent experiments (panel A), and the error bars represent 
the mean plus/minus standard deviation of densitometry readings from three 
experiments (panel B).
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Figure 4.6: The KSHV 1RES is inhibited in the presence of 4E2RCat inhibitor. In
vitro translation in FlexU RRL System with different concentrations of 4ElRCat 
inhibitor. A) The translation products were analysed by SDS-PAGE and 
autoradiography. B) The LUC expression levels were quantitatively measured by 
densitometry analysis. The positive control was set at 100 and the activities of the 
KSHV 1RES elements were expressed as a percentage of this. The results are 
representative of three independent experiments (panel A), and the error bars represent 
the mean plus/minus standard deviation of densitometry readings from three 
experiments (panel B).
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4.11 Interaction of poly(A)-252 fragment with elFs
The RRL proteins bound to the uncapped, capped and A-capped poly(A)-252 fragments 
were analysed by Western blot as above (Figure 4.7). From the results, eIF4A and 
eIF4E are recruited to uncapped transcripts, and the binding is better when the 
transcripts in capped form, which seems logical since the cap itself would act as a 
binding site for eIF4E. The A-capped transcript is used as a baseline in order to 
differentiate between the capped and uncapped transcript binding. From the blot, it 
shows that eIF4A and eIF4E bind internally to the KSHV 1RES. As for the eIF4G, the 
binding of uncapped transcript is not detected while the capped binding is higher 
compared to A-capped. This is probably due to no binding of eIF4G to the 5' end of the 
transcript compared to eIF4A and eIF4E which have a residual binding to the 5' end.
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Figure 4.7: The interaction of T7-poly(A)-252 fragment with elFs in RRL. RNA- 
protein binding assay with different form of mRNA transcript fragments in RRL. The 
binding assay products were analysed by SDS-PAGE and Western blot. A) Detection 
with anti-4A antibody. B) Detection with anti-4E antibody. C) Detection with anti-4G 
antibody. The results are representative of three independent experiments.
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4.12 KSHV 1RES interaction with RRL proteins
RNA affinity chromatography was used to investigate the proteins present in RRL that 
interact with the KSHV 1RES (Figure 4.8). A poly(A) oligonucleotide was used in the 
binding experiments as a negative control to detect non-specific protein binding. As the 
eukaryotic initiation factors eIF4A, eIF4E and eIF4G were proposed by the previous 
functional assay to be involved in 1RES function, their binding to the KSHV 1RES was 
directly assayed by Western blotting. The signal was stronger than the negative control 
of poly(A) for the detection of eIF4A (Figure 4.8A). On the eIF4E detection (Figure 
4.8B), the signal was much stronger than the poly(A) control, and no signal was detected 
from the control with eIF4G compared to binding to the KSHV 1RES (Figure 4.8C). 
From the results, it is suggested that the KSHV 1RES binds specifically to eIF4A, eIF4E 
and eIF4G. These results further supported the previous findings on the elF requirements 
of the KSHV 1RES (Section 4.8, 4.9 and 4.10) and the direct interaction between the 
elFs and KSHV 1RES (Section 4.11).
To identify unknown cellular factors that bind to the KSHV 1RES, the eluted proteins 
from the RNA chromatography assay were analysed by SDS-PAGE and the gel stained 
with Safe Blue (Invitrogen) (Figure 4.9). Proteins that appeared only in the KSHV 1RES 
lane, and not in the control, were excised and labelled according to the apparent 
molecular weight (MW). One band was detected to be not on the same molecular weight 
with the control and analysed by Mass Spectrometry. Out of several proteins hits, 5 
proteins that are known to interact with IRESes were identified (Table 4.1). The most 
significant hit was the Y-box binding protein, a cold shock domain protein (Matsumoto
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and Wolffe, 1998) with the score of 952 and the weakest hit with the score of 26 was the 
poly (rC) binding protein 1 (PCBP1).
Since YB-1 is the most significant hit from the Mass Spectrometry analysis, we then 
analysed YB-1 interaction with the KSHV 1RES by Western blot using anti-YB-1 
antisera (Abeam). The result showed that there was a high signal of specific interaction 
between the KSHV 1RES and YB-1 (Figure 4.10) whereas a very small signal was 
detected from the control sample.
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Figure 4.8: The interaction of the KSHV 1RES with elFs in RRL. An RNA-protein 
binding assay with the KSHV 1RES 252 fragments was conducted with RRL. The 
binding assay products were analysed by SDS-PAGE and Western blot. A) Detection 
with anti-4A antibody. B) Detection with anti-4E antibody C) Detection with anti-4G 
antibody. The results are representative of three independent experiments.
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Figure 4.9: The interaction of the KSHV 1RES with elFs in RRL. An RNA-protein 
binding assay with the KSHV 1RES 252 RNA fragment with RRL. The proteins 
interacting with the 1RES were analysed by SDS-PAGE and the gel stained with Safe 
Blue (Invitrogen). The protein band highlighted was excised and subjected to Mass 
spectrometry analysis.
139
Identity Score
Y-box protein 1 (YB-1) 952
Eukaryotic translation 
elongation factor la  
(EEF1A1 and EEF1A2 )
165
Heterogenous nuclear 
ribonucleoprotein K (hnRPK)
87
Heterogenous nuclear 
ribonucleoprotein C1/C2 
(hnRP C1/C2)
51
Poly(rc) binding protein 1 
(PCBP1)
26
Table 4.1: 1RES trans acting factor interaction with the KSHV 1RES. The band 
excised from Figure 4.10 was analysed by Mass spectrometry and the results were 
analysed with Mascot search engine. Matched proteins are ranked according to the score 
and are derived from the ions scores of the Mascot program interpretation.
YB-1 
"(49 kDa)
Figure 4.10: YB-1 interaction with the KSHV 1RES. An RNA-protein binding assay 
with the KSHV 1RES 252 fragments was conducted with RRL. The binding assay 
products were analysed by SDS-PAGE and Western blot. Detection with anti-YB-1 
antibody. The results are representative of three independent experiments.
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4.13 DISCUSSION
Studies of viral gene expression in the late 1980s led to the discovery of an alternative 
mode of translation initiation in eukaryotic cells that bypasses the requirement for cap- 
dependent scanning and allows the 40S ribosome to be directly recruited to the vicinity 
of the initiation codon (Jackson et ah, 2010; Jackson et ah, 2000; Hellen and Samow, 
2001; Balvay et ah, 2009). The mechanism of internal initiation is directed by an 1RES, 
and the process is independent of 5'-end recognition. Viral IRES-directed translation 
generally has a reduced requirement for canonical translation initiation factors, 
particularly members of the eIF4F complex. Several other initiation factors also appear 
to be dispensable for the internal initiation pathway (Hellen, 2009). However, the need 
for specific canonical initiation factors in IRES-directed translation initiation appears to 
be varies among 1RES elements.
In this chapter, we focussed on the requirement of the KSHV 1RES for the canonical 
eukaryotic initiation factors eIF4A, eIF4E and eIF4G. We also attempted to identify any 
KSHV 1RES ITAFs. For the requirement of eIF4A, it has been reported that different 
IRESes have different eIF4A requirements for the initiation process. For example, the 
EMCV 1RES requires eIF4A to function (Bordeleau et ah, 2006), but the HCV-like 
IRESes, such as AEV, do not require this factor for function (Pestova et ah, 1998; 
Bakhshesh et ah, 2008). A specific inhibitor of eIF4A, hippuristanol blocks eIF4A from 
binding to the mRNA and thus inhibits translation by binding to several motifs in the C- 
terminal domain of eIF4A (Bordeleau et ah, 2006). The binding impairs the eIF4A 
function in a free form and within eIF4F. We have tested the requirement of the KSHV
14 1
IRES for eIF4A using hippuristanol and found out that the 1RES is unable to function 
when eIF4A is inhibited. This result is reminiscent of type II picomavirus IRESes, such 
as the EMCV 1RES, where eIF4A enhances the specific binding of the eIF4G domain to 
the J-K domains of the 1RES (Kolupaeva et ah, 1998, Lomakin et ah, 2000). The 
interaction of the eIF4A/eIF4G complex induces ATP-dependent conformational 
changes at the 3’-border of the 1RES (Kolupaeva et ah, 2003) that likely prepare this 
region for binding of the 43 S complex in a process that presumably involves the 
eIF4G/eIF3 interaction. In the eIF4A requirement study, we only used EMCV 1RES as a 
control. Since EMCV 1RES also require eIF4A to function, it is not suitable to be used 
as a control. However, due to the unavailability of any other 1RES element that does not 
require eIF4A to function, such as HCV 1RES at the time of the experiment was 
performed, we have to use the EMCV 1RES.
The requirement of KSHV 1RES for eIF4E was also investigated. In the experiments, the 
m7GpppG cap analogue was used. eIF4E is the cap binding protein which recognizes 
and binds to the cap structure present at the 5’ UTR of cellular mRNAs and delivers 
these mRNAs to the eIF4F translation initiation complex. This step is rate limiting as 
eIF4E is the least abundant among the initiator factors involved in the eIF4F complex 
(Ritcher and Sonenberg, 2005). We tested the requirement for eIF4E using m7GpppG 
cap analogue (Promega), to saturate eIF4E and prevent its binding to the cap. With 
lower concentrations of cap analogue (50 pM), the KSHV 1RES was inhibited and when 
higher concentrations of cap analogue (500 pM) were used, the activity was almost 
completely abolished (Figure 4.3). The control EMCV 1RES was not affected by the
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inhibitor at either in low or high concentrations of cap analogue, although translation 
from the cap dependent upstream cistron CAT was affected, as expected. The other 
picomavirus 1RES, HAY 1RES, was also affected when the cap analogue was used as 
previously demonstrated by Ali et al (2001).
Besides the cap analogue, we also tested the requirement of KSHV 1RES for eIF4E with 
4E-BP1. Interaction of 4E-BPlwith eIF4E inhibits cap-dependent protein synthesis both 
in vitro and in vivo (Pause et al., 1994b). 4E-BP1 competes with eIF4G for binding to 
eIF4E because they share the same binding motif on eIF4E (Goodfellow and Roberts, 
2008). Thus, 4E-BP1 binds to- and sequesters eIF4E, preventing the interaction of eIF4E 
with eIF4G (Pause et al., 1994b). Unfortunately, we were unable to get desirable results 
from this experiment as the quality of 4E-BP1 used is unreliable and due to time 
constraint, we were unable to optimize the procedures.
We also analysed the requirement for the scaffolding protein, eIF4G, on the KSHV 
1RES. Two inhibitors of eIF4G were used (Section 4.4). Foot and Mouth Disease Vims 
(FMDV) E-protease cleaves eIF4G into N-terminal fragment, which has the binding site 
for the cap-binding factor eIF4E, and C-terminal fragment which interacts with eIF3 and 
also has two binding sites for eIF4A (Kirchweger et al., 1994; Lamphear et al., 1995; 
Imataka and Sonenberg, 1997). Since eIF4G interacts with eIF4A and eIF4E, and as 
previously shown that the KSHV 1RES requires both eIF4A and eIF4E, we suspected 
that the KSHV 1RES would require a fully intact eIF4G in order to function. Indeed, the 
cleavage of eIF4G by E-protease almost completely inhibited the function of the KSHV
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IRES (Figure 4.5) whilst the EMCV 1RES was not affected. A similar result was 
previously observed for the HAY 1RES (Ali et al., 2001), as the HAY 1RES requires a 
fully intact eIF4G for it to function compared to other picomavirus 1RES elements.
The second inhibitor used to assess the eIF4G requirement was the 4E2RCat inhibitor 
(Cencic et al., 2011). From the analysis using different concentrations of the inhibitor, it 
was observed that the KSHV 1RES activity was significantly decreased as the 
concentrations of the inhibitor increased. The EMCV 1RES control was not affected 
even at higher concentrations of 4E2RCat inhibitor, as expected (Figure 4.6).
The outcome of the experiments investigating the requirement of the eIF4F complex for 
the KSHV 1RES to function were suprising, as eIF4E seem to be required. However, the 
KSHV 1RES is not the only viral 1RES which requires eIF4E for efficient function. A 
comparable viral 1RES is the HAY 1RES, where its function resembles the translation of 
capped mRNAs (Ali et al., 2001). Similar results with the HAY 1RES were observed 
when capped dicistronic mRNAs were used, where both cistrons were affected by 4E- 
BP1, cap analogue and E-protease (Ali et al., 2001). It was suggested by Ali et al (2001) 
that the functional relationship between eIF4F and the HAY 1RES is more likely a direct 
physical interaction between eIF4F and the 1RES and not an interaction of eIF4F with 
the 5’ end of the mRNA. It was shown that eIF4F plays a role in HAY 1RES initiation, 
which was totally dependent on the presence of eIF4E in the eIF4F complex. From these 
findings, they proposed two models that might help to understand the mechanism of the 
HAY 1RES. One of the models is that a direct interaction between the eIF4E component
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of eIF4F with a specific internal site in the HAY 1RES, an interaction which would 
involve the cap-binding pocket of eIF4E in order to explain the inhibition of the 1RES by 
cap analogue. This model postulated that a site-specific eIF4E-IRES interaction and 
most probably along with direct eIF4G-IRES interactions (Haghighat and Sonenberg,
1997), place the eIF4G in the appropriate proximity and orientation to deliver the 40S 
ribosomal subunit to the 3’ end of the HAY 1RES, at or very close to the initiation 
codon. The other alternative model is that the HAY 1RES activity requires the eIF4F 
complex, complete with associated eIF4E, not because of an interaction with the 1RES 
but because the eIF4E subunit must be associated with eIF4G in order for the eIF4G to 
be able to adopt a conformation suitable for direct interaction with the 1RES.
Based on the results that we have acquired, and a model on the direct interaction 
proposed by Ali et al (2001), we designed a construct containing a T7 promoter- 
poly(A)-252 (Figure 4.1) that was transcribed into uncapped, capped and A-capped 
mRNAs. The purpose of this experiment is to determine whether the binding of elFs 
especially eIF4E to the KSHV 1RES occurss internally or to the 5' end. With the poly(A) 
located on the upstream of KSHV 1RES transcript in uncapped, capped and A-capped 
form, any detection of elFs by Western blot will confirm that the elFs bind internally to 
the KSHV 1RES transcript and not to the 5' end of the T7-poly(A)-252 transcript.
From the experiments, we found that eIF4A binds to the capped 1RES RNA better than 
to the uncapped and A-capped mRNA transcripts (Figure 4.7A). Similar results was 
shown in eIF4E, where the capped 1RES containing transcript showed better binding of
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eII4E (Figure 4.7B). Finally eIF4G also showed better binding to the capped 1RES 
transcript compared to the A-capped transcript and no binding was detected with the 
uncapped KSHV 1RES transcript (Figure 4.7C). From the results described here, we 
suggest that the capped KSHV 1RES mRNA transcript interacts with the canonical 
initiation factors (eIF4A, eIF4E and eIF4G) internally and not to the 5' end of the 
transcript since the A-capped construct was also able to recruit eIF4E and eIF4A The A- 
capped form of transcript was used as a baseline or background control for this 
experiment as A-capped transcript can be used to substract cap-dependent eIF4E binding 
as opposed to internal binding. The results obtained from this experiment are also in an 
agreement with the proposed model by Ali et at (2001) where they postulated that there 
is a direct physical interaction between the eIF4F complex and the HAV 1RES.
It is obvious that the KSHV 1RES needs ITAFs for it to function, despite its requirement 
for eIF4F. Almost all known 1RES elements whether viral or cellular, require ITAFs to 
function efficiently. It has been proposed that the ribosome might be recruited directly to 
the 1RES via an interaction with ITAFs that are bound to the viral RNA (Cencic et al., 
2011). The binding might stabilize the secondary or tertiary structure of the 1RES and 
allow for direct or indirect recruitment of ribosomes. Another additional hypothesis is 
that ribosomes might be recruited either directly or indirectly to the RNA via a larger 
protein complex, including identified ITAFs as well as yet unidentified factors and 
canonical translation initiation factors. One of the examples is the PCBP2 ITAF which 
was found to bind to the viral RNA of poliovirus and also interacts with the cellular 
protein SRp20. It is proposed that these two proteins are required for viral translation
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(Bedard et al., 2007). Therefore, it might be the case as PCBP2 binding to the RNA 
stabilizes the secondary and tertiary structure of the RNA, and it is possible that PCBP2 
interactions (direct or indirect) with other ITAFs and/or canonical translation initiation 
factors play a part in recruiting the ribosome to the RNA for the initiation of translation.
In order to study the ITAFs that might interact with the KSHV 1RES, we cloned the 
KSHV 1RES 252 fragment into the pSP64poly(A) vector and the transcript was prepared 
for RNA-protein binding assay. Western blot analysis using eIF4A, eIF4E and eIF4G 
antisera confirmed that the components of eIF4F do interact with the KSHV 1RES. 
These preliminary results prompted us to isolate proteins that bind to the KSHV 1RES. 
In this experiment the identification of the eluted proteins was analysed by Mass 
Spectrometry. This method has many advantages compared to Western blot analysis. 
The identification of the proteins is not based on the pre-existing knowledge of the 
identity of a protein, but it is revealed by direct peptide sequencing. Additionally, 
peptide sequencing can resolve a protein mixture into its components. This is particulary 
useful in our experiment because we separated the rescued proteins only in one 
dimension (i.e. molecular weight); therefore the presence of more than one protein in a 
single gel band is likely. These binding studies and Mass Spectrometric analysis also 
have the potential of identifying a novel protein or in defining an additional role of a 
known protein. Studies on the picomavirus 1RES elements have shown that cellular 
proteins with prexisting defined function, unrelated to translation, can also function as 
ITAFs, such as PTB and La (Pestova et al., 1991; Meerovitch et al., 1993). This analysis 
identified several putative KSHV 1RES ITAFs. One of the ITAFs was YB-1, with the
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highest score (952), followed by EEF1A1/2, hnRNP K, hnRNP C and PCBP1. Out of all 
5 ITAFs detected by Mass Spectrometry, we have further tested YB-1 by Western blot 
binding analysis. This also showed a specific interaction between the KSHV 1RES and 
YB-1 (Figure 4.10).
YB-1 is a multifunctional protein that binds DNA and RNA, and plays an important role 
in transcriptional and translational regulation. It was first identified as a DNA-binding 
protein that interacts with the Y-box sequence in major histocompatibility complex class 
II promoters (Didier et al., 1988). It has previously been shown that the protein regulates 
translation in a dose-dependent manner. Translation is stimulated with low 
concentrations and inhibited at high concentrations (Evdokimova et al., 1998). It has 
also been reported that YB-1 functions as an ITAF by regulating the endogenous levels 
of c-myc protein (Cobbold et al., 2008). The c-myc 1RES function in vitro is poorly 
regulated and inefficient; however, in presence of YB-1, the activity of the 1RES in RRL 
system is increased. In vivo, the c-myc activity was suppressed upon inhibition of YB-1 
with siRNA (Cobbold et al., 2008) which proved that YB-1 plays an important role in c- 
myc 1RES regulation. In addition, it was shown by Cobbold et al (2008), that reduced 
levels of YB-1 caused the mRNA to relocates to the inactive subpolysomal particles 
rather than to the polysomes, which strongly suggests that YB-1 has a role in controlling 
the recruitment of c-myc mRNA to the polysomes.
Although the interactions between the rests of the ITAFs have yet to be determined, the 
function of these ITAFs is related to the function of the IRESes such as in cell cycle
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regulation and apoptosis generally. For example, eEFlA is known to be involved in 
several cellular processes, including embryogenesis, senescense, oncogenic 
transformation, cell proliferation and organization of the cytoskeleton (Gangwani et al.,
1998). eEFlA functions as an ITAF, and, with the combination of eEF2, helps in 
stabilizing the binding of the Plautia stali intestine virus (PSIV) IGR-IRES to the 
ribosome in the first elongation cycle of IGR-IRES-mediated translation (Yamamoto et 
al., 2007). hnRNP K, is a protein that can shuttle between nucleus and cytoplasm 
(Michael et al., 1997). The hnRNP K was observed to function as ITAF in c-myc 1RES 
regulation (Evans et al., 2003) and works with other ITAFs such as PCBP1 and PCBP2. 
Another ITAF detected is the hnRNP C1/C2 which has been reported to play a part in 
several steps of RNA biogenesis, including splicing (Choi et al., 1986), RNA turnover 
(Hamilton et ah, 1993), and polyadenylation (Wilusz et ah, 1990). The proteins have 
been reported to function as ITAFs by Holcik et al (2003). The binding of the two 
isoforms to the XIAP 1RES element has been shown and are involved in the modulation 
of XIAP 1RES translation, as part of the XIAP IRES-RNP complex. The last ITAFs 
recognized to be interacting with KSHV 1RES is the PCBP1. The protein is an RNA- 
binding protein that was originally identified as part of the a-globin mRNP complex 
associated with a-globin mRNA stability (Kiledjian et ah, 1995). The PCBP1 protein has 
three KH domains that enable it to interact with a pyrimidine-rich binding sequence in 
target RNAs and functions as an RNA-binding protein implicated in the control of 
mRNA turnover and translation (Ostareck-Lederer et ah, 1998). It has been reported 
that, an association between PCBP1 and several cellular and viral RNAs is important for
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the RNAs’ posttranscriptional regulation, either by stabilizing or directly influencing 
their translational activity (Ostareck-Lederer et ah, 1998).
In this chapter, we have demonstrated the requirement of the KSHV 1RES for the eIF4F 
complex by conducting several experiments. The results showed that the KSHV 1RES 
requires all the factors in the eIF4F complex which is rather unusual for an 1RES. We 
then looked at the binding of the 1RES with the canonical factors of the eIF4F complex 
and showed that all the factors (eIF4A, eIF4E and eIF4G) bind directly to the KSHV 
1RES. A question then came to our minds; since the KSHV 1RES requires the eIF4F 
complex to function, there must be other factors that also play a role in the initiation 
process. These results prompted us to look for KSHV 1RES ITAFs and we found five 
different ITAFs that have an interaction with the KSHV 1RES. We showed that YB-1 
interact with the KSHV 1RES whereas the other ITAFs need to be further studied.
Although some of the experiments in this chapter need further optimization, however, 
we manage to present the ideas on how and what KSHV 1RES is, based on the canonical 
initiation factors and ITAFs requirement. It is rather intriguing to find out that the eIF4F 
complex is needed for KSHV 1RES function. Further questions therefore emerge, 
questioning how these factors interact with the KSHV 1RES, where they bind on the 
1RES, whether specific sequences or structures are involved etc. A thorough analysis 
need to be performed in order to establish a solid foundation on the KSHV 1RES 
functionality. One of the options is to optimize a cell system with different transcription 
promoter, such as CMV promoter instead of T7, and tests all the inhibition experiments
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in cells. Furthermore, a secondary structure analysis of the 252 KSHV 1RES fragment 
will shed an additional light on KSHV 1RES function.
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Chapter 5
Identification of KSHV 1RES 1RES Secondary Structure
5.1 Introduction
A wide range of functions are performed by RNA molecules in the cell. RNAs are 
involved in all steps of protein synthesis, such as, by storing the genetic information 
(messenger RNA), by participating in the structure of the mRNA decoding machinery 
(the ribosome), by carrying the amino acids onto the ribosome (tRNAs). This multi- 
molecular mechanism requires specific and coordinated RNA-RNA and RNA-protein 
interactions. The precise mapping of its secondary and tertiary structure features is of 
prime importance for a detailed understanding of the RNA functions. RNA structure also 
plays a fundamental role in 1RES dependent translation initiation (Costantino et al., 
2008; Femandez-Miragall et al., 2003; Easton et al., 2009; Morris et al., 2010), as well 
as in other processes guided by RNA regulatory elements (Chauhan. and Woodson, 
2008; Zuo et al., 2010; McPheeters et al., 2009). It has been highlighted from several 
studies that different IRESs can share structural homology (Kieft et al., 1999; Odreman- 
Macchioli et al., 2001; Willcocks et al., 2011), suggesting that the presence of specific 
structural elements might be the underlying cause for the viral 1RES function.
Little is known about KSHV 1RES secondary structure let alone the interaction between 
the folding region of the 1RES with the canonical eukaryotic initiation factors and 
ITAFs, although some of the required elFs and ITAFs have been determined as 
described in the previous chapter (Chapter 4). So far, the predicted secondary structure 
of the smallest KSHV 1RES (233 nt) has been predicted (Bieleski et al., 2001) using an
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RNA folding prediction software without any experimental data. Furthermore, no 
mutational analysis was performed to further validate the predicted secondary structure 
of the KSHV 1RES.
The aim of our work was, therefore, to determine the secondary structure of the KSHV 
1RES 252 nucleotide fragment. The analysis will include chemical and enzymatic 
probing. The experimental data obtained from the probing will be used as restraints to 
model the secondary structure of the 1RES using the Mfold program for the secondary 
structure prediction (Zuker, 2003).
5.2 Materials and Methods
5.2.1 Cloning of 252 KSHV 1RES fragment into puCIS vector
The 252 KSHV 1RES fragment in TOPO TA vector was digested (Section 2.4) and 
cloned into pUClB vector (Invitrogen) as described in Section 2.8. The ligated DNA 
was then transformed into E. Coli DH5a cells (Section 2.9), and the positive clones 
were analysed by sequencing (Section 2.11). Once the positive clone has been 
confirmed, plasmid midipreparation was performed by using QIAGEN midiprep kit 
(Section 2.12).
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5.2.2 Preparation of KSHV 1RES RNA
The uncapped RNA transcript of 252 KSHV 1RES was prepared by using the T7 
Megascript kit (Ambion). Linearised plasmids were first prepared and subjected to 
phenol/chloroform extraction and ethanol precipitation as mentioned in Section 2.13. 
The purified plasmids were transcribed according to the manufacturer’s protocol. The 
reaction was then stopped by adding 115 pi sterile nuclease-free water and 15 pi 
Ammonium Acetate (5M, Ambion) and placed on ice. The reaction was then purified 
and quantitated (Section 2.13).
5.2.3 Modification of RNA
The secondary structure of KSHV 1RES RNA was probed by using N-cyclohexyl-NO- 
[N-methylmorpholino)-ethyl]-carbodiimid-4-toluolsulfonate (CMCT) (Sigma), 
Dimethyl sulphate (DMS) (Sigma) and VI RNAse (Ambion). CMCT reacts by 
modifying the exposed based of specific and single-stranded nucleotides which are 
uridine and guanine (Ehresmann et al., 1987). The modifications by CMCT occur 
primarily with N3 of uridine and N1 of guanine which are the functional sites involved 
in canonical Watson-Crick hydrogen bonding (Ehresmann et al., 1987). For DMS, the 
modifications occur by méthylation at NI position of adenosines and N3 position of 
cytidines (Inoue and Cech, 1985). RNase VI, an endonuclease which originally from 
cobra Naja naja oxiana venom, cuts double-stranded RNA or structured regions without 
base specificity and generates fragments with a 5'-phosphate (Vassilenk and Rythe, 
1975).
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5.2.3.1 CMCT modification
For the RNA modification by CMCT, reactions were assembled according to Table 5.1. 
The modification was performed by using different concentration of CMCT. Firstly, on 
ice, an equal amount of RNA was added into 4 different eppendorf tube followed by 
H2O accordingly. An equal amount of buffer (4pl) was later added to each tube and the 
reaction mixture was incubated at 20 °C for 10 mins. Following incubation, 1 pi of 
tRNA (2mg/ml) was added into each tube and along with CMCT based on the table 
below. The reactions were then incubated at 20 °C for 20 mins.
Following the incubation, the reaction was stopped by adding 2 pi of 3M ammonium 
acetate and 60 pi of 100% ethanol. For the purification of CMCT modification products, 
the reaction was mixed, incubated on dry ice for 20 mins and then centrifuged at 4°C at 
13000 rpm for 20 mins. The supernatant was then removed before 50 pi of 70% ethanol 
was added and centrifuged at 13000 rpm for 2 mins. The supernatant was removed and 
the pellets were dried for 10 to 15 mins. The final pellet was resuspended in 8  pi of H2O 
and stored at -80 °C freezer for primer extension reactions.
5.2.3.2 DMS modification
From the initial concentration of 7.95 M, DMS was prepared by dilution with 100% of 
ethanol in 1: 1 ratio prior the experiment. The reaction was assembled based on the 
Table 5.2. Firstly, a volume of 2 pi of 1 pM 252 RNA was added into 4 different tubes 
followed by H2O and 2x DMS buffer, on ice. The mixture was then incubated for 10 
mins at 20 °C. tRNA was then added into respective tube. To complete the modification 
process, 1 pi of diluted DMS was added into each tube at different time length. The first
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tube is for the control with no DMS added. Tube number 2 was added with DMS and 
incubated for 1 min. For the tube number 3, the incubation period is 5 mins and the final 
tube was incubated for 10 mins. All the reactions were incubated at 20 °C with different 
incubation periods as described in order to observed modification activity by DMS. The 
reaction mixture was then stopped and the pellet was resuspended accordingly as 
described in Section 5.2.3.I.
Tube 1 w 2  (pi) 3 W 4 (pi)
252 RNA 
IpM
2 2 2 2
H20 13 1 2 1 1 8
5x CMCT 
Buffer
4 4 4 4
tRNA
(2 mg/ml)
1 1 1 1
CMCT (40 
mg/ml)
- 1 2 5
Total 2 0 2 0 2 0 2 0
Table 5.1: CMCT modification of reaction mixture of 252 KSHV 1RES RNA.
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Tube 1 w 2  (pi) 3 M 4 (pi)
252 RNA 
IpM
2 2 2 2
H20 7 6 6 6
2x DMS 
Buffer
1 0 1 0 1 0 1 0
tRNA
(2 mg/ml)
1 1 1 1
DMS (7.95 
M)
- 1 1 1
Total 2 0 2 0 2 0 2 0
Table 5.2: DMS modification of reaction mixture of 252 KSHV 1RES RNA.
S.2.3.3 RNAse VI Hydrolysis
For this experiment, initial stock enzyme (0.1 U/pl) of RNAse VI was used. The 
enzyme was initially diluted in a 1:5 ratios with IX DMS Buffer before the experiment. 
The reaction was assembled based on the Table 5.3 below. Firstly, 2 pi of KSHV 1RES 
RNA was added into each eppendorf tube and placed on ice. The H2O was then added 
accordingly based on the table before 10 pi of 2X DMS buffer being added. The reaction 
was mixed and incubated at 20 °C for 10 mins. Then, 2 mg/ml of tRNA was added 
followed by RNAse VI as on the table. Each reaction was mixed and incubated for 
further 5 mins at 20 °C.
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Tube 1 # 2  (pi) 3 (pl) 4 (pl)
252 RNA 
IpM
2 2 2 2
H20 7 6.5 6 4.5
2x DMS 
Buffer
1 0 1 0 1 0 1 0
tRNA
(2 mg/ml)
1 1 1 1
RNAse VI 
(0.02 U/pl)
- 0.5 1 2.5
Total 2 0 2 0 2 0 2 0
Table 5.3: RNAse VI modification of reaction mixture of 252 KSHV 1RES RNA.
The reaction was stopped by adding 40 pi of 0.3 M sodium acetate. A volume of 100 pi 
phenol/chloroform was then added. The mixture was vortexed and centrifuged at 4°C at 
5000 rpm for 2 mins. The upper layer of the supernatant from the centrifuged product 
was then transferred into a new tube and 300 pi of 100% ethanol was added. The 
reaction was mixed and incubated on dry ice for 20 mins to precipitate. The mixture was 
further centrifuged at 13000 rpm for 20 mins. The supernatant was removed and 50 pi of 
70% ethanol was added into the eppendorf tube and once again centrifuged at 13000 
rpm for 2 min. The supernatant was removed and the pellet was dried in dessicator on 
vacuum line for 10 to 15 mins. The pellet was resuspended in 8  pi of H2O and stored at - 
80 °C freezer for primer extension reactions.
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5.2.4 32-P Primer labelling
In order to amplify the modified RNA, five different primers were used spanning from 
several parts of the modified KSHV 1RES RNA (Table 5.4). All the primers were 
radioactively labelled with 32-P gamma-ATP (Perkin Elmer).
Primer Sequence Position
Revl 5'TGGAGCGATATGATTCGG3' 2451 -2469
Rev2 5AGGCGTCTAGTTTCAGGC3' 153-136
Rev3 5 TGTTTCCTTTT AAAT AAA A3 ' 213-195
Rev4 5 'GGCGGACATCTTGCCTTTG3 ' 108-91
Rev5 5 'GGTGGG ATTTGTTTTAGTGTTCG3 ' 193-171
Table 5.4: Sequences of primers used for RT-PCR reactions of modified KSHV 
1RES RNA. The primers were designed based on the position of the fragment amplified 
for primer extension analysis.
For the labelling reaction, a total of 20 pi reaction was prepared per primer as in Table 
5.5.
Items Volume (pi)
H20 1 1
10X Polynucleotide Kinase Buffer 2
10 pM primer 1
ATP 32-P-y 5
Polynucleotide kinase 1
Table 5.5: Reaction mixture for primer labelling process.
1 5 9
Once all the reaction has been set up, the reaction was incubated at 37 °C for 1 h. A 
volume of 30 pi H2O was then added into the reaction to increase the volume up to 50 
pi. During the incubation period, G-50 column was prepared by centrifugation at 2000 
rpm in cold room for 2  mins and placed on a collection tube for the labelled primer 
collection. After the incubation is over, the mixture was transferred into the column and 
centrifuged at 2000 rpm for 2 mins. In theory, an estimated 10% of incorporated labelled 
primer will be collected while the other 90% of the unincorporated labelled primer will 
be retained in the column. The labelled primer was stored in -20 °C freezer for primer 
extension and sequencing ladder experiments.
5.2.5 Primer extension
Primer extension reaction was performed on all the modified RNAs. A volume of 4 pi of 
modified RNA and 1 pi of 32-P labelled primer were used in each experiment. The 
mixture of RNA and labelled primer were incubated for 1 min at 90 °C followed by 1 
min at 4 °C and finally for 5 mins at 20 °C. Then, 1 pi of 5X AMY buffer was added 
into the mixture and incubated for further 10 minutes at 20 °C. A volume of 2 pi of 5X 
AMY buffer was latter added into the mixture followed by 2 pi of 2.5 mM dNTP mix, 4 
pi of H20  and finally 1 pi of 2U/pl of AMY RT enzyme. Primer extension was allowed 
to occur for 30 minutes at 37 °C.
Once the primer extension process has finished, 20 pi of 0.3 M sodium acetate was 
added into the mixture to stop the reaction and followed by 100 pi of 100% ethanol. The 
reaction was mixed and incubated on dry ice for 2 0  mins before centrifugation at 13000
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rpm for 20 mins. The supernatant was removed and 200 pi of 80% ethanol was added 
and centrifuged at 13000 rpm for 5 mins. The supemantant was removed and the pellet 
dried in dessicator for 15 mins. The dried pellet was resuspended in 6  pi of mixture of 
Formamide and Xylene Cyanol for sequencing ladder analysis.
5.2.6 Sequencing ladders
Sequencing ladder reactions were performed and used to identify the location of the 
modifications on the KSHV 1RES RNA. In this experiment, 4 eppendorf tubes were 
used representing 4 individual nucleotides (A, G, C and T) and based on Table 5.6. 
Firstly, 2 pi of KSHV 1RES RNA was used as a template and 1 pi of 32-P labelled 
primer was used in each reaction followed by 1 pi of H2O. The mixture was incubated 
for 1 min at 90 °C followed by 1 min at 4 °C and 5 mins at 20 °C. Subsequently, 1 pi of 
5X AMV buffer was added into each tube before further incubation at 20 °C for 10 
mins. A volume of 2 pi of 5X AMV buffer was then added into the mixture. A 
nucleotide mix with lower concentration of respective nucleotide (Table 5.7) was added 
into each individual tube (e.g. A10 representing low concentration of dATP compared to 
other nucleotides). A chain-termination nucleotide was then added into the respective 
individual tube. The reaction mixture was then added with H2 O and AMV reverse 
transcriptase enzyme. The mixture was then incubated for 30 mins at 37 °C.
16 1
A G C T
RNA (IpM) 2 2 2 2
32-P primer 1 1 1 1
H20 1 1 1 1
5X AMV buffer 1 1 1 1
5X AMV buffer 2 2 2 2
A10 (10 mM) 1.5 - - -
GlO(lOmM) - 1.5 - -
CIO (10 mM) - - 1.5 -
TlO(lOmM) - - - 1.5
ddATP (50 (iM) 0.5 - - -
ddGTP (50 |iM) - 0.5 - -
ddCTP (50 pM) - - 0.5 -
ddTTP (50 pM) - - - 0.5
H20 4.5 4.5 4.5 4.5
AMV RT enzyme 
(lOU/pl)
2 2 2 2
Total 15.5 15.5 15.5 15.5
Table 5.6: Reaction mixture of sequencing ladder process of unmodified KSHV 
1RES RNA.
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The reactions were stopped by adding 20 pi of 0.3 M sodium acetate and 100 pi of 
100% ethanol. The reaction was mixed and incubated on dry-ice for 20 mins. The 
reaction was then centrifuged at 13000 rpm for 20 mins before the supernatant was 
removed. A volume of 200 pi of 80% ethanol was added. The mixture was centrifuged 
for 5 mins at 13000 rpm and the supernatant was removed and the eppendorf tube was 
dried in dessicator for 15 mins. The pellet was resuspended in 8  pi of mixture of 
Formamide and Xylene Cyanol.
dATP 
(10 mM)
dCTP 
(10 mM)
dGTP 
(10 mM)
dTTP 
(10 mM)
A10 2.5 pi 1 0  pi 1 0  pi 1 0  pi
CIO 1 0  pi 2.5 pi 1 0  pi 1 0  pi
G 1 0 1 0  pi 1 0  pi 2.5 pi 1 0  pi
T10 1 0  pi 1 0  pi 1 0  pi 2.5 pi
Table 5.7: Reaction mixture of nucleotide mix. The nucleotide mixture (final volume 
of 1 0 0  pi) was used in the sequencing ladder process.
1 6 3
5.2.7 Sequencing gel
For sequencing gel, 8 % gel was prepared accordingly (Appendix). Once the gel was 
prepared, it was pre-run for 30 mins. Three microlitre of modified RNA from the primer 
extension reaction (Section 5.2.5) and 4 pi of RNA from the sequencing ladders 
(Section 5.2.6) were loaded into the gel. The gel was run for 2 h at 40W, 200 V. Once it 
was completed, the gel was transferred onto a 3MM paper and dried in gel drier at 70 °C 
for 80 mins. The dried gel was transferred into a cassette and the BioRad Image screen 
was placed onto the gel and expose overnight or as necessary.
5.2.8 Results interpretation
The exposed gel was scanned by using image analyser (BioRad) and the Quantity One 
programme was used for the analysis. To interpret the results on the scanned gel, several 
parameters have to be taken into consideration. One of them is the modification of the 
RNA by CMCT. The chemical reacts by modifying two sites responsible for hydrogen 
bonding in the single stranded RNA on the N3 of Uridine and N1 of Guanine (Tijerina 
et al., 2007). The modifications of DMS by méthylation occur on the single-stranded N1 
adenosine and N3 cytosine (Fritz et al., 2002). Since the modification of either, the 
CMCT and DMS prevent the addition of nucleotides at the modification sites; the 
modified nucleotide is therefore the band observed before the primer extension stop. For 
the RNAse VI, the enzyme modifies the RNA by specifically cleaving nucleotides 
revealing double-stranded RNA structure (Brunei and Romby, 2000). All the nucleotides 
modification on the gel was then compared with the sequencing ladders. The ladder acts
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as a track for the modified RNA bands. The single-stranded bases on the RNA were 
determined first followed by the double-stranded bases.
Once the all the modified RNA has been determined, the data was transferred into M- 
fold programme (Zuker, 2003). The single-stranded bases data was first inserted into the 
programme constraints list in the form of P n 0 x where n is the first of that run of 
single-stranded bases, x is the number of single-stranded bases in the run (e.g P 32 0 2). 
For the double-stranded bases, the data was inserted in the form of F n 0 x where n and 
x are the similar parameters as the single-stranded form.
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RESULTS
5.3 KSHV 1RES secondary structure prediction analysis
In order to determine the secondary structure of the KSHV 1RES 252 fragment, a 
combination of chemical and enzymatic probing was employed to identify the unpaired 
and paired bases of RNA as described previously (Section 5.2.3). The RNA structure 
was modified by different concentration of CMCT, RNAse VI and with increased 
incubation period of DMS. Modified bases were detected by primer extension using 
reverse transcriptase. This enzyme pauses at the site of modification resulting in the 
formation of intense bands one nucleotide below the modified base (Moazed et al., 
1986a; Moazed et ah, 1986b) and by correspondence to the dideoxy sequencing lanes 
the modified bases were precisely identified (Figure 5.1, 5.2 and 5.3). The modified 
nucleotides were then recorded (Table 5.8) and were later transferred for structure 
prediction by Mfold programme.
In the resulting models, the DMS and CMCT hits are in single-stranded regions and 
RNAse VI sites are within helical regions. In this experiment, all the modifications 
detected were taken into account and those constraints were used as an input for the 
Mfold secondary structure free energy minimization software (Zuker, 2003). The model 
proposed by the software has three domains with the first domain having five stem loops 
la to le, flanking an unstructured region and the second and third domain. The second 
and third domains are much smaller compared to the first domain (Figure 5.4).
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In the first domain of the proposed structure, the first stem loop which is la starts at 
nucleotide C l5 and has a modification by DMS in A21 and A22. The second stem loop 
of lb starts at A3 9 which has a single stranded RNA modification of CMT at U45 and 
DMS at A43 and C46. The single stranded stretch of nucleotides was proposed in 
agreement with the modification of CMCT (G57, U58-U59 and U62) and DMS (A56, 
C61 and A64). Right after the stretch of single stranded RNA, stem loop Ic was 
proposed to starts with modification of double stranded RNA by RNAse VI at G65 
pairing with C74. RNAse VI also cleaved C6 6 , U67 pairing with G73 and A72 
respectively. On the same stem loop, modification by CMCT (G67-G68) and DMS 
(A71-A72) was also observed. The proposed model on stem loop Id showed that most of 
the region was modified by CMT and DMS respectively. The last stem loop of domain I 
which is the le also showed by CMCT (U124, U131, U133 and U135) and DMS (A125- 
A126, C126 and A128.
The unstructured region between domain I and II showed modification by CMCT and 
DMS from nucleotide U173 to G190 with the exception of a few unmodified 
nucleotides. Domain II contains a polypyrimidine tract on half of its domain from U203 
to C219. A modification by RNAse VI was showed on A 200 to A202, CMCT on U203 
to U205 and with one modification of DMS on C207 respectively. On domain III, most 
of the modification by CMCT was observed on the loop of the domain and with some 
RNAse VI modification on the stem of the domain (Figure 5.4).
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Figure 5.1: Chemical and enzyme modification of KSHV 1RES RNA. The KSHV 
1RES RNA was modified with CMCT, DMS and RNAse VI to discriminate between the 
weak and strong modifications. The RNA was reversed transcribed by using Revl 
primer and the products were separated on sequencing gel. Increased modifications are 
detected with increased concentrations (CMCT and RNase VI) and time (DMS). Lists of 
the modification are summarized on Table 5. 8  and secondary structure prediction in 
Figure 5.4.
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Figure 5.2: Chemical and enzyme modification of KSHV 1RES RNA. The KSHV 
1RES RNA was modified with CMCT, DMS and RNAse VI to discriminate between the 
weak and strong modifications. The RNA was reversed transcribed by using Rev2 
primer and the products were separated on sequencing gel. Increased modifications are 
detected with increased concentrations (CMCT and RNase VI) and time (DMS). Lists of 
the modification are summarized on Table 5. 8  and secondary structure prediction in 
Figure 5.4.
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Figure 5.3: Chemical and enzyme modification of KSHV 1RES RNA. The KSHV 
1RES RNA was modified with CMCT, DMS and RNAse VI to discriminate between the 
weak and strong modifications. The RNA was reversed transcribed by using Rev4 
primer and the products were separated on sequencing gel. Increased modifications are 
detected with increased concentrations (CMCT and RNase VI) and time (DMS). Lists 
of the modification are summarized on Table 5. 8  and secondary structure prediction in 
Figure 5.4.
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N u c l e o t i d e s C M C T D M S V ,
A 2 1 •
A 2 2 e
A 3 7 •
A 4 3 •
U 4 5 •
C 4 6 •
A 5 6 •
G 5 7 •
U 5 8 •
U 5 9 •
C 6 i •
U ô 2 •
A ô 4 •
G ô 5 #
C ô 6 #
U ô 7 •
G ôb •
G ô 9 •
A 7 1 •
A 7 2 •
C 7 4 •
U 7 6 •
A 7 7 #
U 7 8 •
U 7 9 •
G s o •
G s s •
C s 6 •
G s 7 •
U s 9 •
U 9 1 •
U 9 2 •
U 9 3 •
U 9 7 •
U 98 •
U 1 0 0 •
A 1 0 1 #
A 103 •
G ]  09 •
A i  10 •
U 1 1 2 •
G |14 •
G ]  19 •
A 1 2 0 •
U 121 •
C 1 2 2 •
U 1 2 4 •
A 1 2 5 •
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A i26 •
C ]  27 •
A ]28 •
U b i •
U 1 3 3 •
U ]35 •
G i s i •
C l52 •
A 162 •
U 1 7 3 •
U 1 7 4 •
A i78 •
U 1 7 9 •
U i80 •
U i s i •
U i82 •
U i84 •
U i85 •
U i8 6 •
G i8 8 •
G l89 •
G 190 •
A .200 •
A 2 0 1 •
A 2 0 2 •
U 2 0 3 •
U 2 0 4 •
U 2 0 5 •
C 2 0 7 •
C 218 •
C 2 1 9 •
U 2 3 2 •
C 2 3 5 •
U 2 3 7 •
U 2 3 9 •
A .240 •
C 2 4 I •
C 2 4 5 •
G 2 4 8 •
C 2 4 9 •
A 2 5 0 •
Table 5.8: Summarized of nucleotide modification by chemical and enzyme.
Modified KSHV 1RES RNA by CMT, DMS and RNAse VI from Figure 5.1, 5.2 and 
5.3 were determined and summarized into table form. The information was later used for 
Mfold program and presented in Figure 5.4
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Figure 5.4: Secondary structure prediction of modified KSHV 1RES RNA.
Chemical and enzyme modifications of the RNA secondary structure of KSHV 1RES. In 
vitro transcribed RNA was chemically and enzymatically modified and reversely 
transcribed. The RT products were then separated on 8% polyacrylamide sequencing gel 
and a sequencing reaction performed with the same primer used for the RT reaction was 
run in parallel to precisely determine the modification sites. Black, line and orange 
arrows indicate CMCT, DMS and RNase VI modification sites respectively. Positions 
of RNA cleavage were mapped onto the most energetically favoured RNA structure that 
was predicted by Mfold (dG = 50.96).
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5.4 DISCUSSION
1RES activity is highly dependent on RNA structure and the properties of some viral 
1RES rely on the integrity of their tertiary folding (Kief, 2008). In order to achieve 
correct RNA-protein recognition, two factors often have to be conserved which are 
nucleotide sequence integrity and correct RNA secondary structure. Indeed, with regard 
to the secondary structure, protein binding may also be needed to promote its correct 
folding. It has been reported that binding of PTB to the EMCV 5' UTR is essential for 
1RES activity only when there is a necessity to stabilize the native secondary structure 
(Kaminski and Jackson, 1998). However, it is not clear whether the 1RES and ITAFs 
need a sequence motif or a RNA secondary structure/sequence motif combination to 
bind to IRES-containing mRNAs.
In this analysis, we experimentally investigated the structure of the KSHV 1RES 
secondary structure based on chemical and enzyme modification. Up to date, no finding 
on the secondary structure of KSHV 1RES has been reported apart from prediction of 
233 nt of KSHV 1RES by Bieleski et al (2001). However, the data from Bieleski et al 
only discussed the proposed structure without any structure modification analysis. 
Furthermore, the sequence of the KSHV 1RES RNA used was different from with the 
one presented here. In their analysis, the proposed secondary structure of 233 nt consists 
of two domains, separated by a short non-base paired region of polypyrimidine rich 
sequence.
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In the secondary structure prediction, the KSHV 1RES RNA structure was modified and 
determined by probing RNA using CMCT, DMS and RNAse VI (Section 5.2.3.1,
S.2.3.2 and 5.2.3.3), CMCT and DMS were used to detect accessible RNA functional 
groups consisting of single stranded regions, while RNAse VI revealed stacked or 
paired nucleotides. CMCT and DMS specifically modify unpaired uracil and guanine or 
adenine and cytosine respectively. RNAse VI gives complementary information since it 
specifically cleaves stacked nucleotides revealing most double stranded regions (Brunei 
and Romby, 2000). Modifications were mapped by reverse transcription using 32P- 
labeled primers. For each run, the reverse transcription pattern of the modified RNA was 
compared to the profile obtained with a non-modified RNA. From 5 primers used, only 
3 were able to generate reverse transcription (Revl, Rev2 and Rev4), while no primer 
extension results obtained from Rev2 and Rev5 primers. The problem may be due to the 
degradation of the sequence within the reverse transcription area which is rich in adenine 
and uridine, and often involves in mRNA decay process (Shaw and Kamen, 1986).
Conducting these processes in parallel, we obtained an extensive map of nucleotide 
accessibility that was used as constraints for Mfold (Table 5.8). In the resulting model, 
the CMCT and DMS hit the single stranded regions. The majority of the RNAse VI sites 
are within helical regions, but some of them in single-stranded region could reflect a yet 
unidentified pairing, or nucleotide stacking (nucleotide at a base of a helix, or within a 
structural loop for example). Only modifications that produced strong signals were used 
as constraints. Although some of the unmodified RNA sequencing results were poor 
(Figure 5.2 and 5.3), the determination of nucleotide modifications were made by
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determining the location of specific nucleotides within the sequence of the KSHV 1RES 
252 fragment.
In viral 1RES, RNA secondary structure has been shown to be crucial for 1RES function 
(Kief et ah, 1999). It has been shown that, domain III and subdomain Hid: of the HCV 
like 1RES are important for 1RES activity and mediates translation initiation by 
recruiting 40S subunit and eIF3 (Kieft et ah, 2001a). These structures are also 
conserved in other viruses that do not share primary sequence similarity. For example, 
the HCV 1RES structure is similar to Classical Swine Fever Virus (CSFV) and Seneca 
Valley Virus (SW ), which highlight important structure function relationship in viral 
IRESes (Brown et ah, 1992 and Willcocks et ah, 2011). Similarly, the structure of 
EMCV 1RES is also shared among other cardio-picomavirus and key domains are 
required to coordinate eIF4G and eIF4A recruitment (Filipenko et ah, 1989). Apart from 
viral 1RES structure similarity studies, the secondary structure of the cellular IRESes 
were also studied such as c-Myc (Le Quesne et ah, 2001), L-Myc (Jopling et ah, 2004), 
and Apaf-1 (Mitchel et ah, 2003) to name a few. Upon determination by using chemical 
and enzymatic probing, no similarities among the cellular 1RES were determined (Baird 
et ah, 2007).
We have derived a secondary structure prediction for the KSHV 1RES (Figure 5.4). The 
proposed KSHV 1RES RNA secondary structure revealed 3 domains, a highly structured 
domain I having five loops, domain II and domain III, with one loop each. We suspected 
that the highly structured domain I might have a functional role with the binding of
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ITAF and an additional domain might functions in translation initiation as the 3' end of 
the KSHV 1RES fragment is similar among other KSHV 1RES constructs (363, 658 and 
856). A polypyrimidine sequence on domain II (nt 203 to nt 219 in Figure 5.4) forming 
a loop was also recognized from the secondary structure prediction analysis. 
Polypyrimidine tract binding protein (PTB) is known to function as an ITAF in EMCV 
(Kafasla et al., 2009) and XIAP IRESs (Holcik et al., 1999). In EMCV 1RES, 
interactions with PTB has been shown to stabilize the three-dimensional fold of the 
1RES. Furthermore, the unique binding of PTB to the EMCV 1RES can stimulate the 
1RES activity (Kafasla et al., 2009). This polypyrimidine tract has also shown previously 
to be important for XIAP 1RES activity, as deletion or mutation of these sequences 
abrogates the activity of the 1RES (Holcik et al., 1999). Other reports have shown that 
PTB also plays an important role in other 1RES activities. The protein stimulates PV 
1RES activity in vitro (Hunt and Jackson, 1999) and HCV and HAV activities in vivo 
(Corset et al., 2000).
We have looked into other herpesvirus 1RES in term of secondary structure analysis. 
Out of several known herpesvirus 1RES, only secondary structure model of Epstein Barr 
virus (EBV) has been reported (Isaksson et al., 2003). However, only predicted structure 
without any chemical or enzymatic modification was presented in the analysis and 
showed no similarity at all in term of structure against the KSHV 1RES. The EBV 1RES 
posses a Y-shaped complex of secondary structure by using Mfold (Isaksson et al., 
2003) which contains five domains (A-E) compared to KSHV 1RES which only has 
three domains. As mentioned earlier, only secondary structure of EBV 1RES has been
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reported whilst there are no reports from any other herpesvirus family 1RES. It is 
possible that structure modification of other herpesvirus 1RES by using chemical and 
enzyme will shed some light on the secondary structure of the 1RES in the herpesvirus 
family.
Regarding the relationship between the secondary structure elements and canonical 
initiation factors, it has been reported that Histone H4 mediates cap-assisted translation 
initiation in a very unique way (Martin et al., 2011). Histone H4 mRNA contains two 
unique structural elements that are important for a successful translation initiation 
process: a structure resembling the eIF4E-sensitive element (4E-SE) and a three-way 
helix junction. The 4E-SE was first discovered in the 3' UTR of cyclin D1 mRNA 
(Culjkovic et al., 2006). The 4E-SE from cyclin D1 is involved in the nucleocytoplasmic 
transport of the eIF4E-bound mRNA (Rousseau et al., 1996). This structure folds and 
binds eIF4E without the need of the cap while tethering the 43 S particles and is loaded 
directly in the vicinity of the AUG (Martin et al., 2011). The three-way helix junction 
structure is located 19 ribonucleotides downstream of the AUG that anchors the m7G 
cap. This structure facilitates direct positioning of the ribosome on the related start 
codon. These two translation initiation modes are considered as a hybrid mechanism 
between the canonical and the IRES-driven translation initiation process (Martin et al., 
2011). Since there is similarity between vCyclin and cyclin D l, it is quite interesting to 
determine the 4E-SE structure on the KSHV 1RES as the KSHV 1RES is located within 
the vCyclin ORF. Upon determination of the 4E-SE site, the requirement and interaction 
of eIF4E by KSHV 1RES can be further ascertained.
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We were interested in identifying novel 1RES that are structurally similar to the KSHV 
1RES, since structure similarity would suggest an important role for secondary structure 
of 1RES. Moreover, 1RES that share a similar secondary structure may also be regulated 
or function in the same manner in terms of RNA binding and translation initiation. A 
program called RSEARCH (Klein and Eddy, 2003) can be used to search a database 
with a sequence that has a known secondary structure. The program relies solely on the 
structure similarity and not sequence homology. It was used to study the structure 
similarity by using a well-studied HCV 1RES structure as a reference and showed a 
match of GB virus B (GBVB), CSFV and bovine viral diarrhea (BVDV) 5' UTR, all of 
which are known to have similar structures to the HCV 1RES (Brown et al., 1992; Grace 
et al., 1999) and not in the similarity of the primary sequence of the HCV 1RES as 
shown by BLAST when compared with CSFV and BVDV (Baird et al., 2007).
In conclusion, we have demonstrated for the first time, the predicted secondary structure 
of KSHV 1RES by using chemical and enzymatic modifications. Although the secondary 
structure of the KSHV 1RES has been determined, little is known in term of the 
properties and function of each domain. Furthermore, data obtained by RNAse VI 
modification is insufficient and needs to be investigated further by manipulating and 
optimizing the parameters used in the experiments. Phylogenetic information can also be 
used to determine the conservation of nucleotides within viral isolates, which should 
reflect the conservation of the RNA structure. To further ascertain the role and 
importance of KSHV 1RES secondary structure, a structure-function studies should be
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undertaken by mutational analysis where specific deletion of 1RES domains or 
subdomains (loops, stems) might result in a loss of translational activity.
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Chapter 6 
General discussion
Eukaryotic translation initiation is a complicated and stepwise process dependent on a 
modified structure (cap) on the 5' end of the mRNA and a group of initiation factor 
proteins (elFs) that function to assemble the 40S ribosomal subunit on the 5' end of the 
mRNA and the subsequent scanning downstream to locate the initiation codon (reviewed 
by Mathews et ah, 2007). Internal initiation of translation is a cap-independent 
mechanism of translation and requires RNA structured elements in the mRNA 5' UTR 
that are known as an internal ribosome entry site (1RES) element. 1RES elements, which 
have been found in a wide range of mRNAs, are highly structured and function in cis 
and trans to recruit the 40S ribosomal subunit (Roberts and Groppelli, 2009), in the 
presence of only a subset of initiation factors. Some viral 1RES elements are able to 
direct internal initiation in a simple manner, for instance the 1RES elements of the 
flavivirus family such as HCV, have a short length (-300 nt) and can directly recruit the 
40S subunit in the presence of only eIF2 and eIF3 (Pestova et al., 1998). The simplest 
mechanism of initiation has been identified in cricket paralysis virus (CrPV) mRNA. A 
short (-200 nt) 1RES element has been discovered in the intergenic region (IGR) of its 
genome; this is able to bind to the ribosome and initiate translation without requiring 
tRNA or any of the initiation factors (Kanamori and Nakashima, 2001; Jan and Samow, 
2002).
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The aim of this study is to identify and characterize the Kaposi’s sarcoma associated 
herpesvirus (KSHV) 1RES element. The KSHV 1RES element has previously been 
identified within the latently expressed KSHV vCyclin gene (Bieleski and Talbot, 2001; 
Grundhoff and Ganem, 2001; Low et ah, 2001). It is unusual to find an 1RES directing 
the translation of an ORF within the coding sequence of an mRNA, although 1RES 
activity has been reported recently within the ORF of the HIV-2 gag (Locker et ah, 
2011). Latently expressed KSHV genes (LANA, vCyclin and vFLIP) are transcribed 
from a common transcription start site in cell lines latently infected with KSHV (Dittmer 
et ah, 1998; Talbot et ah, 1999). Transcripts encoding LANA, vCyclin, vFLIP and a 
bicistronic transcript encoding vCyclin and vFLIP were detected with no mRNA for 
vFLIP alone. The 1RES within the vCyclin sequence was hypothesised to be responsible 
for the expression of vFLIP since a monocistronic transcript coding for vFLIP alone has 
never been detected (Talbot et ah, 1999). Most IRESes examined in RNA viruses are 
located within the 5’ UTR of mRNAs. The KSHV 1RES was the first such element to be 
identified in a DNA virus and may represent a novel mechanism through which this 
virus controls gene expression. Although the minimal size of the 1RES in the coding 
region of the vFLIP 1RES has been identified (Bieleski and Talbot, 2001; Grundhoff and 
Ganem, 2001; Low et ah, 2001), the canonical and non-canonical initiation factors 
required for the 1RES to function had yet to be determined, apart, from the postulated 
role for polypyrimidine tract binding protein (PTB, hnRNPl) as suggested by Bieleski et 
at (2004). This ITAF binds to the KSHV 1RES and the interaction of PTB has been 
reported to contribute to the correct functioning of the KSHV 1RES in infected cells 
(Bieleski et ah, 2004). However, based on Bieleski et al findings, the ITAF mentioned
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above is only detected on a minimal 1RES sequence of 233 nt (Bieleski and Talbot, 
2001) which contradicts the minimal KSHV 1RES sequence we found. Furthermore, 
both fragments do not share any sequence similarities.
We failed to detect any KSHV 1RES activity in cell culture using HEK 293 and SLK 
cell lines as shown by Bieleski and Talbot (2001), although Grundhoff and Ganem 
(2001) did show activity in these cells. The differences in KSHV 1RES activity seen by 
different groups might be due to the different type of promoter used in the plasmids. The 
T7 RNA polymerase promoter-based vector used in our construct and in studies by 
Bieleski, expressed T7 RNA polymerase which allows cytoplasmic transcription of the 
mRNAs. However, Grundhoff and Ganem employed a cytomegalovirus (CMV) 
promoter based vector where the transcripts were made in the nucleus (Stoneley et al., 
1998). As been proposed in cellular IRESes, the discrepancy in transcription of plasmid 
DNAs between the nucleus and cytoplasm of cells is that IRES-containing cellular 
mRNAs require a ‘nuclear experience’ (Holcik et al., 2003; Stoneley et al., 2000; Semler 
et al., 2008). For example, the c-myc 1RES within a bicistronic mRNA only functions 
when the construct was introduced directly into the cytoplasm compartment (Stoneley et 
al., 2000).
We only managed to observe significant KSHV 1RES activity from capped mRNA 
transcripts in the Flexi® RRL system as discussed in Chapter 3. The KSHV 1RES 
function in vitro was also shown by Low et al, (2001). To further confirm that the 
vCyclin ORF contains an 1RES, a stable stem loop was introduced upstream of the 1RES 
sequence. The introduction of stem loop structure should rule out any other
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noncanonical translation mechanism such as reinitiation (Low et ah, 2001). As for 
introduction of a stem loop upstream of the KSHV 1RES, the LUC downstream cistron 
was still expressed showing that the fragment does function as an 1RES.
For the identification of minimal KSHV 1RES fragments, putative KSHV 1RES 
fragments of 233, 252, 356, 653 and 856 nt based on those in Bieleski and Talbot (2001) 
were inserted into the intercistronic region of the dicistronic reporter vector pGEM- 
CAT/LUC (van der Velden et ah, 1995). Comparison of the minimal sequence between 
our KSHV 1RES with the studies from Bieleski and Talbot (2001) showed that a 
fragment of 252 nt is required for the 1RES to function, not the minimal 233 fragment as 
suggested by them (Chapter 3). In addition, the 233 nt and 252 nt fragments do not 
contain any overlapping sequence. Although this fragment showed 1RES activity 
(Bieleski and Talbot, 2001) in vivo, the secondary structure adopted in vitro may differ 
from that generated in vivo and may influence the accessibility of the ribosome to the 
1RES. Furthermore, it has also been shown that the individual fragments of the KSHV 
1RES did not all behave identically (relative to one another) in the two assays when 
comparing DNA-based transfection to RNA-based transfection (Grundhof and Ganem, 
2001). Further testing could be performed by assessing the activity of all KSHV 1RES 
fragments in BCP-1 cells instead of SLK cells and a bicistronic vector containing CMV- 
based promoter.
We then further studied the requirement for canonical and non-canonical initiation 
factors required for KSHV 1RES function. As predicted, the KSHV 1RES showed a 
different and new perspective in term of czs-acting and trans-dLCtmg factor requirements
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(Chapter 4). Based on the results obtained, it was shown that the KSHV 1RES requires 
the eIF4F complex for it to function efficiently, although this requirement is very 
unusual for viral 1RES elements. Similar characteristics have also been shown for the 
HAY 1RES (Ali et al., 2001) and the 'L-myc 1RES (Spriggs et al., 2009) where the 
requirements for initiation factors for these IRESes were remarkably similar to those for 
initiation of translation of capped mRNAs by the scanning ribosome mechanism. We 
found that inhibition of eIF4A by Hippuristanol (Section 4.8) totally blocked KSHV 
1RES function, suggesting that the eIF4A helicase activity is required for the KSHV 
1RES to function. This could reflect that the KHSV 1RES has a strong secondary 
structure. The requirement on eIF4A was also reported for the L-myc 1RES as the 
activity of the 'L-myc 1RES was inhibited with the addition of Hippuristanol (Spriggs et 
al., 2009). Requirement for eIF4E by the KSHV 1RES was also analysed by using cap 
analogue (Section 4.9). The analysis showed that the cap binding protein eIF4E is 
required for KSHV 1RES activity. This inhibitor was also used in HAV 1RES studies 
(Ali et al., 2001) and showed that the HAV 1RES activity was similarly affected. For the 
L-myc 1RES, a knockdown of eIF4E by siRNA reduced the eIF4E level in cells, thus 
inhibiting the L-myc 1RES activity (Spriggs et al., 2009). We also showed that the 
scaffolding protein eIF4G was required by the KSHV 1RES, as L-protease cleavage on 
eIF4G significantly impaired the activity of the KSHV 1RES (Section 4.10). Another 
inhibitor, 4E2RCat, which inhibits the eIF4E:eIF4G interaction was also tested. The 
KSHV 1RES activity decreased significantly, similar to L-protease. The used of L- 
protease was also shown in the HAV 1RES requirement for eIF4G (Ali et al., 2001), and 
resulted in inhibition of HAV 1RES activity. In addition, IRES-dependent activity of L-
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myc required eIF4G, as knockdown of eIF4G by RNAi in cells resulted in inhibition of 
the L-myc 1RES (Spriggs et ak, 2009).
Based on the results above, we set out to determine the binding activity of eIF4A, eIF4E 
and eIF4G on the KSHV 1RES using a bead binding assay approach (Section 4.11). This 
approach was used to determine if the elFs bind directly to the KSHV 1RES or to the cap 
structure at the 5' end, and, are then transferred to the KSHV 1RES. The main objective 
of this approach is to get a clear picture of eIF4F binding on the KSHV 1RES, especially 
eIF4E, as it is uncommon for an 1RES to require eIF4E. From the results, we showed 
that eIF4E, eIF4A and eIF4G bind directly to the KSHV 1RES which is different 
compared to the previously characterized viral 1RES groups, but is reminiscent to HAV 
1RES (Section 1.8.4.1).
Besides canonical translation factors, cellular proteins, known as 1RES trans acting 
factors can also modulate 1RES activity. ITAFs are proposed to function as RNA 
chaperones, regulating the direct binding of the 40S ribosomal subunit through 
modification of RNA secondary and/or tertiary structure. In addition, ITAFs can mimic 
the function of canonical, cap dependent initiation factors by acting as a protein adaptor 
which facilitates RNA ribosome interaction (Graber and Holcik, 2007). Therefore, to 
understand 1RES function, the identification of potential ITAFs and their binding site on 
the 1RES is required. Most of the ITAFs found to be involved in cellular 1RES function 
shuttle between the nucleus and cytoplasm, such as hnRNPAl, an ITAF that represses 
XIAP 1RES activity during osmotic shock (Lewis et al., 2007). As mentioned earlier, 
this protein shuttles from the nucleus, effectively increasing the repression of the XIAP
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IRES via a localized increase in ITAF concentration in the cytoplasm (Lewis et al., 
2007).
Analysis by bead binding assay, followed by mass spectrometry, allowed us to identify 
ITAFs that potentially interact with the KSHV 1RES (Chapter 4). Out of five detected 
KSHV IRES-binding proteins, four of them are known to function as ITAFs in cellular 
1RES activity (YB-1, hnRNP K, hnRNP C1/C2 and PCBP1) and are associated with 
either apoptosis or cell cycle regulation. We also detected strong interaction between 
YB-1 and the KSHV 1RES by Western blot (Figure 4.11), suggesting that YB-1 might 
play a role in KSHV 1RES function. YB-1 binds directly to RNA and regulates gene 
expression in the translation process (Matsumoto et al., 1998; Sommerville, 1999). YB-1 
also functions in stabilizing mRNA as depletion of YB-1 resulted in acceleration of 
mRNA decay (Evdokimova et al., 2001). Besides YB-1, two other identified ITAFs, 
hnRNP K and hnRNP C1/C2 belonging to the hnRNPs group bind to transcripts and 
forms ribonucleoprotein complexes. The functions of hnRNPs include pre-mRNA 
processing as well as mRNA export, localization, stability, and translation (Dreyfuss et 
al., 2002). The hnRNPs group also shuttle between the nucleus and the cytoplasm 
(Komar and Hatzoglou, 2005; Lewis and Holcik, 2008; Spriggs et al., 2005). It was 
reported that hnRNP K acts as an eIF4E regulating factor (4ERF) which regulates eIF4E 
expression in cells, especially in malignancy (Lynch et al., 2005). A knockdown 
experiment by using siRNA on hnRNP K showed that the level of eIF4E was affected. 
The interactions between hnRNP K and eIF4E might also responsible in KSHV 1RES 
regulation as the KSHV 1RES requires eIF4E and interacts with hnRNP K. As for 
hnRNP C1/C2, it was reported that the protein acts as an ITAF for the UNR 1RES
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(Schepens et al., 2007). RNAi knockdown of hnRNP C1/C2 abrogates and retards 
mitosis during G2/M phase of the cell cycle, as the UNR 1RES activity is decreased. 
Interaction between the KSHV 1RES and hnRNP C1/C2 might occur during the cell 
cycle as vFLIP functions in an anti apoptotic mechanism.
Based on the c/s-acting and fnms-acting factor requirements of the KSHV 1RES, there is 
no doubt that all the necessary requirements might have something to do with the 
secondary structure of the KSHV 1RES. This prompted us to analyse the secondary 
structure of the KSHV 1RES (Chapter 5) and look for any similarity with other IRESes. 
To date, KSHV 1RES secondary structure has not been determined, either chemically or 
enzymatically. Based on the modifications performed and prediction by Mfold (Section 
5.4), KSHV 1RES contains three domains with a highly structured domain I. Similar to 
several viral IRESes (HCV, HAV and PV), the KSHV 1RES also contains a 
polypyrimidine tract sequence in domain II (Figure 5.4). The polypyrimidine tract acts 
as an ITAF in these viral 1RES activities (Hunt and Jackson, 1999; Corset et al., 2000). 
ITAFs are thought to function in stabilizing specific 1RES RNA conformations that 
enables binding of other factors or ribosomes to the IRESes. This hypothesis is also 
known as the ‘chaperone model’, as ITAFs like PTB and ITAF45 bind to the FMDV 
1RES and induce structural changes in the 1RES, and synergistically enhance eIF4G and 
eIF4A binding (Filipenko et al., 2000; Song et al., 2005). This is just a proposed model 
and not all ITAF-1RES interactions follow the idea as in some cases, ITAFs could 
interact directly with the ribosome or other factors. A review by Filbin and Kieft (2009) 
further showed an inverse correlation between the folded structure in the unbound 1RES
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RNA with the need for ITAFs and elFs when biophysical characteristics of the crPV 
IGR, HCV, and FMDV 1RES RNAs are compared.
To date, much work has been done to establish the secondary structures of all types of 
1RES elements, the initiation factor requirements and their binding sites. However, a true 
understanding of the mechanism of 1RES action relies on the elucidation of the intimate 
interactions between the 1RES RNA and the protein/ribonucleoprotein factors. Structural 
studies (i.e. X-ray crystallography, NMR, cryo-electronmicroscopy, hydroxyl radical 
probing, mass spectrometry of complexes) of individual elFs and ITAFs, their binding 
domains and elF/ITAF-RNA complexes are extremely helpful in the explanation of 
IRES-mediated translation initiation mechanisms (Deo et al., 1999; Petoukhov et al., 
2006; Vital! et al., 2006; reviewed in Pestova et al., 2007). In the case of PSIV IGR 
1RES element, the crystal structure of the ribosome-binding region of the 1RES has been 
solved by X-ray crystallography (Pfingsten et al., 2006). This approach revealed how the 
RNA molecule creates a ribosome-binding site and the 1RES structural features that are 
involved in interactions with the ribosome.
Little is known about the KSHV 1RES let alone the mechanism of how the 1RES 
regulates vFLIP expression. Requirement for canonical initiation factors by the KSHV 
1RES resembles those of the cap-dependent mechanism. The KSHV 1RES also requires 
non-canonical initiation factors for function, but the exact role and binding site of the 
ITAFs with the KSHV 1RES are yet to be determined. Furthermore, vCyclin is derived 
from cellular genes. The KSHV 1RES lies in a naturally bicistronic context in the KSHV 
genome. vFLIP expression has been linked with the 1RES within the vCyclin gene
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(Bieleski and Talbot, 2001), and transcription of 1.7 kb bicistronic message encoding 
vCyclin and vFLIP has been reported, but not the monocistronic transcript of vFLIP. 
The mRNA transcript properties of vCyclin probably show that the 1RES within vCylin 
require canonical pathway located upstream from the 1RES for vFLIP transcription and 
translation processes. Therefore the capped bicistronic reporter system assay reflects 
exactly the natural context of vFLIP translation and could explain why the 1RES is only 
active in this context. Since it was postulated that vFLIP translation was mediated by the 
1RES located in vCyclin ORF, any changes in the 1RES might affect vFLIP function and 
thus affect its anti-apoptotic properties. Interaction between vFLIP and NF-kB has been 
shown to be associated with lymphoproliferative disorder in PEL cell lines (Keller et al. 
2000; Liu et al. 2002; Field et al. 2003) and has been a subject of study for the 
therapeutic approach for the treatment of KSHV lymphomas by targeting the vFLIP and 
NF-kB pathway. Any targeted approach on the KSHV 1RES might open a new 
dimension for KSHV lymphoma treatment.
Further work needs to be carried out to shed some light on the KSHV 1RES properties, 
especially secondary structure analysis by using selective hydroxyl acétylation primer 
extension (SHAPE), apart from optimization of chemical and enzyme modifications. In 
addition, mutational analysis should be performed by removing individual KSHV 1RES 
domains in order to identify domains that are critical for 1RES activity. Subsequently, 
the bead binding assay could be performed to determine whether these domains are 
involved with the binding to elFs and ITAFs. Furthermore, in my supervisor’s 
laboratory, the KSHV fragments have recently been cloned into a pRF plasmid
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containing a CMV-based promoter for the KSHV 1RES activity analysis in SLK cells 
and the system is functioning well. The successful demonstration of KSHV 1RES 
activity using a pRF plasmid as a vector has been reported by Grundhoff and Ganem, 
(2001). Mutational analysis of KSHV 1RES can also be performed as above in SLK cells 
and together this will provide a useful dataset on the KSHV 1RES properties in vitro and 
in vivo. To confirm my data using translation inhibitors in the RRL system, these 
inhibitors should also be used to assess 1RES activity in cells. Alternatively, the KSHV 
1RES activity could be examined in the monocistronic reporter.
Here, we presented a study on the initiation factor requirements of the KSHV 1RES 
along with the predicted secondary structure. Based on the findings, we can conclude 
that the KSHV 1RES is unlike other 1RES groups, including HCV and the CrPV IGR 
1RES. In terms of canonical initiation factor requirements, similarity has been shown 
with the HAV 1RES and 'L-myc 1RES. The KSHV 1RES interacts with a number of 
ITAFs; however the mechanism and role of these interactions is yet to be determined. 
As it stands, the KSHV 1RES does not belong to any viral IRESes type and is a novel 
viral 1RES element.
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Appendix
Solutions
General Solutions 
TAE Buffer (50X): 1 Litre
242 g Tris
57 ml glacial acetic acid 
100ml 0.5M EDTA (pH 8.0)
Made up to 1L with sterile distilled water. 
Sterilise by autoclaving.
TE Buffer: 500ml
5ml IM Tris (pH 7.6)
1ml 0.5M EDTA (ph 8.0)
Sterilise by autoclaving.
Luria-Bertani (LB) broth: 1 Litre
10 g Tryptone 
5 g Yeast extract 
10 g Nad
Adjust pH to 7.5 with 5M NaOH.
Sterilise by autoclaving.
Luria-Bertani (LB) agar: ILitre
To LB broth (above) solution 15g (1.5 %) agar (w/v) (BACTO™ Agar) was added and 
sterilise by autoclaving.
SDS-PAGE Solutions
AX2 buffer (resolving gel buffer): 500ml
0.75 M Tris (pH 8.8)
Or 45.3g Tris made to 500ml with distilled water.
Adjust pH with HCI drops.
BX2 buffer (stacker gel buffer): 500ml
0.25 M Tris (pH 6.8)
Or 15.12g Tris made up to 500mls with distilled water.
Adjust pH with HCL drops.
SDS-PAGE Running buffer
3 g Tris 
14.4 g Glycine 
5 ml 20 % SDS
Made up to 1L with distilled water.
2 3 0
Coomassie stain for protein gels
1.25 g Coomassie brilliant blue 
125 ml Methanol 
50 ml Acetic acid 
325 ml distilled water
Destain
125 ml Methanol 
50 ml Acetic acid 
325 ml distilled water
Western Blot solutions 
Western Blot Transfer Buffer
3 g Tris 
14.4g Glycine
Make up to 800 ml with cold distilled water 
Add 200 ml Methanol 
Keep cool at 4 C before use.
Resolving Gels Stacker Gel
Contents 6.5% 10% 12% 4%
Sterile d.H20 6.2 ml 4.5 ml 3.2 ml 3.7 ml
AX2 10 ml 10 ml 10 ml -
BX2 - - - 5 ml
Acrylamid Bis 
40%
3.2 ml 5 ml 6.3 ml 1 ml
De- aerate gel mixes
10% SDS 200 pi 200 pi 200 pi 100 pi
Ammonium
Persulfate
200 pi 200 pi 200 pi 100 pi
Temed 50 pi 50 pi 50 pi 30 pi
2 3 1
10X TBS-O.l % Tween
24.2 g Tris 
80 g NaCl
Dissolve in 800ml distilled water
pH to 7.6 with cone.HCL
Add 10 ml Tween-20
Make up to litre with distilled water.
Store at 4°C.
Blocking Solutions
5 % w/v Marvel in IX TBS-Tween 
Radioimmunoprecipitation (RIPA) Buffer
10 ml 10% Triton
1 ml 10% SDS
3 ml 5M NaCl
5 ml IM Tris pH 7.5
1 g Sodium deoxycholate
Make up to 100 ml with sterile dHiO.
Store at 4°C.
Buffer A
50 mM Tris-Cl (pH 7.9)
100 mM NaCl
3 mM MgCL
1 mM dithiothreitol
0.2 mM phenylmethylsulfonyl fluoride
Dynabead protein-RNA binding assay Solutions 
SSC (20X): 1 Litre
175.3 g NaCl
88.2 g Sodium citrate 
800 ml dHzO
Dissolve NaCl and Sodium citrate in 800 ml dHzO.
Adjust the pH to 7.0 with a few drops of 5 M NaOH solution. 
Sterilise by autoclaving.
Used 0.5X concentration in Dynabead protein-RNA binding assay.
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Bead-binding buffer (10X)
100 mM KC1 
10 mM Tris, pH 7.5 
2 mM MgCli
Make up the volume with dHaO.
Sterilise by autoclaving.
Used in IX concentration in Dynabead protein-RNA binding assay.
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